,X.2,X.1,...1,X,PG.ProteinGroups,PG.Genes,short.name,GO,sub.cell,description,GO.ID,ConditionNorm_P_0_1,ConditionNorm_P_0_2,ConditionNorm_P_0_3,ConditionNorm_P_50_1,ConditionNorm_P_50_2,ConditionNorm_P_50_3,median,Log2,logFC,AveExpr,t,P.Value,adj.P.Val,B,mass,neglog.adj.P.Val.,TotalPeptidesOverallInGene,P0_Undetected,P50_Undetected,medians_.ConditionNorm_P_0_1_ConditionNorm_P_0_2_ConditionNorm_P_0_3,medians_.ConditionNorm_P_50_1_ConditionNorm_P_50_2_ConditionNorm_P_50_3,Ratio,Ratio_log2
1,1,2,2,2,Q96CX2,KCTD12,KCD12_HUMAN,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260],"SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}.",BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),GO:0003723; GO:0030054; GO:0042734; GO:0042802; GO:0045211; GO:0051260,1E-07,1E-07,3.71722704243115E-05,0.0783711308930924,0.0764905785721226,0.077023621065528,0.077023621065528,-3.698555240484550,0.0772826527534396,0.0386537838001946,143.002064651485,4.60041976538795E-09,1.96897965958604E-05,10.4590984329579,35701,4.70575877028909,11,2,0,1E-07,0.077023621065528,770236.21065528,19.554941423727
2,2,3,3,3,Q9Y4C2,TCAF1,TCAF1_HUMAN,plasma membrane [GO:0005886]; ion channel binding [GO:0044325]; negative regulation of cell migration [GO:0030336]; positive regulation of anion channel activity [GO:1901529]; positive regulation of protein targeting to membrane [GO:0090314],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25559186}. Note=Colocalizes with TRPM8 on the plasma membrane. {ECO:0000269|PubMed:25559186}.,TRPM8 channel-associated factor 1 (TRP channel-associated factor 1),GO:0005886; GO:0030336; GO:0044325; GO:0090314; GO:1901529,0.00027490217046511,0.00046083122285587,0.00101702675008962,0.0986867900723252,0.101420497541532,0.100464207763757,0.100464207763757,-3.315246488796660,0.0996062450780676,0.0503873759201707,124.116469178562,8.45130761792772E-09,2.41143977364871E-05,9.71060060758257,102126,4.61772358022713,15,0,0,0.00046083122285587,0.100464207763757,218.006512538709,7.76822742324922
3,3,6,6,6,P40925,MDH1,MDHC_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; diiodophenylpyruvate reductase activity [GO:0047860]; L-malate dehydrogenase activity [GO:0030060]; malic enzyme activity [GO:0004470]; NAD binding [GO:0051287]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],SUBCELLULAR LOCATION: Cytoplasm.,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)",GO:0004470; GO:0005615; GO:0005739; GO:0005829; GO:0006094; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060; GO:0043209; GO:0047860; GO:0051287; GO:0070062,1E-07,1E-07,2.29184387426119E-05,0.0193586139793967,0.0198131048606987,0.0190499252177329,0.0193586139793967,-5.6908805262444600,0.0193995085396952,0.00970746041609516,90.3644402082357,3.30125210004174E-08,4.70978632939289E-05,8.03267744016226,36426,4.32699879522154,12,2,0,1E-07,0.0193586139793967,193586.139793967,17.5626161379671
4,4,8,8,8,Q14318,FKBP8,FKBP8_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; FK506 binding [GO:0005528]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; chaperone-mediated protein folding [GO:0061077]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16176796}. Mitochondrion membrane {ECO:0000305}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 1: Mitochondrion membrane {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane {ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.",Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase),GO:0001708; GO:0001933; GO:0003755; GO:0005528; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0061077; GO:0097718,0.00103262810879975,0.00041218841173132,0.00038041899589778,0.10480420541408,0.100865505038869,0.105096809952713,0.10480420541408,-3.25423148671133,0.102980428296411,0.0520986259870151,77.2781861814169,6.46119655466517E-08,6.91348031349173E-05,7.20543507127627,44562,4.16030326949501,9,0,0,0.00041218841173132,0.10480420541408,254.262862397974,7.99017694733205
5,5,11,11,11,P08579,SNRPB2,RU2B_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; snRNA stem-loop binding [GO:0035614]; snRNP binding [GO:0070990]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166}.",U2 small nuclear ribonucleoprotein B'' (U2 snRNP B''),GO:0000398; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030619; GO:0035614; GO:0070990; GO:0071005; GO:0071007; GO:0071013,9.22975866994174E-05,0.00034483481617647,0.00019449454533826,0.0155181520015932,0.0158602099349102,0.0151108198005354,0.0155181520015932,-6.0098994271516500,0.0152858515962749,0.00785346811420883,69.0648737814339,1.04653011336321E-07,8.14390706399005E-05,6.61127106880129,25486,4.08916719102728,4,0,0,0.00019449454533826,0.0155181520015932,79.7870807873014,6.31808325746289
6,6,12,12,12,Q9BRJ7,NUDT16L1,TIRR_HUMAN,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28241136}.,Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos),GO:0003723; GO:0005634; GO:0016787; GO:0030515; GO:2001033,0.00277186788625238,0.00307579627901896,0.00366479884692849,0.0354666012728506,0.0368454825287341,0.0353603790586104,0.0354666012728506,-4.8173951048282800,0.0327199999493317,0.0195308209787325,62.1297362655046,1.64801331306533E-07,0.00011755828299866,6.05176430406055,23338,3.92974676565533,7,0,0,0.00307579627901896,0.0354666012728506,11.5308681250381,3.52742922821876
7,7,14,14,14,O95155,UBE4B,UBE4B_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ES00}. Nucleus {ECO:0000250|UniProtKB:Q9ES00}.,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0031175; GO:0034450; GO:0043161; GO:0051117; GO:0051865,1.39958115160364E-05,1E-07,1E-07,0.0245221297323032,0.0238196137656897,0.0230298567244442,0.0238196137656897,-5.3917061696391000,0.023785801470307,0.0118976326723255,57.1316460537194,2.36171216790088E-07,0.00014440182969451,5.60840079361253,146185,3.84042730384952,21,2,0,1E-07,0.0238196137656897,238196.137656897,17.8617904945724
8,8,15,15,15,Q96Q42,ALS2,ALS2_HUMAN,"centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]",NA,Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein),GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035022; GO:0035023; GO:0035249; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036,4.74363000177913E-05,7.01012029420113E-05,0.00012907699012042,0.0472078565435826,0.0441243210251037,0.0458315237223095,0.0458315237223095,-4.4475159391906400,0.0456390289326385,0.022901719297346,52.9956894115995,3.26004024459726E-07,0.00017751060605385,5.21119333131904,183634,3.75077569323957,19,0,0,7.01012029420113E-05,0.0458315237223095,653.790830953671,9.35268533404046
9,9,16,16,16,Q9Y512,SAMM50,SAM50_HUMAN,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrial sorting and assembly machinery complex [GO:0001401]; mitochondrion [GO:0005739]; cristae formation [GO:0042407]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein import into mitochondrial outer membrane [GO:0045040],SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:15644312}; Multi-pass membrane protein. Cytoplasm {ECO:0000250|UniProtKB:Q6AXV4}. Mitochondrion {ECO:0000269|PubMed:25781180}.,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),GO:0001401; GO:0005739; GO:0005741; GO:0016021; GO:0033108; GO:0042407; GO:0045040; GO:0070062,6.16757071233721E-05,3.36595320297912E-05,2.20463593568895E-06,0.0140906518291248,0.0132657776199849,0.0140635471009228,0.0140635471009228,-6.1518956736356500,0.0137741455583145,0.00691958607085355,52.5406326369231,3.3828823991003E-07,0.00017751060605385,5.1656153111858,51976,3.75077569323957,12,0,0,3.36595320297912E-05,0.0140635471009228,417.817665690525,8.70672968185738
10,10,17,17,17,Q9HA65,TBC1D17,TBC17_HUMAN,"autophagosome [GO:0005776]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of vesicle fusion [GO:0031338]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, autophagosome {ECO:0000269|PubMed:24752605}.",TBC1 domain family member 17,GO:0005096; GO:0005776; GO:0005829; GO:0006886; GO:0006914; GO:0012505; GO:0017137; GO:0031338; GO:0042147; GO:0055037; GO:0090630,0.00013006517653756,0.0003113492760995,0.00124620600068953,0.0464747959003712,0.0461195737257407,0.0438424625243269,0.0461195737257407,-4.4384770112733800,0.0449164038990374,0.0230207421006276,52.037802668943,3.52532745667699E-07,0.00017751060605385,5.11479220073198,72728,3.75077569323957,6,0,0,0.0003113492760995,0.0461195737257407,148.128090431153,7.2107014433852
11,12,20,20,20,Q9NRN7,AASDHPPT,ADPPT_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12815048}.,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.-) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog),GO:0000287; GO:0005829; GO:0008897; GO:0015939; GO:0019878; GO:0070062,7.51775249477019E-05,1E-07,1E-07,0.0511419592302291,0.0549248156721117,0.0541289728806344,0.0541289728806344,-4.2074551771900100,0.0533734567526758,0.0267118542179872,48.0132460775734,4.97870819209828E-07,0.0002130887106218,4.68943460235956,35776,3.67143955847223,12,2,0,1E-07,0.0541289728806344,541289.728806344,19.0460414870215
12,13,21,21,21,Q06455,RUNX1T1,MTG8_HUMAN,"nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; generation of precursor metabolites and energy [GO:0006091]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00440, ECO:0000269|PubMed:10973986}. Note=Colocalizes with ATN1 in discrete nuclear dots.",Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2),GO:0003677; GO:0003700; GO:0003714; GO:0005654; GO:0006091; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872,1E-07,1E-07,1E-07,0.175344566981819,0.188955265891109,0.186212201128237,0.186212201128237,-2.424980489603400,0.183503911333722,0.0917520556668608,45.7528278316303,6.12228800642701E-07,0.00022043255139799,4.43465704793476,67566,3.65672427257582,4,3,0,1E-07,0.186212201128237,1862122.01128237,20.8285161746081
13,14,23,23,23,Q9BWM7,SFXN3,SFXN3_HUMAN,integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; iron ion homeostasis [GO:0055072],SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000269|Ref.4}; Multi-pass membrane protein {ECO:0000269|Ref.4}.,Sideroflexin-3,GO:0005739; GO:0015075; GO:0016021; GO:0031966; GO:0055072,1E-07,1E-07,1E-07,0.0314774080573051,0.0297049193734526,0.0291875409189048,0.0297049193734526,-5.0731543170658900,0.0301231894498875,0.0150616947249437,45.0048361491096,6.57059572126704E-07,0.00022043255139799,4.34757942945392,35503,3.65672427257582,9,3,0,1E-07,0.0297049193734526,297049.193734526,18.1803423471456
14,15,24,24,24,O94856,NFASC,NFASC_HUMAN,axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; myelination [GO:0042552]; neutrophil degranulation [GO:0043312]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.,Neurofascin,GO:0002175; GO:0005622; GO:0005886; GO:0005925; GO:0007411; GO:0007422; GO:0016021; GO:0019226; GO:0019904; GO:0030425; GO:0030913; GO:0033010; GO:0033268; GO:0033270; GO:0042552; GO:0043194; GO:0043209; GO:0043312; GO:0045162; GO:0050808; GO:0071205; GO:0072659; GO:0086080; GO:0097454; GO:0101003,1E-07,1E-07,1E-07,0.0358819980981721,0.0387462811519627,0.0380857540898328,0.0380857540898328,-4.7146047287303100,0.0375712444466559,0.0187857222233279,44.9494933906792,6.60534767722353E-07,0.00022043255139799,4.34107951853587,150027,3.65672427257582,20,3,0,1E-07,0.0380857540898328,380857.540898328,18.5388919354812
15,16,25,25,25,Q92604,LPGAT1,LGAT1_HUMAN,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15485873}; Multi-pass membrane protein {ECO:0000269|PubMed:15485873}.,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-),GO:0003841; GO:0005737; GO:0005789; GO:0008654; GO:0016020; GO:0016021; GO:0036148; GO:0045723; GO:0047144,1E-07,1E-07,1E-07,0.0322896263647056,0.0302758587572329,0.0300252893616641,0.0302758587572329,-5.0456883080638600,0.0308634914945342,0.0154318457472671,44.6100517686837,6.82352496169753E-07,0.00022043255139799,4.30103745152505,43089,3.65672427257582,9,3,0,1E-07,0.0302758587572329,302758.587572329,18.2078083561477
16,17,26,26,26,P54105,CLNS1A,ICLN_HUMAN,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Nucleus {ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21081503}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:18984161}. Note=A small fraction is also associated with the cytoskeleton (PubMed:18984161).","Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0046982,1E-07,1E-07,1E-07,0.0257879518711243,0.0255615256769904,0.0274954628219472,0.0257879518711243,-5.2771589937204100,0.0262815467900207,0.0131408733950103,44.5951144470191,6.83332843583254E-07,0.00022043255139799,4.29926841334861,26215,3.65672427257582,3,3,0,1E-07,0.0257879518711243,257879.518711243,17.9763376704911
17,18,27,27,27,P19086,GNAZ,GNAZ_HUMAN,cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; heterotrimeric G-protein complex [GO:0005834]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein coupled receptor binding [GO:0001664]; G-protein coupled serotonin receptor binding [GO:0031821]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; G-protein coupled receptor signaling pathway [GO:0007186]; protein folding [GO:0006457],SUBCELLULAR LOCATION: Membrane; Lipid-anchor.,Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha),GO:0001664; GO:0003924; GO:0005525; GO:0005635; GO:0005783; GO:0005829; GO:0005834; GO:0005886; GO:0006457; GO:0007186; GO:0007188; GO:0007193; GO:0030425; GO:0031683; GO:0031821; GO:0044297; GO:0046872,0.00139910087846692,0.00255518187247284,0.00221003450151514,0.0211768859556352,0.0209944433854521,0.0219481103165676,0.0211768859556352,-5.5613657320150100,0.0193183741350666,0.0117139594850183,44.4150308213145,6.95289589689927E-07,0.00022043255139799,4.27789440234418,40924,3.65672427257582,13,0,0,0.00221003450151514,0.0211768859556352,9.58215174519533,3.26034966050718
18,19,29,29,29,O15498,YKT6,YKT6_HUMAN,"apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; ER to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903]","SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasmic vesicle membrane; Lipid-anchor; Cytoplasmic side. Golgi apparatus membrane; Lipid-anchor; Cytoplasmic side. Note=Probably cycles through vesicles between Golgi and endosomes.",Synaptobrevin homolog YKT6 (EC 2.3.1.-),GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0006906; GO:0015031; GO:0019706; GO:0030133; GO:0030659; GO:0031201; GO:0033116; GO:0042147; GO:0043025; GO:0045296; GO:0097440; GO:0097441,1E-07,6.37126762556843E-06,1E-07,0.0120644674842034,0.0131124056564549,0.012869480493063,0.012869480493063,-6.279902372829080,0.0126799274553653,0.00634215415022448,41.4256530380802,9.37284898755669E-07,0.00026748956813854,3.90989508429143,22418,3.5726931504211,6,2,0,1E-07,0.012869480493063,128694.80493063,16.9735942913825
19,20,31,31,31,Q24JP5,TMEM132A,T132A_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687],SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.,Transmembrane protein 132A (HSPA5-binding protein 1),GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0043687; GO:0044267; GO:0070062,0.00409584655272037,0.00819962939744129,0.0106444181199801,0.0917531736919801,0.0892332267860789,0.0919385631916319,0.0917531736919801,-3.4460981289252100,0.0833283565331831,0.0493108096233055,41.1080830214264,9.68712221062475E-07,0.00026748956813854,3.86925833378687,110110,3.5726931504211,13,0,0,0.00819962939744129,0.0917531736919801,11.1899171590135,3.48412745070813
20,21,32,32,32,O95297,MPZL1,MPZL1_HUMAN,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; structural molecule activity [GO:0005198]; cell-cell signaling [GO:0007267]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Myelin protein zero-like protein 1 (Protein zero-related),GO:0005198; GO:0005887; GO:0005925; GO:0007169; GO:0007267; GO:0009986,0.00104147433738215,9.42405655940191E-05,0.00015382686559655,0.0144325240347078,0.0141433871862483,0.0147702550628266,0.0144325240347078,-6.1145325618844300,0.0140188748384033,0.00743928467539257,40.7728101481861,1.00331299582464E-06,0.00026838622638309,3.82601584133664,29082,3.57123977598185,3,0,0,0.00015382686559655,0.0144325240347078,93.8231691761877,6.55187232816156
21,22,33,33,33,Q9NPH2,ISYNA1,INO1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; inositol phosphate metabolic process [GO:0043647]; phospholipid biosynthetic process [GO:0008654],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Inositol-3-phosphate synthase 1 (IPS 1) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase) (hIPS) (Myo-inositol 1-phosphate synthase A1) (hINO1),GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0008654; GO:0043647,1E-07,1E-07,2.69127051379248E-05,0.0437847604297142,0.046985530693214,0.0432181955302326,0.0437847604297142,-4.5134273719625900,0.0446537913160077,0.0223359332263831,39.4464419744004,1.15606538386361E-06,0.00029987635411734,3.65140414912619,61068,3.52305777792577,8,2,0,1E-07,0.0437847604297142,437847.604297142,18.7400692922489
22,23,35,35,35,Q8N806,UBR7,UBR7_HUMAN,transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567],NA,Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7),GO:0008270; GO:0016567; GO:0016740,1.04461041838129E-05,2.87803487479666E-05,2.57015003122769E-05,0.107483115709509,0.098291724810919,0.100344102579825,0.100344102579825,-3.316972265719040,0.102018005049003,0.0510306451755829,37.9494866265765,1.3644832692124E-06,0.00033371362241309,3.44717789593513,47999,3.47662606479236,6,0,0,2.57015003122769E-05,0.100344102579825,3904.21186937065,11.9308156302362
23,24,36,36,36,Q14671,PUM1,PUM1_HUMAN,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; mRNA destabilization [GO:0061157]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional gene silencing [GO:0016441]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:26724866}. Cytoplasm, P-body {ECO:0000305|PubMed:20818387}. Cytoplasmic granule {ECO:0000269|PubMed:25340845}. Note=Recruited to cytoplasmic stress granules upon viral infection. {ECO:0000269|PubMed:25340845}.",Pumilio homolog 1 (HsPUM) (Pumilio-1),GO:0000932; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0016607; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637,0.00107501666793635,0.00090436597663427,0.00044521645710093,0.0786217091339805,0.0740191643790934,0.0813328173148195,0.0786217091339805,-3.6689284633528800,0.0771830305754073,0.0393997149882608,37.3193820637298,1.46594489033617E-06,0.00034424950965073,3.35880749745984,126473,3.46312666967999,9,0,0,0.00090436597663427,0.0786217091339805,86.9357220033671,6.44187719905663
24,25,37,37,37,O43924,PDE6D,PDE6D_HUMAN,"cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; response to stimulus [GO:0050896]; visual perception [GO:0007601]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:9712853}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:9712853}; Peripheral membrane protein {ECO:0000269|PubMed:9712853}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:24166846}.","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)",GO:0004114; GO:0005095; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0017137; GO:0030659; GO:0031410; GO:0050896,1.88009331196325E-06,1E-07,0.00218056602812153,0.0495410224448051,0.0533441312059379,0.0500019298639667,0.0500019298639667,-4.3218724118584800,0.0502348457977587,0.0258449382726905,37.1420839109763,1.49615571953636E-06,0.00034424950965073,3.33367442220761,17420,3.46312666967999,3,1,0,1.88009331196325E-06,0.0500019298639667,26595.4511650026,14.6988918905809
25,26,39,39,39,P47756,CAPZB,CAPZB_HUMAN,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; barbed-end actin filament capping [GO:0051016]; blood coagulation [GO:0007596]; cytoskeleton organization [GO:0007010]; ER to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril, sarcomere {ECO:0000250}.",F-actin-capping protein subunit beta (CapZ beta),GO:0003779; GO:0005829; GO:0005856; GO:0005884; GO:0006888; GO:0007010; GO:0007596; GO:0008290; GO:0010591; GO:0015629; GO:0019886; GO:0022604; GO:0030017; GO:0030036; GO:0045296; GO:0051015; GO:0051016; GO:0051490; GO:0070062; GO:0071203,9.25272817276245E-05,0.00051825984407085,6.03203935480555E-05,0.0324566698816166,0.0295176391198618,0.0307025440988402,0.0307025440988402,-5.0254979834721700,0.030668581860324,0.0155579934366109,36.672414359529,1.57997390106536E-06,0.0003444848281183,3.26651513737867,31350,3.46282990063472,15,0,0,9.25272817276245E-05,0.0307025440988402,331.821529019087,8.37426368306503
26,27,41,41,41,P26196,DDX6,DDX6_HUMAN,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P granule [GO:0043186]; P-body [GO:0000932]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cytoplasmic mRNA processing body assembly [GO:0033962]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; negative regulation of neuron differentiation [GO:0045665]; regulation of translation [GO:0006417]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]; viral RNA genome packaging [GO:0019074],"SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:16364915, ECO:0000269|PubMed:16699599, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:22915799, ECO:0000269|PubMed:26184334}. Cytoplasm {ECO:0000269|PubMed:26184334}. Nucleus {ECO:0000269|PubMed:26184334}. Note=Upon cellular stress, relocalizes to stress granules (PubMed:26184334). {ECO:0000269|PubMed:26184334}.",Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK),GO:0000792; GO:0000932; GO:0001520; GO:0003723; GO:0003724; GO:0004004; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006417; GO:0007283; GO:0010494; GO:0010501; GO:0016020; GO:0016442; GO:0019074; GO:0019827; GO:0019904; GO:0033962; GO:0036464; GO:0043186; GO:0043928; GO:0045296; GO:0045665; GO:0097227,7.28660780672823E-05,3.40215571124832E-05,8.02844051252515E-05,0.0247218523826675,0.0225957977408745,0.0228572515436526,0.0228572515436526,-5.4512042517835100,0.0233292432089632,0.0117270122845833,36.0929458510374,1.69151702982213E-06,0.00034879014670485,3.18246746723082,54417,3.4574357923523,28,0,0,7.28660780672823E-05,0.0228572515436526,313.688511169037,8.29318888126743
27,28,43,43,43,P09104,ENO2,ENOG_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form. {ECO:0000250}.,Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE),GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0016020; GO:0043204; GO:0043209; GO:0061621; GO:0070062,1E-07,3.42619252897631E-06,1E-07,0.00198483903298533,0.00212229420790742,0.00193628556010702,0.00198483903298533,-8.97676227262390000,0.0020132642028236,0.00100784083225479,35.7645358573668,1.75904805644856E-06,0.00035017328751627,3.1342366672019,47269,3.45571698654142,17,2,0,1E-07,0.00198483903298533,19848.3903298533,14.2767343915876
28,29,44,44,44,P11413,G6PD,G6PD_HUMAN,"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]",NA,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034599; GO:0042802; GO:0042803; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0055114; GO:0061052; GO:0070062; GO:1904879; GO:2000378,0.00020980574848882,0.00029227539469147,0.00015597357063969,0.0263972899536549,0.0239676582509134,0.0246669651591146,0.0246669651591146,-5.3412759617420400,0.024791286216621,0.0126149946795838,35.510063089407,1.81367095153481E-06,0.00035284143966222,3.09656085095691,59257,3.45242041458398,14,0,0,0.00020980574848882,0.0246669651591146,117.570492404449,6.87738221080406
29,30,45,45,45,O94776,MTA2,MTA2_HUMAN,"histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, transcription factor binding [GO:0000989]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin assembly or disassembly [GO:0006333]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}.",Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex),GO:0000118; GO:0000122; GO:0000790; GO:0000981; GO:0000989; GO:0001085; GO:0001103; GO:0003682; GO:0004407; GO:0005654; GO:0005667; GO:0006306; GO:0006333; GO:0008270; GO:0010762; GO:0016020; GO:0016581; GO:0032991; GO:0042826; GO:0043044; GO:0043565; GO:0044212; GO:0045944,0.0001853773643852,0.00049767689625175,0.00041813252672138,0.0784139519180435,0.0825433086304507,0.0870027333674567,0.0825433086304507,-3.5987049219037800,0.0822862690428642,0.0415101967838849,34.3555178009912,2.08942570670061E-06,0.00039745520109682,2.92218622865954,75023,3.40071181546759,11,0,0,0.00041813252672138,0.0825433086304507,197.409441637275,7.62504718198813
30,31,47,47,47,Q9H6U8,ALG9,ALG9_HUMAN,"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:15148656}; Multi-pass membrane protein {ECO:0000305}.,"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)",GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926,0.00019641623052523,1E-07,1E-07,0.0124778397901318,0.0112931654612126,0.0123082787184527,0.0123082787184527,-6.3442271710867700,0.011960889246424,0.00604598336672039,32.9597449842006,2.49540016509745E-06,0.00045108207502392,2.7034377671732,69863,3.34574443043469,8,2,0,1E-07,0.0123082787184527,123082.787184527,16.9092694931248
31,32,48,48,48,Q9P291,ARMCX1,ARMX1_HUMAN,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q9CX83}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:Q9CX83}; Single-pass membrane protein {ECO:0000255}.,Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1) (Protein ALEX1),GO:0005741; GO:0016021,1E-07,3.00141505403925E-05,0.00188172394572541,0.0548465253864364,0.0503718669447695,0.0503540413390706,0.0503718669447695,-4.3112379868301200,0.0512201985246702,0.0262473786277571,32.7817099729808,2.55392859308253E-06,0.00045108207502392,2.67487682338142,49180,3.34574443043469,6,1,0,3.00141505403925E-05,0.0503718669447695,1678.27061695382,10.7127596501768
32,33,49,49,49,Q68D91,MBLAC2,MBLC2_HUMAN,extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-),GO:0016787; GO:0046872; GO:0070062,1E-07,1E-07,1E-07,0.024123626231375,0.0268952369030108,0.0259376119802641,0.0259376119802641,-5.2688105298775200,0.02565205837155,0.012826129185775,32.6977144832983,2.58212870048743E-06,0.00045108207502392,2.66134852048074,31372,3.34574443043469,7,3,0,1E-07,0.0259376119802641,259376.119802641,17.984686134334
33,34,50,50,50,O75326,SEMA7A,SEM7A_HUMAN,anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; neuropilin binding [GO:0038191]; axon extension [GO:0048675]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; regulation of inflammatory response [GO:0050727],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10201933, ECO:0000269|PubMed:17671519, ECO:0000269|PubMed:9712866}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:10201933, ECO:0000269|PubMed:17671519, ECO:0000269|PubMed:9712866}; Extracellular side {ECO:0000269|PubMed:10201933, ECO:0000269|PubMed:17671519, ECO:0000269|PubMed:9712866}. Note=Detected in a punctate pattern on the cell membrane of basal and supra-basal skin keratinocytes.",Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108),GO:0001649; GO:0005178; GO:0005886; GO:0006954; GO:0006955; GO:0007229; GO:0009897; GO:0016020; GO:0021988; GO:0031225; GO:0038191; GO:0045773; GO:0048675; GO:0050727; GO:0050919; GO:0060907; GO:0070374,0.00126645496470915,0.0007076611386479,0.00155871410033689,0.0904582615459895,0.0856431871739713,0.0956347375076083,0.0904582615459895,-3.4666039196851300,0.0894011186746251,0.0458781694052105,31.9900794373049,2.83560815783056E-06,0.00048545611662059,2.54598876786386,74824,3.31385002254464,8,0,0,0.00126645496470915,0.0904582615459895,71.4263547198173,6.15838458942356
34,35,52,52,52,Q9UPW5,AGTPBP1,CBPC1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; protein side chain deglutamylation [GO:0035610],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23085998}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q641K1}. Nucleus {ECO:0000269|PubMed:23085998}. Mitochondrion {ECO:0000250|UniProtKB:Q641K1}. Note=Localizes in both the cytoplasm and nuclei of interphase and dividing cells. {ECO:0000269|PubMed:23085998}.",Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog),GO:0001754; GO:0004181; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0007005; GO:0008270; GO:0015631; GO:0021702; GO:0021772; GO:0035609; GO:0035610; GO:0043231; GO:0050905,0.00010880541980363,0.00035587782622467,0.00018792891883786,0.0239874721362364,0.0266527181080647,0.0245128333488302,0.0245128333488302,-5.3503189400841100,0.0248334704760884,0.0126342726263329,31.4373348332801,3.05519675238594E-06,0.00050293238846968,2.45410495558652,138448,3.29849039523863,23,0,0,0.00018792891883786,0.0245128333488302,130.436728420596,7.02720635113341
35,36,54,54,54,O60231,DHX16,DHX16_HUMAN,"cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20423332, ECO:0000269|PubMed:20841358, ECO:0000269|PubMed:25296192}. Nucleus, nucleoplasm {ECO:0000269|PubMed:20423332}.",Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),GO:0000398; GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887,4.29132145127235E-05,2.21903618048442E-05,0.00098944000750158,0.0305327247888652,0.0320560415523751,0.0286997011035375,0.0305327247888652,-5.0334998460874800,0.0300779746203196,0.0153905018380995,30.5099981935366,3.47277159241487E-06,0.00054228973937165,2.29629300628739,119264,3.26576861274402,14,0,0,4.29132145127235E-05,0.0305327247888652,711.499362971572,9.47471865483546
36,37,58,58,58,Q9Y4X5,ARIH1,ARI1_HUMAN,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11278816, ECO:0000269|PubMed:21590270, ECO:0000269|PubMed:23059369}. Nucleus {ECO:0000269|PubMed:23059369}. Nucleus, Cajal body {ECO:0000269|PubMed:23059369}. Note=Mainly cytoplasmic (PubMed:11278816). Present in Lewy body (PubMed:21590270). {ECO:0000269|PubMed:11278816, ECO:0000269|PubMed:21590270}.",E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1),GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019787; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413,2.54110525371874E-05,5.57829818807471E-06,4.69378310387196E-05,0.0784335221301072,0.0700659870002073,0.0776411954342747,0.0776411954342747,-3.6870338585105900,0.0753542591276085,0.0377031052910589,29.2763319761239,4.14334617674486E-06,0.0006115007460851,2.07881788504002,64118,3.21360300874962,9,0,0,2.54110525371874E-05,0.0776411954342747,3055.41044868771,11.577150482222
37,38,61,61,61,Q96MZ0,GDAP1L1,GD1L1_HUMAN,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1-L1),GO:0004364; GO:0005737; GO:0006749,1E-07,1E-07,1E-07,0.017832742490691,0.0197008315922564,0.0175909339620289,0.017832742490691,-5.809327598227200,0.0183747360149921,0.00918746800749606,28.5500397135476,4.61322680248384E-06,0.00064560318846286,1.94649939532742,41973,3.19003433341547,12,3,0,1E-07,0.017832742490691,178327.42490691,17.4441690659843
38,39,63,63,63,Q86Y82,STX12,STX12_HUMAN,early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],SUBCELLULAR LOCATION: Endosome membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Golgi apparatus membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Endomembrane system {ECO:0000305}; Single-pass type IV membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Early endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000305}. Recycling endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}.,Syntaxin-12,GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038,1E-07,1E-07,1E-07,0.0542704844823696,0.061537450014585,0.0572230137639814,0.0572230137639814,-4.1272607077051700,0.0576768827536454,0.0288385413768227,28.3226873049546,4.77365346743169E-06,0.00064861069335262,1.90439410929075,31642,3.18801589558634,3,3,0,1E-07,0.0572230137639814,572230.137639814,19.1262359565064
39,40,64,64,64,Q8NCB2,CAMKV,CAMKV_HUMAN,cytoplasmic vesicle membrane [GO:0030659]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Predominantly observed in association with the plasma membrane of soma and in neurites, both axons and dendrites. May be associated with vesicular structures (By similarity). {ECO:0000250}.",CaM kinase-like vesicle-associated protein,GO:0004683; GO:0005516; GO:0005524; GO:0005622; GO:0005886; GO:0018105; GO:0018107; GO:0030659; GO:0035556,0.0002750373934231,0.00044790307542458,0.0012433332604308,0.0199765688986593,0.0216131493074287,0.0194124492390039,0.0199765688986593,-5.6455473773132800,0.0196786312386045,0.0104947401957284,28.1488908858768,4.9009428929384E-06,0.00065362008877292,1.87198113757756,54354,3.18467460838941,9,0,0,0.00044790307542458,0.0199765688986593,44.6002048093172,5.47897843007123
40,41,65,65,65,P25787,PSMA2,PSA2_HUMAN,"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; threonine-type endopeptidase activity [GO:0004298]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; response to virus [GO:0009615]; ubiquitin-dependent protein catabolic process [GO:0006511]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}. Nucleus {ECO:0000269|PubMed:12181345}. Note=Colocalizes with TRIM5 in cytoplasmic bodies. {ECO:0000250|UniProtKB:P49722}.,Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3),GO:0000502; GO:0000932; GO:0004298; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0006511; GO:0009615; GO:0016579; GO:0019773; GO:0034774; GO:0043312; GO:0043687; GO:0070062; GO:1904813,1.97589672596505E-05,1E-07,0.0001402847659201,0.00690846491802502,0.00671488234936424,0.00612261134378832,0.00671488234936424,-7.21842216207202000,0.00652860495933261,0.00331768372405956,28.06585135152,4.96323665540191E-06,0.00065362008877292,1.85642432602873,25899,3.18467460838941,8,1,0,1.97589672596505E-05,0.00671488234936424,339.839742691239,8.40871076869711
41,42,66,66,66,Q8IV08,PLD3,PLD3_HUMAN,endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15794758}; Single-pass type II membrane protein {ECO:0000269|PubMed:15794758}.,Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3),GO:0004630; GO:0005789; GO:0016021; GO:0016042; GO:0070062; GO:0070290,1E-07,1E-07,1E-07,0.0665402970726648,0.0625553666346431,0.0584905232917149,0.0625553666346431,-3.9987225310420700,0.0625286289996743,0.0312644144998371,27.8807165858009,5.10566772395134E-06,0.00066037394033071,1.82157620082015,54705,3.18021007319525,7,3,0,1E-07,0.0625553666346431,625553.666346431,19.2547741331695
42,43,67,67,67,P51149,RAB7A,RAB7A_HUMAN,"alveolar lamellar body [GO:0097208]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; retromer complex binding [GO:1905394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intracellular transport [GO:1902583]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, phagosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:21255211}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Late endosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lysosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Melanosome membrane {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lipid droplet {ECO:0000250|UniProtKB:P51150}. Endosome membrane {ECO:0000269|PubMed:22431521}. Note=Colocalizes with OSBPL1A at the late endosome (PubMed:16176980). Found in the ruffled border (a late endosomal-like compartment in the plasma membrane) of bone-resorbing osteoclasts. Recruited to phagosomes containing S.aureus or Mycobacterium (PubMed:21255211). Lipid droplet localization is increased upon ADRB2 stimulation (By similarity). {ECO:0000250|UniProtKB:P51150, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:21255211}.",Ras-related protein Rab-7a,GO:0000045; GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0019886; GO:0022615; GO:0030667; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0034045; GO:0042147; GO:0043312; GO:0045022; GO:0045335; GO:0045453; GO:0045732; GO:0048365; GO:0048524; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:0097208; GO:1902583; GO:1903542; GO:1903543; GO:1905366; GO:1905394,1E-07,4.64074349419732E-05,2.29701447799555E-05,0.00316207795606819,0.00355048328428716,0.00351746255684743,0.00351746255684743,-8.15124921851031000,0.00338684873916029,0.00171658356282079,27.8006610236034,5.16881471987824E-06,0.00066037394033071,1.8064363064336,23490,3.18021007319525,13,1,0,2.29701447799555E-05,0.00351746255684743,153.131928011045,7.25863130592962
43,44,70,70,70,P13489,RNH1,RINI_HUMAN,angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765],SUBCELLULAR LOCATION: Cytoplasm.,Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI),GO:0005654; GO:0005829; GO:0006402; GO:0008428; GO:0032311; GO:0045765; GO:0070062,4.13039557279289E-05,0.0001464729103836,0.00013512021842477,0.0220763811273982,0.0229187208610592,0.0201057303116692,0.0220763811273982,-5.5013524921809900,0.0215926450718634,0.0109039548974438,26.8152379336239,6.03086478851241E-06,0.0007374886084238,1.61646089840854,49973,3.13224468360321,9,0,0,0.00013512021842477,0.0220763811273982,163.383255183898,7.35211632196674
44,45,72,72,72,Q9Y3A3,MOB4,PHOCN_HUMAN,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872],"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:11319234}. Membrane {ECO:0000269|PubMed:11319234}; Peripheral membrane protein {ECO:0000269|PubMed:11319234}. Golgi apparatus, Golgi stack membrane {ECO:0000269|PubMed:11319234}; Peripheral membrane protein {ECO:0000269|PubMed:11319234}. Note=In a perinuclear punctate pattern. Associated with membranes and the Golgi stacks.",MOB-like protein phocein (2C4D) (Class II mMOB1) (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3),GO:0005737; GO:0005794; GO:0032580; GO:0046872; GO:0048471,1E-07,1E-07,1E-07,0.00836545569872579,0.0093825728514435,0.00946356451972634,0.0093825728514435,-6.7358006976304900,0.00907043102329855,0.00453531551164927,26.5698082802687,6.27253281732037E-06,0.00074573445717031,1.56807222624339,26032,3.12741578957235,3,3,0,1E-07,0.0093825728514435,93825.728514435,16.517695966581
45,46,73,73,73,Q96B54,ZNF428,ZN428_HUMAN,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,Zinc finger protein 428 (Enzyme-like protein PIT13),GO:0003676; GO:0046872,0.00026135065379903,0.00018183947663466,0.00053605450629791,0.113072172204182,0.117303067548437,0.102711665481913,0.113072172204182,-3.144684178493690,0.1107025535326,0.0556776916452106,26.4569738911098,6.38763519633915E-06,0.00074630872837509,1.54567752461144,20481,3.12708147910455,3,0,0,0.00026135065379903,0.113072172204182,432.645453763168,8.75704143268415
46,47,77,77,77,O15394,NCAM2,NCAM2_HUMAN,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein.,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2),GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802,7.28488764646994E-05,0.00011310106336496,0.00012898556905238,0.0803170795515437,0.0921228745280165,0.0846588111150883,0.0846588111150883,-3.5621959611043300,0.0855946098952555,0.0429022834505884,25.7254905099335,7.20043622269122E-06,0.00080046407878229,1.39816776196346,93046,3.09665815248505,15,0,0,0.00011310106336496,0.0846588111150883,748.523564645075,9.54790392497819
47,48,81,81,81,Q15771,RAB30,RAB30_HUMAN,cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030],"SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:22188167}. Cytoplasm {ECO:0000269|PubMed:22188167}. Golgi apparatus {ECO:0000269|PubMed:22188167}.",Ras-related protein Rab-30,GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0031985; GO:0043231,1E-07,1E-07,1E-07,0.0465013512102636,0.0514557445707701,0.0450021104759181,0.0465013512102636,-4.4265835519191300,0.0476529687523173,0.0238265843761586,25.3210352593635,7.70465217020714E-06,0.00081422003181448,1.31481785926263,23058,3.08925821711325,3,3,0,1E-07,0.0465013512102636,465013.512102636,18.8269131122924
48,49,83,83,83,P63096,GNAI1,GNAI1_HUMAN,cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein coupled receptor binding [GO:0001664]; G-protein coupled serotonin receptor binding [GO:0031821]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G-protein coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of protein localization to cell cortex [GO:1904778]; protein folding [GO:0006457]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434],"SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P10824}. Cytoplasm {ECO:0000269|PubMed:17635935}. Cell membrane {ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:26766442}; Peripheral membrane protein {ECO:0000250|UniProtKB:P10824}; Cytoplasmic side {ECO:0000250|UniProtKB:P10824}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:17635935}. Cytoplasm, cell cortex {ECO:0000269|PubMed:22327364}. Membrane {ECO:0000250|UniProtKB:P63096}; Lipid-anchor {ECO:0000250|UniProtKB:P63096}. Note=Localizes in the centrosomes of interphase and mitotic cells, but not in centrosomes during cytokinesis. Detected at the cleavage furrow or the midbody (PubMed:17635935). Localized at the plasma membrane throughout mitosis. Colocalizes with RIC8A and RGS14 at the plasma membrane. {ECO:0000250|UniProtKB:P10824, ECO:0000269|PubMed:17635935}.",Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005765; GO:0005813; GO:0005834; GO:0005886; GO:0006457; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0019003; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0043434; GO:0043949; GO:0045121; GO:0050805; GO:0051301; GO:0060236; GO:0070062; GO:0099738; GO:1904322; GO:1904778,1E-07,1E-07,1E-07,0.0247274125483873,0.0239796445673122,0.0274385118096636,0.0247274125483873,-5.3377449043091900,0.0253817563084544,0.0126909781542272,25.0267808631724,8.09900259667511E-06,0.00083527062924745,1.25334826379719,40361,3.07817278949085,3,3,0,1E-07,0.0247274125483873,247274.125483873,17.9157517599023
49,50,85,85,85,P52292,KPNA2,IMA1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; modulation by virus of host process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of DNA recombination [GO:0000018],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7604027}. Nucleus {ECO:0000269|PubMed:7604027}.,Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha),GO:0000018; GO:0003723; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0008565; GO:0016020; GO:0019054; GO:0042826; GO:0061608,6.20300138779632E-05,0.00017425386115444,0.00192732484400432,0.10792217829156,0.110712764494801,0.0965155208289729,0.10792217829156,-3.21193672196745,0.104328951632099,0.0528856787223951,24.655879310072,8.63214331431814E-06,0.00086930760906545,1.174843367888,57862,3.06082651897062,7,0,0,0.00017425386115444,0.10792217829156,619.338805904044,9.27458503358789
50,51,87,87,87,Q13586,STIM1,STIM1_HUMAN,cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],"SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein {ECO:0000269|PubMed:11004585, ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:27185316, ECO:0000269|PubMed:28219928}. Endoplasmic reticulum membrane; Single-pass type I membrane protein {ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:26322679, ECO:0000269|PubMed:27185316}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19632184}. Sarcoplasmic reticulum {ECO:0000269|PubMed:25326555}. Note=Translocates from the endoplasmic reticulum to the cell membrane in response to a depletion of intracellular calcium and is detected at punctae corresponding to junctions between the endoplasmic reticulum and the cell membrane (PubMed:19249086, PubMed:16005298, PubMed:16208375, PubMed:18854159). Associated with the microtubule network at the growing distal tip of microtubules (PubMed:19632184). Colocalizes with ORAI1 at the cell membrane (PubMed:27185316). Colocalizes preferentially with CASQ1 at endoplasmic reticulum in response to a depletion of intracellular calcium (PubMed:27185316). {ECO:0000269|PubMed:16005298, ECO:0000269|PubMed:16208375, ECO:0000269|PubMed:18854159, ECO:0000269|PubMed:19249086, ECO:0000269|PubMed:19632184, ECO:0000269|PubMed:27185316}.",Stromal interaction molecule 1,GO:0002020; GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006874; GO:0030176; GO:0032237; GO:0032541; GO:0033017; GO:0042802; GO:0045766; GO:0051010; GO:0051924; GO:0070166; GO:1903779; GO:2001256,1E-07,1E-07,1E-07,0.0305546305803051,0.0274051062078938,0.0317132658286981,0.0305546305803051,-5.0324651514983700,0.029890900872299,0.0149455504361495,24.0604469378463,9.58162208437515E-06,0.00094044530544352,1.04634588018375,77423,3.02666645714155,3,3,0,1E-07,0.0305546305803051,305546.305803051,18.2210315127132
51,52,89,89,89,Q96SW2,CRBN,CRBN_HUMAN,Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of ion transmembrane transport [GO:0034766]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of protein homodimerization activity [GO:0090073]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20223979}. Nucleus {ECO:0000269|PubMed:20223979}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,Protein cereblon,GO:0005634; GO:0005730; GO:0005737; GO:0016020; GO:0016567; GO:0031464; GO:0032463; GO:0034766; GO:0043161; GO:0046872; GO:0090073,1E-07,1E-07,0.00610573051111219,0.0496588822836957,0.0510467781620671,0.0516824817815894,0.0510467781620671,-4.2920362820759500,0.0487607372387467,0.0264156787897441,23.8195193261953,1.00021293145627E-05,0.00095232961062377,0.993459603653314,50546,3.02121271201495,8,2,0,1E-07,0.0510467781620671,510467.781620671,18.9614603821356
52,53,90,90,90,P51812,RPS6KA3,KS6A3_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0018105; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944,1E-07,1E-07,1E-07,0.0487067749930329,0.0467763651715201,0.0419980333881093,0.0467763651715201,-4.4180764305376000,0.0458269578508874,0.0229135789254437,23.8135623255159,1.00128113266518E-05,0.00095232961062377,0.992145310137232,83736,3.02121271201495,7,3,0,1E-07,0.0467763651715201,467763.651715201,18.8354202336739
53,54,91,91,91,O43292,GPAA1,GPAA1_HUMAN,endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:11483512}; Multi-pass membrane protein {ECO:0000269|PubMed:11483512}.,Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1),GO:0005789; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003,0.00165448992761509,0.00531713263329784,0.00080251095622355,0.0411510094317191,0.0388819512263666,0.0420084993224164,0.0411510094317191,-4.6029283694735400,0.0380891088211219,0.0216359322496064,23.6362036760583,1.03373829721741E-05,0.00097239558507484,0.952865574915993,67623,3.01215702163247,5,0,0,0.00165448992761509,0.0411510094317191,24.8723239379507,4.63646940650817
54,55,92,92,92,Q96MY1,NOL4L,NOL4L_HUMAN,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,Nucleolar protein 4-like,GO:0005654; GO:0005829,0.00665528508221589,1E-07,1E-07,0.152454275124542,0.148689654678574,0.169906548403226,0.152454275124542,-2.713551487901470,0.154798331041376,0.0796176605480931,23.2392916041489,1.11119774159988E-05,0.00103389702914075,0.863899134044365,47215,2.98552271259877,4,2,0,1E-07,0.152454275124542,1524542.75124542,20.5399451763101
55,56,93,93,93,Q9UQL6,HDAC5,HDAC5_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; core promoter binding [GO:0001047]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; protein deacetylase activity [GO:0033558]; protein kinase C binding [GO:0005080]; repressing transcription factor binding [GO:0070491]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the nucleus and the cytoplasm. In muscle cells, it shuttles into the cytoplasm during myocyte differentiation. The export to cytoplasm depends on the interaction with a 14-3-3 chaperone protein and is due to its phosphorylation at Ser-259 and Ser-498 by AMPK, CaMK1 and SIK1.",Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9),GO:0000118; GO:0000122; GO:0001047; GO:0001085; GO:0003682; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006338; GO:0006342; GO:0006351; GO:0006476; GO:0006954; GO:0008134; GO:0010830; GO:0010832; GO:0014823; GO:0016575; GO:0016607; GO:0030182; GO:0030183; GO:0032041; GO:0032869; GO:0033558; GO:0040029; GO:0042113; GO:0042220; GO:0042826; GO:0043393; GO:0045892; GO:0045944; GO:0046872; GO:0051091; GO:0070491; GO:0071222; GO:0090051,0.0229612773079974,0.0695824179218064,0.0116587618831538,0.577609258951312,0.559837584524303,0.525963546488841,0.559837584524303,-0.836919749836729,0.519735977617166,0.294602141179569,23.0957221301475,1.14096595834384E-05,0.00104743504543692,0.831349702072377,121978,2.9798728994194,6,0,0,0.0229612773079974,0.559837584524303,24.3818136515128,4.60773354031738
56,57,95,95,95,Q13951,CBFB,PEBB_HUMAN,"core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),GO:0000122; GO:0000209; GO:0000981; GO:0001649; GO:0001959; GO:0003700; GO:0003713; GO:0005654; GO:0006366; GO:0006367; GO:0016020; GO:0016513; GO:0030098; GO:0030099; GO:0030111; GO:0033146; GO:0043371; GO:0043378; GO:0043565; GO:0045589; GO:0045616; GO:0045637; GO:0045652; GO:0045944; GO:0048469; GO:0050855; GO:0060216; GO:1902036; GO:2000810,1E-07,1E-07,1E-07,0.0395218361072021,0.0342402584549381,0.0391161602631004,0.0391161602631004,-4.6760914309688100,0.0376259849417468,0.0188130924708734,22.9737165036906,1.16703808801837E-05,0.00104743504543692,0.803532235748106,21508,2.9798728994194,4,3,0,1E-07,0.0391161602631004,391161.602631004,18.5774052332427
57,58,96,96,96,Q9H2V7,SPNS1,SPNS1_HUMAN,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; vesicle [GO:0031982]; sphingolipid transporter activity [GO:0046624]; locomotion [GO:0040011]; sphingosine-1-phosphate signaling pathway [GO:0003376]; transmembrane transport [GO:0055085],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:12815463}; Multi-pass membrane protein {ECO:0000269|PubMed:12815463}. Note=Colocalizes with SDHB.,Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1),GO:0003376; GO:0005743; GO:0005765; GO:0016021; GO:0031982; GO:0040011; GO:0046624; GO:0055085,0.00547656840820406,1E-07,1E-07,0.045718054664116,0.0463658678488652,0.0439297827285213,0.045718054664116,-4.451092172620880,0.0435123122777662,0.0235817456082844,22.9385287484755,1.17469350890122E-05,0.00104743504543692,0.795482363287444,56630,2.9798728994194,3,2,0,1E-07,0.045718054664116,457180.54664116,18.8024044915907
58,59,97,97,97,Q9UI30,TRMT112,TR112_HUMAN,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:25851604}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:25851604}. Note=Localizes to a polarized perinuclear structure, overlapping partially with the Golgi and lysosomes (PubMed:25851604). {ECO:0000269|PubMed:25851604}.",Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234,1E-07,1E-07,1E-07,0.042579049593952,0.0372563341037572,0.037122529697171,0.0372563341037572,-4.7463704647844900,0.0389858711316267,0.0194930355658134,22.4795353799396,1.28044972539941E-05,0.00112501223308622,0.689351544793606,14199,2.94884275512332,6,3,0,1E-07,0.0372563341037572,372563.341037572,18.507126199427
59,60,98,98,98,Q96S59,RANBP9,RANB9_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; Ran GTPase binding [GO:0008536]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; protein-containing complex assembly [GO:0065003],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Nucleus {ECO:0000269|PubMed:14511641, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. Cell membrane; Peripheral membrane protein {ECO:0000269|PubMed:14722085}. Note=The unphosphorylated form is predominantly cytoplasmic. A phosphorylated form is associated with the plasma membrane. {ECO:0000269|PubMed:14722085}.",Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7),GO:0000165; GO:0005088; GO:0005634; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007020; GO:0007411; GO:0008536; GO:0019899; GO:0065003; GO:0070373,0.0045929561594038,0.00921217112117963,0.0153386500681327,0.0998672883930188,0.0949411495320069,0.0914483711607594,0.0949411495320069,-3.3968226719845700,0.0857043439123563,0.0525667644057502,22.4486396961736,1.28798129488843E-05,0.00112501223308622,0.682131324438309,77847,2.94884275512332,6,0,0,0.00921217112117963,0.0949411495320069,10.3060557910967,3.36542040243861
60,61,99,99,99,P51116,FXR2,FXR2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148],SUBCELLULAR LOCATION: Cytoplasm.,Fragile X mental retardation syndrome-related protein 2,GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0016020; GO:0017148; GO:0022625; GO:0042802; GO:0042803; GO:0046982,0.00091167787473095,0.00232950903605502,0.0006930938619805,0.0592791785776936,0.0691823223403844,0.0636293834104186,0.0636293834104186,-3.9741630483051900,0.0627188678519101,0.0326708608502105,22.3219917282885,1.3194307216466E-05,0.00114084110881767,0.652431643974403,74223,2.94277483793838,11,0,0,0.00091167787473095,0.0636293834104186,69.7937124219414,6.12502516762216
61,62,100,100,100,Q8TAD8,SNIP1,SNIP1_HUMAN,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of transcription, DNA-templated [GO:0006355]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10887155}.,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0007249; GO:0035196,1E-07,1E-07,1E-07,0.0680814465425365,0.0666940467417492,0.0582931946842277,0.0666940467417492,-3.9062982007707000,0.0643561293228378,0.0321781646614189,21.8073396990296,1.45738056795628E-05,0.00124559696975922,0.530014175656856,45778,2.90462245697369,4,3,0,1E-07,0.0666940467417492,666940.467417492,19.3471984634408
62,63,101,101,101,Q5JU69,TOR2A,TOR2A_HUMAN,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein homooligomerization [GO:0051260],SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000250}.,Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1),GO:0005524; GO:0005788; GO:0051085; GO:0051260,1E-07,1E-07,1E-07,0.035658554053597,0.0315106290049283,0.0306201125786437,0.0315106290049283,-4.9880176365226200,0.0325963318790563,0.0162982659395282,21.7545223011356,1.47252188242037E-05,0.00124559696975922,0.51729057820109,35714,2.90462245697369,3,3,0,1E-07,0.0315106290049283,315106.290049283,18.2654790276889
63,64,102,102,102,P19404,NDUFV2,NDUV2_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; nervous system development [GO:0007399]",SUBCELLULAR LOCATION: Mitochondrion inner membrane.,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (NADH-ubiquinone oxidoreductase 24 kDa subunit)",GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009055; GO:0032981; GO:0043209; GO:0046872; GO:0048738; GO:0051537,1E-07,1E-07,1E-07,0.00518738126340539,0.00439568288240274,0.00485557581399394,0.00485557581399394,-7.68614189226488000,0.00481277998660069,0.00240648999330035,21.6646628135535,1.49872982951404E-05,0.00124559696975922,0.495573745220572,27392,2.90462245697369,6,3,0,1E-07,0.00485557581399394,48555.7581399394,15.5673547719467
64,65,103,103,103,Q9NP72,RAB18,RAB18_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; lipid particle organization [GO:0034389]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,Ras-related protein Rab-18,GO:0001654; GO:0003924; GO:0005525; GO:0005622; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0015031; GO:0019003; GO:0030667; GO:0034389; GO:0043312; GO:0051170; GO:0071782; GO:0071786,0.00260721953807314,0.00148084060077253,0.00581571477569092,0.0645389383633154,0.0650106570870551,0.0572743539284469,0.0645389383633154,-3.9536863434431600,0.0589733914880936,0.0327879540488923,21.6644562058126,1.49879074632243E-05,0.00124559696975922,0.495523711347854,22977,2.90462245697369,6,0,0,0.00260721953807314,0.0645389383633154,24.7539332307293,4.62958587267064
65,66,107,107,107,Q9H0E2,TOLLIP,TOLIP_HUMAN,"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1, Type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,Toll-interacting protein,GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0007267; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0033235; GO:0035325; GO:0035556; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0043312; GO:0045087; GO:0045092; GO:0045321; GO:0045323; GO:0048471; GO:0070062; GO:0070498,1E-07,0.00032969835031174,1E-07,0.0422583717246738,0.0372344415802906,0.0439002700191436,0.0422583717246738,-4.5646190105282500,0.0410210616579321,0.0206204969457366,21.1659192036226,1.65510040913157E-05,0.00132408032730526,0.37340848369524,30282,2.87808566697547,5,2,0,1E-07,0.0422583717246738,422583.717246738,18.6888776536833
66,67,108,108,108,Q8N350,CBARP,CBARP_HUMAN,cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]; ion channel binding [GO:0044325]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of voltage-gated calcium channel activity [GO:1901386],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q66L44}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:Q66L44}. Cell membrane {ECO:0000250|UniProtKB:Q66L44}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:Q66L44}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q66L44}.",Voltage-dependent calcium channel beta subunit-associated regulatory protein,GO:0005886; GO:0016021; GO:0030054; GO:0030141; GO:0030426; GO:0030672; GO:0044325; GO:0045955; GO:1901386; GO:1903170,0.0084531931706784,0.00707743929864754,0.00361837494062206,0.0362298495485486,0.0355150090702108,0.0360279747060872,0.0360279747060872,-4.7947386360840900,0.0295412753049662,0.0211536401224658,21.052570829187,1.69339846013307E-05,0.00134217507580918,0.34525046484683,73929,2.87219083029327,11,0,0,0.00707743929864754,0.0360279747060872,5.09053814321967,2.3478181780133
67,68,109,109,109,Q8NFT8,DNER,DNER_HUMAN,dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Note=Present on the membrane of dendrites and cell bodies but excluded from axonal membrane. Also found in early endosomes in the somatodendritic region (By similarity). {ECO:0000250}.,Delta and Notch-like epidermal growth factor-related receptor,GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741,0.00299779358766243,0.0103106372202326,0.00596213356547506,0.133619320593388,0.154660035464849,0.137617687264885,0.137617687264885,-2.861262191057650,0.135542159649917,0.0741946012827487,20.6787881058028,1.82766927134779E-05,0.0014353072442878,0.251330196077543,78475,2.8430551231696,8,0,0,0.00596213356547506,0.137617687264885,23.0819530883689,4.52869339823341
68,69,111,111,111,O00560,SDCBP,SDCB1_HUMAN,"adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytoskeletal adaptor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; neutrophil degranulation [GO:0043312]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]","SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000269|PubMed:11179419}. Cell junction, adherens junction {ECO:0000269|PubMed:11179419}. Cell membrane {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:25893292, ECO:0000269|PubMed:27386966}; Peripheral membrane protein {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:27386966}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}. Nucleus {ECO:0000269|PubMed:11179419}. Melanosome {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}. Cytoplasm, cytosol {ECO:0000269|PubMed:11179419}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11179419}. Secreted, exosome {ECO:0000269|PubMed:22660413}. Membrane raft {ECO:0000269|PubMed:25893292}. Note=Mainly membrane-associated. Localized to adherens junctions, focal adhesions and endoplasmic reticulum. Colocalized with actin stress fibers. Also found in the nucleus. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Associated to the plasma membrane in the presence of FZD7 and phosphatidylinositol 4,5-bisphosphate (PIP2) (PubMed:27386966). {ECO:0000269|PubMed:11179419, ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:27386966}.",Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0043231; GO:0043312; GO:0045121; GO:0045545; GO:0046330; GO:0046982; GO:0047485; GO:0048013; GO:0070062; GO:0072562; GO:1903543; GO:1903553; GO:1903561,1E-07,7.44294034248357E-07,1E-07,0.00536972674586908,0.00495490219811647,0.0058990081008379,0.00536972674586908,-7.54093561030801000,0.00540756425026307,0.00270409688980962,20.4682873135353,1.90906277270805E-05,0.00147221417426855,0.197702502378764,32444,2.83202900525879,4,2,0,1E-07,0.00536972674586908,53697.2674586908,15.7125610539035
69,70,113,113,113,P51784,USP11,UBP11_HUMAN,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726}. Cytoplasm {ECO:0000269|PubMed:15314155}. Chromosome {ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}. Note=Predominantly nuclear (PubMed:12084015, PubMed:15314155). Associates with chromatin (PubMed:20601937, PubMed:20233726). {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}.",Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11),GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016579; GO:0036459,0.00075834735020277,0.00060179288076604,0.0004240866361353,0.0282794626077139,0.0334551375063042,0.0322760021604831,0.0322760021604831,-4.9533942982852400,0.030742125135799,0.0159658048569342,20.2997357386358,1.97747170238685E-05,0.00149734104963587,0.154370865154567,109817,2.8246792690588,22,0,0,0.00060179288076604,0.0322760021604831,53.6330740892083,5.74505104163231
70,71,114,114,114,Q6IEE7,TMEM132E,T132E_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Transmembrane protein 132E,GO:0016021,0.00519156589455286,0.00257359130156002,0.00595723861151061,0.0734429446153301,0.0833319790890928,0.072185593554902,0.0734429446153301,-3.7672322865680800,0.0717460404839005,0.0404471521778247,20.2537887142873,1.99664098085051E-05,0.00149734104963587,0.142497560651421,107094,2.8246792690588,6,0,0,0.00519156589455286,0.0734429446153301,14.1465881599208,3.82238224417898
71,72,116,116,116,Q8NFZ8,CADM4,CADM4_HUMAN,cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2),GO:0005102; GO:0005887; GO:0005913; GO:0007156; GO:0007157; GO:0008037; GO:0042803; GO:0050839,1E-07,1E-07,1E-07,0.0699266356877477,0.0633698159432273,0.0585736983419084,0.0633698159432273,-3.9800603645251000,0.0639566166576278,0.0319784083288139,20.1402598354906,2.04499546164253E-05,0.00150906561652242,0.113046746379604,42785,2.82129187601364,6,3,0,1E-07,0.0633698159432273,633698.159432273,19.2734362996864
72,73,117,117,117,Q9BTT0,ANP32E,AN32E_HUMAN,cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone binding [GO:0042393]; phosphatase inhibitor activity [GO:0019212]; histone exchange [GO:0043486]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; regulation of apoptotic process [GO:0042981],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.,Acidic leucine-rich nuclear phosphoprotein 32 family member E (LANP-like protein) (LANP-L),GO:0000812; GO:0005634; GO:0006334; GO:0006913; GO:0019212; GO:0031410; GO:0042393; GO:0042981; GO:0043486,1E-07,1E-07,1E-07,0.00605005396307853,0.00547759525720416,0.00506255374073315,0.00547759525720416,-7.51224161628163000,0.00552996765367195,0.00276508382683597,19.9798759574533,2.11578871140285E-05,0.00154796165552209,0.0711629537650218,30692,2.81023980140598,5,3,0,1E-07,0.00547759525720416,54775.9525720416,15.7412550479299
73,74,118,118,118,O75164,KDM4A,KDM4A_HUMAN,"cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959, ECO:0000269|PubMed:16024779}.",Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A),GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0008270; GO:0010507; GO:0010629; GO:0016032; GO:0016577; GO:0031625; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045892; GO:0051864; GO:0070544,1E-07,1.08922508626597E-05,1E-07,0.043504702610598,0.0516855089156837,0.045691868513397,0.045691868513397,-4.451918748762780,0.0469569959296053,0.0234821953817569,19.8970969016638,2.15350724021143E-05,0.00156220525222117,0.049416498785595,120662,2.80626190640563,5,2,0,1E-07,0.045691868513397,456918.68513397,18.8015779154488
74,75,119,119,119,Q8TC26,TMEM163,TM163_HUMAN,cell junction [GO:0030054]; early endosome membrane [GO:0031901]; integral component of synaptic vesicle membrane [GO:0030285]; zinc ion binding [GO:0008270],"SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Early endosome membrane {ECO:0000250}. Note=Glutamatergic synaptic vesicles. {ECO:0000250}.",Transmembrane protein 163,GO:0008270; GO:0030054; GO:0030285; GO:0031901,0.00039119283662443,0.00019739276380277,0.00023421787541616,0.0143595401327647,0.0162828614755613,0.0171249856232212,0.0162828614755613,-5.9405019352662700,0.0156481945852346,0.00809836511789842,19.7559400326871,2.2197542468106E-05,0.00158701450172676,0.0121288925547915,31469,2.79941910475672,5,0,0,0.00023421787541616,0.0162828614755613,69.520148479828,6.11935925832395
75,76,120,120,120,Q92993,KAT5,KAT5_HUMAN,"NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; androgen receptor binding [GO:0050681]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to estradiol stimulus [GO:0071392]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone acetylation [GO:0016573]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein acetylation [GO:1901985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of growth [GO:0040008]; response to ionizing radiation [GO:0010212]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17360565}. Nucleus, nucleolus. Cytoplasm, perinuclear region. Note=Upon stimulation with EDN1, it is exported from the nucleus to the perinuclear region and UV irradiation induces translocation into punctuate subnuclear structures named nuclear bodies.",Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (cPLA(2)-interacting protein),GO:0000122; GO:0000729; GO:0000812; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006302; GO:0006303; GO:0006351; GO:0006978; GO:0010212; GO:0016032; GO:0016407; GO:0016573; GO:0030521; GO:0032703; GO:0032777; GO:0035267; GO:0040008; GO:0043161; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0050681; GO:0070491; GO:0071392; GO:1901985; GO:1904837,1E-07,1E-07,1E-07,0.0192944807656719,0.0213636723181382,0.0231576833638137,0.0213636723181382,-5.5486965287143200,0.0212718454825413,0.0106360227412706,19.7454294337891,2.22478668466369E-05,0.00158701450172676,0.00934202366124737,58582,2.79941910475672,3,3,0,1E-07,0.0213636723181382,213636.723181382,17.7048001354972
76,77,121,121,121,Q8IV32,CCDC71,CCD71_HUMAN,NA,NA,Coiled-coil domain-containing protein 71,NA,0.00229509542347874,0.00510524143082336,0.00461529169232683,0.120711417563979,0.126050914108978,0.106178763445263,0.120711417563979,-3.050365954139110,0.11364182219053,0.0608261206108081,19.6235907824043,2.28416001470156E-05,0.00161590163023516,-0.0230696354412299,49648,2.7915850809045,3,0,0,0.00461529169232683,0.120711417563979,26.154667052717,4.70899649960213
77,79,123,123,123,Q9P2S2,NRXN2,NRX2A_HUMAN,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha),GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793,0.00032730805896553,0.00011722938713364,0.00026843055994615,0.0431888479140821,0.05076171790974,0.0512333148002215,0.05076171790974,-4.30011529518349,0.0481569708726661,0.0243161414383482,19.1387165885878,2.5406653368044E-05,0.00176813782788989,-0.15403625553488,184982,2.75248388436877,14,0,0,0.00026843055994615,0.05076171790974,189.105584401133,7.56304815733983
78,80,124,124,124,P42224,STAT1,STAT1_HUMAN,"axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; CCR5 chemokine receptor binding [GO:0031730]; core promoter binding [GO:0001047]; DNA binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nuclear hormone receptor binding [GO:0035257]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; repressing transcription factor binding [GO:0070491]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding [GO:0000983]; transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000982]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-like protein ligase binding [GO:0044389]; blood circulation [GO:0008015]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; JAK-STAT cascade [GO:0007259]; macrophage derived foam cell differentiation [GO:0010742]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; renal tubule development [GO:0061326]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to interferon-beta [GO:0035456]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; transcription, DNA-templated [GO:0006351]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:27796300, ECO:0000269|PubMed:28753426}. Nucleus {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28753426}. Note=Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to IFN-gamma and signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4 (PubMed:15322115). Monomethylation at Lys-525 is required for phosphorylation at Tyr-701 and translocation into the nucleus (PubMed:28753426). Translocates into the nucleus in response to interferon-beta stimulation (PubMed:26479788). {ECO:0000269|PubMed:15322115, ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:28753426}.",Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84),GO:0000122; GO:0000790; GO:0000978; GO:0000979; GO:0000981; GO:0000982; GO:0000983; GO:0001047; GO:0001937; GO:0002053; GO:0002230; GO:0003340; GO:0003690; GO:0003700; GO:0005164; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006351; GO:0007221; GO:0007259; GO:0007584; GO:0008015; GO:0009612; GO:0010742; GO:0016032; GO:0016525; GO:0019221; GO:0019899; GO:0030424; GO:0030425; GO:0031730; GO:0032727; GO:0032869; GO:0032991; GO:0033209; GO:0034097; GO:0035035; GO:0035257; GO:0035456; GO:0035458; GO:0038114; GO:0042393; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0043124; GO:0043434; GO:0044389; GO:0045296; GO:0045648; GO:0045893; GO:0045944; GO:0046725; GO:0048471; GO:0048661; GO:0051591; GO:0051607; GO:0051721; GO:0051770; GO:0060333; GO:0060334; GO:0060337; GO:0061326; GO:0070102; GO:0070106; GO:0070491; GO:0070757; GO:0071346; GO:0071407; GO:0072136; GO:0072162; GO:0072308; GO:1990841,7.59357229944397E-05,1.68484393202887E-05,1E-07,0.0384481228123816,0.0448896966650259,0.0459338719104872,0.0448896966650259,-4.4774718422702400,0.0430596024085266,0.0215607625917016,19.0601727495808,2.58548859048094E-05,0.00178482115600942,-0.175555961337603,87335,2.74840529487365,13,1,0,1.68484393202887E-05,0.0448896966650259,2664.32372825002,11.3795536721636
79,81,125,125,125,Q9HCD6,TANC2,TANC2_HUMAN,in utero embryonic development [GO:0001701],NA,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",GO:0001701,0.00077948014173808,0.00934722749592745,0.00047999277371524,0.073398918167352,0.078571032511672,0.0833273027967513,0.078571032511672,-3.669858670606230,0.0748968510214648,0.040983992314526,19.0073765369844,2.61616581429996E-05,0.00179155034963261,-0.190069979066797,219650,2.7467709819381,29,0,0,0.00077948014173808,0.078571032511672,100.799274163001,6.65534144006882
80,82,127,127,127,Q8IVW6,ARID3B,ARI3B_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0001205]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:10446990, ECO:0000269|PubMed:17400556}.",AT-rich interactive domain-containing protein 3B (ARID domain-containing protein 3B) (Bright and dead ringer protein) (Bright-like protein),GO:0000977; GO:0000978; GO:0000980; GO:0000981; GO:0001077; GO:0001205; GO:0001228; GO:0003677; GO:0005634; GO:0005654,0.00035148534545217,0.00068255409571036,0.00036899053473545,0.106758407834015,0.113503225866054,0.0939774580856109,0.106758407834015,-3.227578400097570,0.104278687269928,0.0526070202935964,18.8680623194349,2.69929103637097E-05,0.00181936466703429,-0.228558174901845,60637,2.74008024375795,13,0,0,0.00036899053473545,0.106758407834015,289.325599938644,8.17655017038943
81,83,128,128,128,Q96IG2,FBXL20,FXL20_HUMAN,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),GO:0000209; GO:0001662; GO:0004842; GO:0005829; GO:0043687,7.09139218819764E-05,5.39277516230444E-05,7.65169294522795E-05,0.0279561957731262,0.0325532038518666,0.0335710972025077,0.0325532038518666,-4.9410566508773000,0.0312930460748477,0.015713642571743,18.7726871556485,2.75807764385349E-05,0.00183504822985909,-0.255067688131222,48423,2.73635251686889,10,0,0,7.09139218819764E-05,0.0325532038518666,459.052369237815,8.84251493716097
82,84,129,129,129,Q86U70,LDB1,LDB1_HUMAN,"beta-catenin-TCF complex [GO:1990907]; cell leading edge [GO:0031252]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enhancer sequence-specific DNA binding [GO:0001158]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription corepressor activity [GO:0003714]; transcription factor activity, transcription factor binding [GO:0000989]; anterior/posterior axis specification [GO:0009948]; cellular component assembly [GO:0022607]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial structure maintenance [GO:0010669]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; histone H3-K4 acetylation [GO:0043973]; multicellular organism development [GO:0007275]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of cell adhesion [GO:0045785]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of focal adhesion assembly [GO:0051893]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of kinase activity [GO:0043549]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; Wnt signaling pathway [GO:0016055]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (hLdb1) (Nuclear LIM interactor),GO:0000790; GO:0000972; GO:0000989; GO:0001102; GO:0001158; GO:0001702; GO:0001942; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006351; GO:0006355; GO:0006366; GO:0007275; GO:0009948; GO:0010669; GO:0016055; GO:0019899; GO:0021702; GO:0022607; GO:0030182; GO:0030274; GO:0030334; GO:0031252; GO:0032784; GO:0032991; GO:0035019; GO:0042803; GO:0043549; GO:0043621; GO:0043973; GO:0045647; GO:0045785; GO:0045892; GO:0045944; GO:0046985; GO:0051893; GO:1902036; GO:1990907,0.00821134929723639,1E-07,6.79658929028217E-06,0.053387468203666,0.0555510277340775,0.0566224815424723,0.0555510277340775,-4.1700425870147000,0.0524475771978964,0.0289632038944571,18.7609271323262,2.7654348323811E-05,0.00183504822985909,-0.25834548468422,46533,2.73635251686889,6,1,0,6.79658929028217E-06,0.0555510277340775,8173.3683413098,12.9967150371872
83,85,133,133,133,Q8N2K0,ABHD12,ABD12_HUMAN,AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996],SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.,Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12),GO:0002084; GO:0004622; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0052651,9.08575774364466E-05,0.00012612314900031,0.00010365343655635,0.0338526322126245,0.0309613253883585,0.0380007108284581,0.0338526322126245,-4.8845881748087400,0.034164678088816,0.017189217098739,17.3282372891978,3.87528185897403E-05,0.00249416636938479,-0.673449770251707,45097,2.60307458097137,6,0,0,0.00010365343655635,0.0338526322126245,326.594402822534,8.35135625596714
84,86,135,135,135,O43526,KCNQ2,KCNQ2_HUMAN,axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10788442, ECO:0000269|PubMed:9836639}; Multi-pass membrane protein {ECO:0000255}.",Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2),GO:0005249; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0071805,0.0146164008314944,0.0213728194919574,0.0161100316066065,0.0944180060489899,0.085967639889093,0.10029760066305,0.0944180060489899,-3.4047941738272000,0.0761946648903583,0.0554637497551986,17.0291852140434,4.17235767923829E-05,0.00262776305627535,-0.764299168504268,95848,2.58041379740425,10,0,0,0.0161100316066065,0.0944180060489899,5.86082065849395,2.55110269144683
85,87,136,136,136,Q9BYV9,BACH2,BACH2_HUMAN,"Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0001206]; import into nucleus [GO:0051170]; protein ubiquitination [GO:0016567]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17018862}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978, ECO:0000269|PubMed:17018862}. Note=Nucleocytoplasmic shuttling is controlled by phosphorylation. {ECO:0000269|PubMed:17018862}.",Transcription regulator protein BACH2 (BTB and CNC homolog 2),GO:0000980; GO:0000981; GO:0001206; GO:0003700; GO:0005634; GO:0005829; GO:0006366; GO:0016567; GO:0031463; GO:0051170,0.0075793632058428,0.00011185778111509,6.48942922698347E-05,0.0906871313804255,0.0784639773112212,0.0779441298738631,0.0784639773112212,-3.6718257228055100,0.079779707762094,0.0424752256407896,17.0266913272737,4.17495065015709E-05,0.00262776305627535,-0.765063285229251,92537,2.58041379740425,12,0,0,0.00011185778111509,0.0784639773112212,701.461950425156,9.45422103927675
86,88,137,137,137,P61006,RAB8A,RAB8A_HUMAN,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein kinase binding [GO:0019901]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; post-translational protein modification [GO:0043687]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:12221131}; Lipid-anchor {ECO:0000305|PubMed:12221131}; Cytoplasmic side {ECO:0000305|PubMed:12221131}. Golgi apparatus {ECO:0000269|PubMed:15837803}. Recycling endosome membrane {ECO:0000269|PubMed:19864458}. Cell projection, cilium {ECO:0000269|PubMed:21844891}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Cytoplasmic vesicle, phagosome membrane {ECO:0000250|UniProtKB:Q92930}; Lipid-anchor {ECO:0000250|UniProtKB:Q92930}; Cytoplasmic side {ECO:0000250|UniProtKB:Q92930}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000250|UniProtKB:P55258}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:P55258}. Midbody {ECO:0000269|PubMed:22159412}. Note=Colocalizes with OPTN at the Golgi complex and in vesicular structures close to the plasma membrane (PubMed:15837803). In the GDP-bound form, present in the perinuclear region (PubMed:12221131). Shows a polarized distribution to distal regions of cell protrusions in the GTP-bound form (PubMed:12221131). Colocalizes with PARD3, PRKCI, EXOC5, OCLN, PODXL and RAB11A in apical membrane initiation sites (AMIS) during the generation of apical surface and lumenogenesis (PubMed:20890297). Localizes to tubular recycling endosome (PubMed:19864458). Recruited to phagosomes containing S.aureus or M.tuberculosis (PubMed:21255211). {ECO:0000269|PubMed:12221131, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:19864458, ECO:0000269|PubMed:20890297, ECO:0000269|PubMed:21255211}.",Ras-related protein Rab-8A (Oncogene c-mel),GO:0000139; GO:0003924; GO:0005525; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017137; GO:0017157; GO:0019003; GO:0019901; GO:0030140; GO:0030496; GO:0030667; GO:0030670; GO:0031489; GO:0032588; GO:0032869; GO:0036064; GO:0043025; GO:0043197; GO:0043687; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060271; GO:0070062; GO:0072659; GO:0097546; GO:0097730; GO:0098969,1E-07,1E-07,1E-07,0.0219976707357339,0.0190731319982342,0.0236184993724284,0.0219976707357339,-5.5065054203844000,0.0215630007021322,0.0107816003510661,16.7979755583331,4.42141734363585E-05,0.00276257901178999,-0.835606779254491,23668,2.55868529198785,4,3,0,1E-07,0.0219976707357339,219976.707357339,17.7469912438271
87,89,138,138,138,Q9P2Y5,UVRAG,UVRAG_HUMAN,"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; protein-containing complex [GO:0032991]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; multivesicular body sorting pathway [GO:0071985]; positive regulation of autophagosome maturation [GO:1901098]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of vesicle-mediated transport [GO:0060627]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]","SUBCELLULAR LOCATION: Late endosome {ECO:0000269|PubMed:18843052}. Lysosome {ECO:0000269|PubMed:18843052}. Early endosome {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:18843052}. Endoplasmic reticulum {ECO:0000269|PubMed:24056303}. Midbody {ECO:0000269|PubMed:20643123}. Chromosome, centromere {ECO:0000269|PubMed:22542840}. Note=Colocalizes with RAB9-positive compartments involved in retrograde transport from late endosomes to trans-Golgi network. Colocalization with early endosomes is only partial.",UV radiation resistance-associated gene protein (p63),GO:0000149; GO:0000775; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035493; GO:0045335; GO:0046718; GO:0051684; GO:0060627; GO:0071900; GO:0071985; GO:0097680; GO:1901098,0.00029064824949434,0.0260472690639087,0.00043557900975412,1.03881118627187,1.12130456432587,1.27677084485421,1.12130456432587,0.16517819051087,1.13670436637626,0.577276681962518,16.758048096783,4.46626014538993E-05,0.00277037585829984,-0.848017201790036,78151,2.55746130598532,4,0,0,0.00043557900975412,1.12130456432587,2574.28512213854,11.329956136789
88,90,139,139,139,Q14344,GNA13,GNA13_HUMAN,brush border membrane [GO:0031526]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; type 1 angiotensin receptor binding [GO:0031702]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G-protein coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10747909}; Lipid-anchor {ECO:0000269|PubMed:10747909}. Melanosome {ECO:0000269|PubMed:17081065}. Cytoplasm {ECO:0000269|PubMed:10747909, ECO:0000269|PubMed:18703424}. Nucleus {ECO:0000269|PubMed:18703424}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Detected in the cytoplasm of Leydig cells and in the seminiferous epithelium, including differentiating cells from the spermatogonia to mature spermatozoa stages (PubMed:18703424). In round spermatids, also present in the nuclei (PubMed:18703424). {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18703424}.",Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13),GO:0001569; GO:0001701; GO:0003924; GO:0005085; GO:0005089; GO:0005525; GO:0005634; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031702; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062,0.00018598020303809,0.00014588741350679,0.00010078704246661,0.019891772587495,0.0189182552072478,0.0161251033334628,0.0189182552072478,-5.7240771518334500,0.018167492156398,0.00922796429786952,16.6703221795535,4.56676656603879E-05,0.00281233969822245,-0.875385573384083,44050,2.55093222271578,9,0,0,0.00014588741350679,0.0189182552072478,129.677089698813,7.01877980816567
89,91,140,140,140,Q96PB7,OLFM3,NOE3_HUMAN,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; eye photoreceptor cell development [GO:0042462],"SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Cell junction, synapse {ECO:0000250}.",Noelin-3 (Olfactomedin-3) (Optimedin),GO:0005615; GO:0005794; GO:0030054; GO:0032281; GO:0042462; GO:0045202,0.0690147618512916,0.0739736122877707,0.0755084231085009,0.153529515085336,0.151505959328862,0.13964033686964,0.151505959328862,-2.722553553168630,0.0753930046787581,0.110528768088567,16.4305530654769,4.85600639705985E-05,0.00296910105420231,-0.950906200350826,54930,2.52737502081569,4,0,0,0.0739736122877707,0.151505959328862,2.04810816510456,1.03429190925355
90,92,141,141,141,P50542,PEX5,PEX5_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; negative regulation of protein homotetramerization [GO:1901094]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; protein ubiquitination [GO:0016567]",SUBCELLULAR LOCATION: Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13).,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),GO:0000268; GO:0005052; GO:0005622; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016567; GO:0019899; GO:0031267; GO:0032991; GO:0045046; GO:0047485; GO:0051262; GO:1901094,0.00224713364208029,0.00013571884492697,0.00021560190382077,0.0385438218263584,0.0326215910757706,0.032340115306243,0.0326215910757706,-4.9380290404304900,0.0336356912725147,0.0176839970998667,16.3059295585571,5.01523941081511E-05,0.00304471272032463,-0.990581926920443,70865,2.51645367835576,19,0,0,0.00021560190382077,0.0326215910757706,151.304744984483,7.24131342160063
91,94,144,144,144,Q9H4M3,FBXO44,FBX44_HUMAN,cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; protein polyubiquitination [GO:0000209],NA,F-box only protein 44 (F-box protein FBX30) (F-box/G-domain protein 3),GO:0000209; GO:0004842; GO:0005829; GO:0010498; GO:0019005; GO:0043687,0.00522866891745668,0.00265003308350982,0.00353120338371854,0.066910320480708,0.0545174054553487,0.0597098171533426,0.0597098171533426,-4.0658880389535600,0.0565758792349048,0.0320912414123474,15.9648604956508,5.48504757234573E-05,0.0032605560568944,-1.10068610024926,29747,2.48670832881317,3,0,0,0.00353120338371854,0.0597098171533426,16.9091979886089,4.07973632853851
92,95,145,145,145,O00506,STK25,STK25_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; neuron projection morphogenesis [GO:0048812]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of mitotic cell cycle [GO:0007346]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15037601}. Golgi apparatus {ECO:0000269|PubMed:15037601}. Note=Localizes to the Golgi apparatus.,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),GO:0000139; GO:0004672; GO:0005524; GO:0005737; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0007346; GO:0008349; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0042981; GO:0046777; GO:0046872; GO:0048812; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168,0.00022463425474581,4.2373442252058E-05,0.00011648817134582,0.0317440819893575,0.0276976868779272,0.034732713278379,0.0317440819893575,-4.9773685327059900,0.03126366209244,0.0157596630023346,15.8858278299256,5.60153385115182E-05,0.00330356974010576,-1.12652404546785,48112,2.48101652057251,4,0,0,0.00011648817134582,0.0317440819893575,272.509059268502,8.09016038129546
93,96,146,146,146,Q9P0I2,EMC3,EMC3_HUMAN,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975],SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:22119785}; Multi-pass membrane protein {ECO:0000269|PubMed:22119785}.,ER membrane protein complex subunit 3 (Transmembrane protein 111),GO:0016021; GO:0034975; GO:0072546,1E-07,1E-07,1E-07,0.0235645757855431,0.0288243036207422,0.0289253825697706,0.0288243036207422,-5.1165704361921400,0.0271046539920187,0.0135524269960093,15.8637654722941,5.63459324831122E-05,0.00330356974010576,-1.13375902163895,29952,2.48101652057251,4,3,0,1E-07,0.0288243036207422,288243.036207422,18.1369262280194
94,97,148,148,148,Q6L8Q7,PDE12,PDE12_HUMAN,"mitochondrial matrix [GO:0005759]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]","SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:21245038, ECO:0000269|PubMed:21666256, ECO:0000269|PubMed:22285541}.","2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)",GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005759; GO:0006397; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503,1E-07,6.62712574602149E-07,8.41892988307405E-06,0.00382282546659327,0.00466034357710286,0.00471881982340086,0.00466034357710286,-7.74534796525239000,0.00439760240821311,0.00220186175159245,15.716179638106,5.86202418394379E-05,0.0033850683863866,-1.18240883843641,67352,2.47043255311463,9,1,0,6.62712574602149E-07,0.00466034357710286,7032.2244600544,12.7797654049499
95,98,149,149,149,O43252,PAPSS1,PAPS1_HUMAN,cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103],NA,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428,2.39545729325481E-05,1.97495995909339E-05,3.43353749080633E-05,0.0531453218094854,0.0448620385335785,0.0430731171908062,0.0448620385335785,-4.4783610117164700,0.0470008126621462,0.0235264195135503,15.6971063255596,5.89223352303275E-05,0.0033850683863866,-1.18872829433919,70833,2.47043255311463,11,0,0,2.39545729325481E-05,0.0448620385335785,1872.79642429453,10.8709783697087
96,99,150,150,150,Q01082,SPTBN1,SPTB2_HUMAN,axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasm, myofibril, sarcomere, M line {ECO:0000250}. Note=Colocalizes with ANK2 in a distinct intracellular compartment of neonatal cardiomyocytes. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.","Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",GO:0000165; GO:0000281; GO:0003723; GO:0003779; GO:0005088; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0006888; GO:0007009; GO:0007182; GO:0007411; GO:0008091; GO:0014069; GO:0014731; GO:0030506; GO:0030673; GO:0031430; GO:0032437; GO:0032991; GO:0043001; GO:0044877; GO:0045296; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:1900042; GO:1903076; GO:1903078,7.07943784170472E-05,4.82721825268303E-05,4.48830217180345E-05,0.00107194673997846,0.00106052463252762,0.00088550576884657,0.00106052463252762,-9.88100615430495000,0.00095134251956357,0.00053032112066909,15.5775932218295,6.0859452877581E-05,0.00347304611088062,-1.22849551905848,274609,2.45928945061723,126,0,0,4.82721825268303E-05,0.00106052463252762,21.9696847545306,4.4574422634042
97,100,151,151,151,P61018,RAB4B,RAB4B_HUMAN,insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; glucose import [GO:0046323]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,Ras-related protein Rab-4B,GO:0003924; GO:0005525; GO:0005886; GO:0015031; GO:0030100; GO:0030667; GO:0032593; GO:0043312; GO:0046323; GO:0048471; GO:0055037,0.00397380354986047,0.00907544409773847,0.00355502353301168,0.0551311371243598,0.0565116582220698,0.0479729906119647,0.0551311371243598,-4.1809888312850100,0.0476705049259279,0.0293700095231675,15.5028245361811,6.21112096994054E-05,0.00352100632468152,-1.25352436133694,23587,2.45333319481854,3,0,0,0.00397380354986047,0.0551311371243598,13.8736443391359,3.79427490052969
98,101,152,152,152,P56211,ARPP19,ARP19_HUMAN,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of glucose import [GO:0046326],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,cAMP-regulated phosphoprotein 19 (ARPP-19),GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0015459; GO:0019212; GO:0019888; GO:0035308; GO:0045722; GO:0046326; GO:0051301; GO:0051721,0.00051281634772493,0.0130923474149059,0.00056488509492229,0.065763765957496,0.0686084504970245,0.0674113085345128,0.0674113085345128,-3.8908655598193900,0.0625378253771601,0.0359922623077644,15.1934762425366,6.76391082318046E-05,0.00380914977937005,-1.3583316216938,12323,2.41917195013375,3,0,0,0.00056488509492229,0.0674113085345128,119.336320148058,6.89888938555595
99,102,155,155,155,Q9H3K2,GHITM,GHITM_HUMAN,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:18417609}; Multi-pass membrane protein {ECO:0000269|PubMed:18417609}.,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),GO:0005739; GO:0005743; GO:0006915; GO:0016021; GO:0070062,8.3222951229239E-05,8.61809069664106E-05,6.75353417456324E-05,0.00856853688907367,0.00721192545497774,0.00688844943560659,0.00721192545497774,-7.11539980002297000,0.00747732419323891,0.00381764182993321,15.0450031502563,7.0506626752029E-05,0.00389378532256367,-1.40936688522155,37205,2.40962799626644,3,0,0,8.3222951229239E-05,0.00721192545497774,86.6578912241693,6.4372592246722
100,104,158,158,158,O94985,CLSTN1,CSTN1_HUMAN,cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17332754}; Single-pass type I membrane protein {ECO:0000269|PubMed:17332754}. Golgi apparatus membrane {ECO:0000269|PubMed:17332754}. Cell projection {ECO:0000269|PubMed:17332754}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Nucleus {ECO:0000269|PubMed:17332754}. Note=Neurite tips. Localized in the postsynaptic membrane of both excitatory and inhibitory synapses (By similarity). The AlcICD fragment is translocated to the nucleus upon interaction with APBB1. {ECO:0000250}.",Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)],GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0030054; GO:0042988; GO:0042995; GO:0045211; GO:0050806; GO:0051965,0.0073028986921557,0.0145606749398158,0.0170814271663615,0.130813619579548,0.107472125031335,0.123552473309659,0.123552473309659,-3.016804203639000,0.10763107237407,0.0667972031198125,14.8827243055085,7.38136959180931E-05,0.00399839378050566,-1.4657052777797,109793,2.39811443676139,3,0,0,0.0145606749398158,0.123552473309659,8.48535344826687,3.084974754929
101,105,159,159,159,Q9Y3I1,FBXO7,FBX7_HUMAN,classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Note=Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria.",F-box only protein 7,GO:0000151; GO:0000209; GO:0000422; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043687; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:2000134,0.0015629129678563,1.32254608741598E-05,1.69098068040687E-05,0.0433534550101814,0.0373681834531893,0.0473228428806708,0.0433534550101814,-4.5277092176094800,0.0421504777028357,0.0216062549299294,14.8610722436084,7.42692302687384E-05,0.00399839378050566,-1.47326688441337,58503,2.39811443676139,5,0,0,1.69098068040687E-05,0.0433534550101814,2563.80545990331,11.3240710798946
102,106,162,162,162,Q9BZA7,PCDH11X,PC11X_HUMAN,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S),GO:0005509; GO:0005886; GO:0005887; GO:0007156; GO:0010923,6.13953333015862E-05,8.81179027104362E-05,0.0002119726864792,0.0170442993415345,0.0134972603774084,0.0145587998167584,0.0145587998167584,-6.1019647607339000,0.01491295787107,0.00757697424303208,14.6852689783524,7.80988160442234E-05,0.0041267028724602,-1.53505831021265,147558,2.38439679971875,3,0,0,8.81179027104362E-05,0.0145587998167584,165.219545279011,7.36824055576422
103,107,165,165,165,P07858,CTSB,CATB_HUMAN,endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; neutrophil degranulation [GO:0043312]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718],"SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:16733801}. Melanosome. Secreted, extracellular space {ECO:0000250}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.",Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],GO:0004197; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0005622; GO:0005730; GO:0005764; GO:0006508; GO:0008233; GO:0008234; GO:0030574; GO:0030855; GO:0036021; GO:0042470; GO:0042981; GO:0043231; GO:0043312; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0070062; GO:0097067; GO:1904813,1E-07,6.10251918503103E-07,1E-07,0.0174977117200815,0.0219351387338804,0.0182270681216663,0.0182270681216663,-5.7777736715410000,0.0192197027745699,0.00961012147125779,14.4951265392415,8.25177560696838E-05,0.00428092116337269,-1.60269502785762,37822,2.36846276997636,7,2,0,1E-07,0.0182270681216663,182270.681216663,17.4757229926705
104,108,166,166,166,P38606,ATP6V1A,VATA_HUMAN,"apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]",NA,V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha),GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0005902; GO:0006879; GO:0008286; GO:0015991; GO:0016241; GO:0016324; GO:0016469; GO:0033180; GO:0033572; GO:0034220; GO:0036295; GO:0043209; GO:0046034; GO:0046961; GO:0070062,6.08247966076147E-05,5.16535715940891E-05,5.67864427895499E-05,0.0225075042839487,0.0233985858816339,0.0184048759009068,0.0225075042839487,-5.4734500955230800,0.0213805670851661,0.0107467051462468,14.4062162006367,8.46893049681533E-05,0.00436711114775538,-1.63461467720857,68304,2.35980575466841,33,0,0,5.67864427895499E-05,0.0225075042839487,396.353481188482,8.63064383747338
105,109,167,167,167,P42229,STAT5A,STA5A_HUMAN,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; 2-oxoglutarate metabolic process [GO:0006103]; allantoin metabolic process [GO:0000255]; citrate metabolic process [GO:0006101]; creatine metabolic process [GO:0006600]; creatinine metabolic process [GO:0046449]; cytokine-mediated signaling pathway [GO:0019221]; fatty acid metabolic process [GO:0006631]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-7-mediated signaling pathway [GO:0038111]; isoleucine metabolic process [GO:0006549]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; lactation [GO:0007595]; oxaloacetate metabolic process [GO:0006107]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; succinate metabolic process [GO:0006105]; taurine metabolic process [GO:0019530]; transcription, DNA-templated [GO:0006351]; valine metabolic process [GO:0006573]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15534001}. Nucleus {ECO:0000269|PubMed:15534001}. Note=Translocated into the nucleus in response to phosphorylation.,Signal transducer and activator of transcription 5A,GO:0000255; GO:0000981; GO:0001938; GO:0003677; GO:0003700; GO:0004713; GO:0005654; GO:0005829; GO:0006101; GO:0006103; GO:0006105; GO:0006107; GO:0006351; GO:0006357; GO:0006549; GO:0006573; GO:0006600; GO:0006631; GO:0007259; GO:0007595; GO:0019221; GO:0019530; GO:0035723; GO:0038110; GO:0038111; GO:0040014; GO:0043536; GO:0046449; GO:0060397,0.0404813359046158,0.0196016355944869,0.0101997708608355,0.161386250144665,0.149389855530892,0.157296769854642,0.157296769854642,-2.668439050087590,0.132596711056753,0.0897259363150227,14.2877991485614,8.76917012655678E-05,0.00449485606486982,-1.67742228723838,90647,2.34728421076805,3,0,0,0.0196016355944869,0.157296769854642,8.02467575200117,3.00444309934638
106,110,169,169,169,O14775,GNB5,GNB5_HUMAN,cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P62881}.,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),GO:0001750; GO:0001917; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0007212; GO:0031682; GO:0043209; GO:0043547; GO:0051087; GO:1901386; GO:1902773,0.00195855459669664,0.00307958464778847,0.00096669654956062,0.0228833352445786,0.0269974810945608,0.0221969943498603,0.0228833352445786,-5.4495588496277700,0.0220243249649846,0.0130137744138409,14.1002105435005,9.27205268861673E-05,0.00468781022236785,-1.74593652905536,43566,2.32902997827126,4,0,0,0.00195855459669664,0.0228833352445786,11.6837872598366,3.546436089597
107,111,170,170,170,Q9ULU8,CADPS,CAPS1_HUMAN,cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; catecholamine secretion [GO:0050432]; exocytosis [GO:0006887]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein transport [GO:0015031]; synaptic vesicle priming [GO:0016082]; vesicle organization [GO:0016050],"SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Membrane-associated to vesicles. Strongly enriched in synaptic fractions. Preferentially binds to DCVs but not to SVs. Binds phosphoinosides, with a strong selectivity for PtdIns(4,5)P2 over PtdIns(3,4,5)P3. Probably localizes to different vesicles compared to CADPS2 (By similarity). {ECO:0000250}.",Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1),GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016050; GO:0016082; GO:0019901; GO:0030054; GO:0030659; GO:0046872; GO:0050432; GO:0098793; GO:0099525,2.81561991047886E-05,2.12572126126583E-05,0.00022173959569045,0.00396079737619359,0.00437205191750981,0.005039476649545,0.00437205191750981,-7.83747375174714000,0.00436705764528017,0.00227391315844272,14.0722540537035,9.35000013469655E-05,0.00468781022236785,-1.75622196046799,152786,2.32902997827126,34,0,0,2.81561991047886E-05,0.00437205191750981,155.278484188807,7.27871412958007
108,112,171,171,171,Q9Y315,DERA,DEOC_HUMAN,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25229427}. Cytoplasmic granule {ECO:0000269|PubMed:25229427}. Nucleus {ECO:0000269|PubMed:25229427}. Note=Recruited to stress granules but not to processing bodies upon arsenite or clotrimazole treatment or energy deprivation. {ECO:0000269|PubMed:25229427}.,Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),GO:0004139; GO:0005576; GO:0005634; GO:0005829; GO:0006098; GO:0009264; GO:0016052; GO:0034774; GO:0043312; GO:0046121; GO:0046386; GO:1904813,0.00095142928783335,1E-07,1E-07,0.00750554753369428,0.00920212728110235,0.0081453736088682,0.0081453736088682,-6.9398034114116300,0.00796713971194382,0.00430077961858303,14.0437721733411,9.43024205206452E-05,0.00468781022236785,-1.7667208289517,35231,2.32902997827126,10,2,0,1E-07,0.0081453736088682,81453.736088682,16.3136932527999
109,113,173,173,173,O96005,CLPTM1,CLPT1_HUMAN,external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of T cell differentiation in thymus [GO:0033081],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,Cleft lip and palate transmembrane protein 1,GO:0005887; GO:0007275; GO:0009897; GO:0016020; GO:0030154; GO:0033081,0.00044639830858009,0.00023164279022412,0.00025670328116627,0.0106475723860951,0.0114938065050205,0.0135198226156534,0.0114938065050205,-6.4429995226470300,0.0115754857089328,0.00609932431445659,14.0282966751792,9.47419589333689E-05,0.00468781022236785,-1.77243389147254,76097,2.32902997827126,7,0,0,0.00025670328116627,0.0114938065050205,44.7746770232197,5.48461112042792
110,114,174,174,174,Q92945,KHSRP,FUBP2_HUMAN,"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19198587}. Cytoplasm {ECO:0000269|PubMed:19198587}. Note=A small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites. {ECO:0000250}.,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),GO:0000375; GO:0003677; GO:0003723; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006397; GO:0006402; GO:0008380; GO:0010494; GO:0010586; GO:0010989; GO:0016020; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345; GO:2000628,2.80646522476799E-05,6.0386979280118E-05,0.00044731089266739,0.0203782846205133,0.0233864042031236,0.0263146498049579,0.0233864042031236,-5.4181861338610500,0.0231811920347999,0.011769183525465,13.9723946205698,9.63508158695346E-05,0.00473891585185536,-1.79312153376736,73115,2.32432100292738,13,0,0,6.0386979280118E-05,0.0233864042031236,387.275609442902,8.59721683329482
111,115,175,175,175,Q8IUH5,ZDHHC17,ZDH17_HUMAN,aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],"SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:15603740, ECO:0000269|PubMed:18794299}; Multi-pass membrane protein {ECO:0000255}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:18794299}; Multi-pass membrane protein {ECO:0000255}. Cell junction, synapse, presynaptic cell membrane {ECO:0000269|PubMed:18032660}; Multi-pass membrane protein {ECO:0000255}. Note=Low extracellular Mg(2+) induces increase in Golgi and in post-Golgi membrane vesicles. {ECO:0000269|PubMed:18794299}.",Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17),GO:0000139; GO:0005794; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018345; GO:0019706; GO:0030054; GO:0030659; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0043123; GO:0043231,1E-07,1E-07,0.0100241450239323,0.0603377256669506,0.0679563213176299,0.0587781721156013,0.0603377256669506,-4.0507958723230900,0.0590159580254165,0.032849427354019,13.9541877866364,9.68820413638655E-05,0.00473891585185536,-1.79987643058247,72640,2.32432100292738,3,2,0,1E-07,0.0603377256669506,603377.256669506,19.2027007918884
112,116,176,176,176,O94898,LRIG2,LRIG2_HUMAN,cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15145052}; Single-pass type I membrane protein {ECO:0000269|PubMed:15145052}. Cytoplasm {ECO:0000269|PubMed:15145052}.,Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2),GO:0005102; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222,1E-07,1E-07,1E-07,0.0622307576192189,0.0493711548584221,0.0510015973106939,0.0510015973106939,-4.2933137584527400,0.054201069929445,0.0271006349647225,13.8935673142218,9.86769115248915E-05,0.0047992861514379,-1.82242810254093,118965,2.31882335502996,12,3,0,1E-07,0.0510015973106939,510015.973106939,18.9601829057588
113,117,177,177,177,Q9UDT6,CLIP2,CLIP2_HUMAN,cytoplasmic microtubule [GO:0005881]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O55156}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9Z0H8}. Note=Localizes preferentially to the ends of tyrosinated microtubules. {ECO:0000250|UniProtKB:Q9Z0H8}.",CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),GO:0005875; GO:0005881; GO:0008017; GO:0035371; GO:0051010,4.63425307709555E-05,7.552596231712E-05,6.63201770509543E-05,0.00033570179885525,0.00034656854995511,0.00032357119457232,0.00033570179885525,-11.54053211182410000,0.00027255095774789,0.00019900503558695,13.8371399104149,0.0001003844754707,0.00485475203406361,-1.84350463287406,115837,2.31383294762788,36,0,0,6.63201770509543E-05,0.00033570179885525,5.06183508221529,2.33966050429846
114,118,178,178,178,P35716,SOX11,SOX11_HUMAN,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; translation factor activity, RNA binding [GO:0008135]; cardiac ventricle formation [GO:0003211]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; signal transduction involved in cell cycle checkpoint [GO:0072395]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:24886874}.",Transcription factor SOX-11,GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001077; GO:0001105; GO:0001158; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005737; GO:0008135; GO:0008284; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:0072395; GO:2000648; GO:2000678; GO:2001111,0.0180673475878318,0.0251279470539765,0.0386938210718024,0.165682311576004,0.197341308390667,0.195623493836295,0.195623493836295,-2.353848450539350,0.158919332696452,0.106756038252763,13.8051263443668,0.00010136939074235,0.00487008701544413,-1.85549877724566,46679,2.3124632790339,3,0,0,0.0251279470539765,0.195623493836295,7.78509654672874,2.96071493097073
115,119,181,181,181,Q9Y3C6,PPIL1,PPIL1_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.",Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718,2.26433162697624E-05,1.94523898647999E-05,3.32280383156579E-05,0.00618059981392255,0.00496936957519748,0.00640208063270249,0.00618059981392255,-7.33803742928647000,0.00582557542579077,0.00293789562771212,13.5458488379582,0.00010979986199284,0.00518931574685859,-1.95363018232626,18237,2.28488990360716,7,0,0,2.26433162697624E-05,0.00618059981392255,272.95470947319,8.09251777887225
116,120,182,182,182,O75746,SLC25A12,CMC1_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; acidic amino acid transmembrane transporter activity [GO:0015172]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; aspartate transmembrane transport [GO:0015810]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:9722566}; Multi-pass membrane protein {ECO:0000269|PubMed:9722566}.,Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12),GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0042802; GO:0043209; GO:0043490; GO:0051592,0.0021014461967166,1E-07,3.18373515043283E-05,0.0154417991288671,0.0140494916816974,0.0128309305163952,0.0140494916816974,-6.1533382558808800,0.0133962792595796,0.00740926747919677,13.5302628729566,0.00011033358246825,0.00518931574685859,-1.95958616069568,74762,2.28488990360716,13,1,0,3.18373515043283E-05,0.0140494916816974,441.289586534463,8.7855818930543
117,121,183,183,183,Q86XL3,ANKLE2,ANKL2_HUMAN,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22770216}; Single-pass type III membrane protein {ECO:0000269|PubMed:22770216}.,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721,6.07381274533E-05,0.0001481883960257,9.20485370828681E-05,0.034554394061074,0.0435734721664263,0.044264659248712,0.0435734721664263,-4.5204061103133300,0.0406971834718835,0.020448916756129,13.4810501088655,0.0001120398535336,0.00520275444893455,-1.97843525259643,104114,2.28376667073845,15,0,0,9.20485370828681E-05,0.0435734721664263,473.374955727961,8.88683957095745
118,122,184,184,184,Q13895,BYSL,BYST_HUMAN,"apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; female pregnancy [GO:0007565]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; trophectodermal cell differentiation [GO:0001829]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17381424}. Nucleus, nucleolus {ECO:0000269|PubMed:17381424}. Note=Associated with 40S ribosomal subunits.",Bystin,GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007155; GO:0007565; GO:0008283; GO:0016020; GO:0043231; GO:0045177,2.63102129302489E-05,6.93716872172458E-05,8.20939472372235E-05,0.0640883870123604,0.0764371509922254,0.0837837729089922,0.0764371509922254,-3.7095821833848700,0.0747105116887311,0.0374145144601605,13.4716806022188,0.00011236836994678,0.00520275444893455,-1.98203132533927,49601,2.28376667073845,6,0,0,6.93716872172458E-05,0.0764371509922254,1101.84938637651,10.1057113176657
119,123,188,188,188,P26378,ELAVL4,ELAV4_HUMAN,AU-rich element binding [GO:0017091]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA processing [GO:0006396],NA,ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD),GO:0003723; GO:0003730; GO:0006396; GO:0006397; GO:0017091,1E-07,4.82261814132281E-05,1E-07,0.0651288383139016,0.0519689444370659,0.0671286707875152,0.0651288383139016,-3.9405596958461000,0.0613926757856898,0.030712479953316,13.3778948371916,0.00011572279474061,0.00520827084822247,-2.01815886550635,41770,2.28330643902706,5,2,0,1E-07,0.0651288383139016,651288.383139016,19.3129369683654
120,124,190,190,190,Q86Y79,PTRH1,PTH_HUMAN,aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723],NA,Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29),GO:0003723; GO:0004045,0.00012183710639809,0.00010300317883813,0.0102041985337707,0.0699286733049071,0.0592878063445754,0.0698008933667386,0.0698008933667386,-3.8406106884756800,0.062862778065738,0.0349077353058713,13.3664977652661,0.00011613876453649,0.00520827084822247,-2.02256561433742,22937,2.28330643902706,4,0,0,0.00012183710639809,0.0698008933667386,572.903407100555,9.16214810738854
121,125,191,191,191,Q96S55,WRNIP1,WRIP1_HUMAN,membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; innate immune response [GO:0045087]; regulation of DNA-dependent DNA replication initiation [GO:0030174],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18842586}. Cytoplasm {ECO:0000269|PubMed:29053956}. Note=Colocalizes with WRN in granular structures in the nucleus. {ECO:0000269|PubMed:18842586, ECO:0000269|PubMed:29053956}.",ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006260; GO:0016020; GO:0016887; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471,0.00033238318972098,0.00042024309462495,0.0016231156265449,0.0493000008360739,0.0523457028919994,0.0403950701419512,0.0493000008360739,-4.3422685187050100,0.0465550106530446,0.0240694192968192,13.3644803973428,0.00011621258551524,0.00520827084822247,-2.02334601524706,72133,2.28330643902706,5,0,0,0.00042024309462495,0.0493000008360739,117.313053960047,6.87421974734894
122,126,192,192,192,Q9UQ35,SRRM2,SRRM2_HUMAN,"Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; C2H2 zinc finger domain binding [GO:0070742]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]",SUBCELLULAR LOCATION: Nucleus speckle.,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071007; GO:0071013,1.19390649027948E-05,1E-07,1E-07,0.027318968211472,0.0222905417756487,0.0291445194670609,0.027318968211472,-5.193953193127040,0.0262472967964263,0.0131276947531807,13.2707687612157,0.00011970617461251,0.00533690028480789,-2.05972180937036,299615,2.27271091152324,25,2,0,1E-07,0.027318968211472,273189.68211472,18.0595434710845
123,127,193,193,193,Q92879,CELF1,CELF1_HUMAN,"cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; regulation of RNA splicing [GO:0043484]; RNA interference [GO:0016246]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8948631}. Cytoplasm {ECO:0000269|PubMed:8948631}. Note=RNA-binding activity is detected in both nuclear and cytoplasmic compartments.,CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2),GO:0000900; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0007281; GO:0009792; GO:0016020; GO:0016246; GO:0036002; GO:0042835; GO:0043484; GO:1990904,1E-07,1E-07,1E-07,0.0263934740963336,0.0320985011165938,0.0249712684642931,0.0263934740963336,-5.2436749288537800,0.0278209812257402,0.0139105906128701,13.2368941720344,0.00012100068831905,0.00536666265290719,-2.07293105300536,52063,2.27029570349916,7,3,0,1E-07,0.0263934740963336,263934.740963336,18.0098217353578
124,128,194,194,194,Q92616,GCN1,GCN1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:E9PVA8}. Note=Associates with ribosomes in undifferentiated neuroblastoma cells and increases after neuronal differentiation. {ECO:0000250|UniProtKB:E9PVA8}.,eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1),GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253,0.00010066554348009,8.65091541590641E-05,8.21662875678662E-05,0.00033826028888686,0.00032186447823402,0.00032605252570749,0.00032605252570749,-11.58260798419250000,0.00023894543587378,0.00020925304633923,13.1662600832223,0.00012375571454223,0.00546056142516244,-2.10057833520808,292758,2.26276270320821,68,0,0,8.65091541590641E-05,0.00032605252570749,3.76899449401595,1.91417968742422
125,129,195,195,195,Q9ULH0,KIDINS220,KDIS_HUMAN,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; activation of MAPKK activity [GO:0000186]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; regulation of protein kinase activity [GO:0045859],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. Late endosome {ECO:0000250}. Note=Localized at late endosome before or after nerve growth factor (NGF) stimulation.,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),GO:0000186; GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0045859; GO:0048813; GO:1990090,1E-07,2.6282160019403E-05,1E-07,0.00049391322881897,0.00041970631512828,0.00052714476584578,0.00049391322881897,-10.98345476961840000,0.00047142738325788,0.00024454107830207,13.135469265689,0.00012498077037312,0.00548633535586619,-2.11267454864348,196542,2.26071764938355,35,2,0,1E-07,0.00049391322881897,4939.1322881897,12.2700418945931
126,130,197,197,197,Q9Y2H5,PLEKHA6,PKHA6_HUMAN,NA,NA,Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3),NA,1E-07,3.48140397027661E-06,1E-07,0.105993382404252,0.101440450144453,0.0812034489163771,0.101440450144453,-3.301295042289030,0.0962112000203707,0.0481068271448421,13.0851918460312,0.00012701330916795,0.00551895394151128,-2.13248420941087,117128,2.25814323032882,15,2,0,1E-07,0.101440450144453,1014404.50144453,19.9522016219225
127,131,198,198,198,Q9BRK4,LZTS2,LZTS2_HUMAN,cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cell cycle [GO:0007049]; cell division [GO:0051301]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein localization to nucleus [GO:1900181]; Wnt signaling pathway [GO:0016055],"SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Localized to the centrosome throughout the cell cycle. Localized to the midbody in cells undergoing cytokinesis.",Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1),GO:0001822; GO:0005815; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0008285; GO:0016055; GO:0031982; GO:0051301; GO:0090090; GO:1900181,0.00010613577047341,9.56958556988894E-05,0.00011856103701624,0.103680399240862,0.135098378112565,0.130475942949604,0.130475942949604,-2.938144266534590,0.122978109213281,0.0615958521610366,13.0113557817547,0.00013007236413616,0.00562333048992707,-2.16170775216951,72759,2.25000639172911,4,0,0,0.00010613577047341,0.130475942949604,1229.33052982634,10.2636571496239
128,132,200,200,200,P48664,SLC1A6,EAA4_HUMAN,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; metal ion binding [GO:0046872]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; regulation of membrane potential [GO:0042391],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7791878}; Multi-pass membrane protein {ECO:0000305}.,Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6),GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0014047; GO:0015171; GO:0015183; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0098712,1E-07,0.000834455292299,1E-07,0.0576889824008521,0.072810239905539,0.0751033628421335,0.072810239905539,-3.779714826959780,0.0682559766187419,0.0344062067401373,12.9298475346745,0.00013355504488196,0.00571615592094818,-2.19415148349233,61565,2.24289593336535,4,2,0,1E-07,0.072810239905539,728102.39905539,19.4737818372518
129,133,202,202,202,A1L0T0,ILVBL,ILVBL_HUMAN,integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; transferase activity [GO:0016740],SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein.,Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein),GO:0000287; GO:0016020; GO:0016021; GO:0016740; GO:0030976,0.00013463481934808,0.00085310873572574,7.69649787491257E-05,0.0257954681120389,0.0302810670285731,0.0231267428311579,0.0257954681120389,-5.2767385623657700,0.026046189812649,0.0133779977509321,12.8376551472042,0.00013763331144725,0.0058082027953044,-2.23108293156093,67868,2.23595822850905,8,0,0,0.00013463481934808,0.0257954681120389,191.595816275047,7.58192224821238
130,134,204,204,204,Q6PI78,TMEM65,TMM65_HUMAN,integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26403541}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion inner membrane {ECO:0000269|PubMed:24765583, ECO:0000269|PubMed:28295037}; Multi-pass membrane protein {ECO:0000255}. Note=Localizes at the intercalated disk in the ventricular tissue (PubMed:26403541). {ECO:0000269|PubMed:26403541}.",Transmembrane protein 65,GO:0003231; GO:0005743; GO:0005886; GO:0014704; GO:0016021; GO:1903779,1E-07,3.64448392627277E-05,3.63106895119942E-05,0.0158266350671928,0.0208720266922114,0.0196525385355695,0.0196525385355695,-5.6691405110753900,0.0187594482553997,0.00940400930395807,12.7880999682103,0.00013988864925905,0.00586983743949763,-2.25103846833267,25498,2.23137392602781,5,1,0,3.63106895119942E-05,0.0196525385355695,541.232865574691,9.08010563729684
131,135,206,206,206,O14525,ASTN1,ASTN1_HUMAN,clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; locomotory behavior [GO:0007626]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q61137}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q61137}. Perikaryon {ECO:0000250|UniProtKB:Q61137}. Endosome {ECO:0000250|UniProtKB:Q61137}. Cytoplasmic vesicle, clathrin-coated vesicle {ECO:0000250|UniProtKB:Q61137}. Note=Detected close to the anterior pole and at the base of the leading process in migrating neurons. Is internalized from the membrane via clathrin-coated vesicles and endosomes, and recycled to the anterior pole of the migrating cell. {ECO:0000250|UniProtKB:Q61137}.",Astrotactin-1,GO:0001764; GO:0005768; GO:0007158; GO:0007626; GO:0009897; GO:0016021; GO:0030136; GO:0043204,7.32687361714565E-05,5.65748604432584E-05,4.60341080499001E-05,0.00050554564769957,0.00041268578281603,0.00046582792195274,0.00046582792195274,-11.06791526156480000,0.00040272721593457,0.00025998950952216,12.6705247936841,0.00014542391410958,0.0060248728794348,-2.29868027491877,144913,2.22005211196345,19,0,0,5.65748604432584E-05,0.00046582792195274,8.23383245319608,3.04156409216144
132,136,209,209,209,O94910,ADGRL1,AGRL1_HUMAN,axon [GO:0030424]; cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G-protein coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G-protein coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129],"SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell projection, axon {ECO:0000250|UniProtKB:O88917}. Cell projection, growth cone {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:O88917}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:O88917}. Note=Colocalizes with TENM2 on the cell surface, across intercellular junctions and on nerve terminals near synaptic clefts. {ECO:0000250|UniProtKB:O88917}.",Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2),GO:0004930; GO:0005622; GO:0005886; GO:0007157; GO:0007166; GO:0007186; GO:0016021; GO:0016524; GO:0030054; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0051965; GO:0090129,1E-07,1E-07,1.13744553392717E-06,0.0855113030301507,0.0842968880323383,0.065533793650534,0.0842968880323383,-3.5683768172453600,0.0784468824224964,0.0392238870264262,12.5706289563687,0.0001503394435697,0.00615744323902714,-2.33948881830026,162717,2.2105995829141,16,2,0,1E-07,0.0842968880323383,842968.880323383,19.6851198469662
133,137,210,210,210,P50148,GNAQ,GNAQ_HUMAN,"cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; type 2A serotonin receptor binding [GO:0031826]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; entrainment of circadian clock [GO:0009649]; forebrain neuron development [GO:0021884]; G-protein coupled acetylcholine receptor signaling pathway [GO:0007213]; G-protein coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; maternal behavior [GO:0042711]; negative regulation of protein kinase activity [GO:0006469]; neuron remodeling [GO:0016322]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]; platelet activation [GO:0030168]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; skeletal system development [GO:0001501]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Membrane {ECO:0000250}. Nucleus membrane {ECO:0000250}. Note=Colocalizes with the adrenergic receptors, ADREN1A and ADREN1B, at the nuclear membrane of cardiac myocytes. {ECO:0000250}.",Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q),GO:0001501; GO:0001508; GO:0001750; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005765; GO:0005834; GO:0005886; GO:0006469; GO:0007186; GO:0007189; GO:0007202; GO:0007213; GO:0007215; GO:0007507; GO:0007596; GO:0007603; GO:0009649; GO:0009791; GO:0016322; GO:0021884; GO:0030168; GO:0030425; GO:0031683; GO:0031826; GO:0031965; GO:0042711; GO:0042733; GO:0044297; GO:0045634; GO:0046872; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0070062,1E-07,1E-07,1E-07,0.0184347926427106,0.0155754800551748,0.0208183599068189,0.0184347926427106,-5.7614250009001200,0.0182761108682348,0.00913815543411738,12.4944842468401,0.0001542237724682,0.00628645472537081,-2.37080159225999,42142,2.20159420785921,7,3,0,1E-07,0.0184347926427106,184347.926427106,17.4920716633114
134,138,211,211,211,Q9UHV9,PFDN2,PFD2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17936702}. Cytoplasm {ECO:0000269|PubMed:17936702}. Mitochondrion {ECO:0000269|PubMed:17936702}.,Prefoldin subunit 2,GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495,1E-07,1E-07,1E-07,0.0104569534633439,0.00809278839743856,0.00833039962978136,0.00833039962978136,-6.90739857777782000,0.00895994716352128,0.00448007358176064,12.3494389701738,0.00016196965876066,0.00657090179616743,-2.43095101044103,16648,2.18237502340472,4,3,0,1E-07,0.00833039962978136,83303.9962978136,16.3460980864337
135,139,214,214,214,Q9GZM8,NDEL1,NDEL1_HUMAN,axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, spindle. Note=Localizes to the cell body of the motor neurons and colocalizes with assembled neurofilaments within axonal processes. Localizes to the microtubules of the manchette in elongated spermatids. Colocalizes with DISC1 in the perinuclear region, including the centrosome (By similarity). Localizes to the interphase centrosome and the mitotic spindle. Localizes to the kinetochore in a CENPF-dependent manner. {ECO:0000250}.",Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:1900029; GO:1904115; GO:1990138; GO:2000574,1.4322491780589E-05,0.0097576804640626,2.01656674090568E-05,0.0682229489715092,0.0613969897349475,0.0550646917698622,0.0613969897349475,-4.0256882670933800,0.0582974872843556,0.0324127998499285,12.08691366849,0.00017724224209403,0.00708415136761831,-2.54153640314318,38375,2.14971216777854,8,0,0,2.01656674090568E-05,0.0613969897349475,3044.62969112408,11.572051052936
136,140,215,215,215,P15822,HIVEP1,ZEP1_HUMAN,"mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding [GO:0001206]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Isoform 1: Nucleus.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm {ECO:0000269|Ref.2}. Nucleus {ECO:0000269|Ref.2}.,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),GO:0000980; GO:0000981; GO:0001206; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006366; GO:0007165; GO:0007275; GO:0016604; GO:0043565; GO:0044212; GO:0046872,0.00237018381418246,0.00281527526329234,0.0020832369278512,0.339648631098851,0.430736102767194,0.333842740257219,0.339648631098851,-1.557885055248060,0.365652926039313,0.185249361688098,12.075728259335,0.00017793137196704,0.00708415136761831,-2.54629829533552,296865,2.14971216777854,9,0,0,0.00237018381418246,0.339648631098851,143.300544483722,7.16290028103893
137,141,216,216,216,Q9Y6D9,MAD1L1,MD1L1_HUMAN,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],"SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:22351768}. Nucleus envelope {ECO:0000269|PubMed:22351768}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:22351768}. Note=Detected at the nucleus envelope during interphase (PubMed:22351768). From the beginning to the end of mitosis, it is seen to move from a diffusely nuclear distribution to the centrosome, to the spindle midzone and finally to the midbody. Detected at kinetochores during prometaphase (PubMed:22351768). Colocalizes with NEK2 at the kinetochore (PubMed:14978040). Colocalizes with IK at spindle poles during metaphase and anaphase (PubMed:22351768). {ECO:0000269|PubMed:14978040, ECO:0000269|PubMed:22351768}.",Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181),GO:0000776; GO:0000777; GO:0000922; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0007093; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0048538; GO:0051301; GO:0051315; GO:0072686; GO:0090235,0.00528534687999708,1E-07,1E-07,0.0305301881322631,0.0261266641125455,0.031165039875155,0.0305301881322631,-5.0336197100680000,0.0275121150799888,0.0155179064999934,12.0316246147919,0.00018068083287852,0.00716031448814904,-2.5651148658462,83067,2.14506790262673,10,2,0,1E-07,0.0305301881322631,305301.881322631,18.2198769541435
138,142,218,218,218,Q14137,BOP 1.00,BOP1_HUMAN,"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03027, ECO:0000269|PubMed:12429849}. Nucleus, nucleoplasm {ECO:0000255|HAMAP-Rule:MF_03027, ECO:0000269|PubMed:12429849}.",Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein),GO:0000027; GO:0000448; GO:0000463; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008283; GO:0030687; GO:0042254; GO:0043021; GO:0051726; GO:0070545; GO:1901796; GO:1990904,0.00016516415430755,0.00020593634102729,0.00024141837190753,0.00074465915539801,0.00090574598716069,0.00085297861175464,0.00085297861175464,-10.19520281280350000,0.00063028829569032,0.00051931710359262,11.8612903976974,0.00019180155280558,0.00753129033034758,-2.63840229937363,83630,2.12313061007526,8,0,0,0.00020593634102729,0.00085297861175464,4.14195283600579,2.05031112583077
139,143,219,219,219,Q9Y216,MTMR7,MTMR7_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16787938}.,Myotubularin-related protein 7 (EC 3.1.3.-),GO:0004438; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0016020; GO:0046855; GO:0046856; GO:0052629,0.0057738503024179,0.0113845519775463,0.014763361977164,0.0840357975895197,0.0666491350542444,0.0785687756962532,0.0785687756962532,-3.6699001100918700,0.0657773146942963,0.0435292454328576,11.8251866599588,0.00019426554643666,0.00758700684847979,-2.65406333478657,75833,2.11992952391595,12,0,0,0.0113845519775463,0.0785687756962532,6.90134981606778,2.78687856225226
140,144,220,220,220,Q13526,PIN1,PIN1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; motor activity [GO:0003774]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of type I interferon production [GO:0032480]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of signal transduction by p53 class mediator [GO:1901796]; synapse organization [GO:0050808],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16476580, ECO:0000269|PubMed:23623683}. Nucleus speckle {ECO:0000269|PubMed:21497122}. Cytoplasm {ECO:0000269|PubMed:21497122}. Note=Colocalizes with NEK6 in the nucleus (PubMed:16476580). Mainly localized in the nucleus but phosphorylation at Ser-71 by DAPK1 results in inhibition of its nuclear localization (PubMed:21497122). {ECO:0000269|PubMed:16476580}.",Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1),GO:0000413; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007088; GO:0008013; GO:0016607; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0032091; GO:0032465; GO:0032480; GO:0032794; GO:0035307; GO:0042177; GO:0043005; GO:0043524; GO:0043525; GO:0043547; GO:0045944; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0061051; GO:0070373; GO:0090263; GO:1900180; GO:1901796; GO:2000146,1E-07,1E-07,1E-07,0.0213194157379426,0.0188371954715892,0.0254116920633031,0.0213194157379426,-5.5516882884282300,0.021856001090945,0.0109281005454725,11.8146325131527,0.00019499316666653,0.00758700684847979,-2.65864999469082,18243,2.11992952391595,3,3,0,1E-07,0.0213194157379426,213194.157379426,17.7018083757833
141,145,222,222,222,Q969G2,LHX4,LHX4_HUMAN,"nucleus [GO:0005634]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; animal organ morphogenesis [GO:0009887]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,LIM/homeobox protein Lhx4 (LIM homeobox protein 4),GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0043066; GO:0043565; GO:0045944; GO:0046872,1E-07,1E-07,0.00012968832912367,0.0857460552987717,0.0634131552737831,0.0719133932526008,0.0719133932526008,-3.7975957045109400,0.0736475718320106,0.0368670820257132,11.7257914266272,0.00020125246600849,0.00776000499564298,-2.69741227602263,43124,2.11013799915683,4,2,0,1E-07,0.0719133932526008,719133.932526008,19.4559009597006
142,146,223,223,223,Q9NZV5,SELENON,SELN_HUMAN,endoplasmic reticulum membrane [GO:0005789]; calcium ion binding [GO:0005509]; oxidoreductase activity [GO:0016491]; calcium ion homeostasis [GO:0055074]; positive regulation of response to oxidative stress [GO:1902884]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; skeletal muscle fiber development [GO:0048741],SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12700173}.,Selenoprotein N (SelN),GO:0005509; GO:0005789; GO:0016491; GO:0048741; GO:0055074; GO:0060314; GO:1902884,0.0167022480472935,0.0217693627910286,0.020448094868758,0.0712158406940965,0.0634342025971458,0.0783583050077421,0.0712158406940965,-3.8116580110974400,0.0513628808639681,0.0453213423343441,11.6485016809322,0.00020689947714794,0.00794197096137413,-2.73135967972125,65813,2.10007170520188,6,0,0,0.020448094868758,0.0712158406940965,3.48276165340493,1.80023174389314
143,147,224,224,224,Q04637,EIF4G1,IF4G1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; developmental process [GO:0032502]; energy homeostasis [GO:0097009]; mitochondrion organization [GO:0007005]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to stress [GO:0080135]; regulation of gene silencing by miRNA [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413]; viral process [GO:0016032]",NA,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),GO:0000184; GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006413; GO:0006446; GO:0007005; GO:0008135; GO:0008190; GO:0008284; GO:0010507; GO:0010801; GO:0010942; GO:0016020; GO:0016032; GO:0016281; GO:0030307; GO:0031369; GO:0031669; GO:0032270; GO:0032502; GO:0032947; GO:0033138; GO:0034645; GO:0042802; GO:0043488; GO:0045666; GO:0060964; GO:0080135; GO:0097009; GO:1900087; GO:1901215; GO:1905537; GO:1905606; GO:1905612; GO:1905618; GO:1905696,1E-07,1E-07,1E-07,0.00161597072473564,0.00118849159776555,0.00139447259764579,0.00139447259764579,-9.48606469997600000,0.00139954497338232,0.00069987248669116,11.635753330244,0.00020784949091982,0.00794281983157886,-2.73697935194262,175491,2.10002528851929,27,3,0,1E-07,0.00139447259764579,13944.7259764579,13.7674319642355
144,148,225,225,225,Q08174,PCDH1,PCDH1_HUMAN,cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399],SUBCELLULAR LOCATION: Cell junction. Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Note=Found at cell-cell boundaries and probably at cell-matrix boundaries.,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),GO:0005509; GO:0005634; GO:0005730; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007267; GO:0007399; GO:0030054; GO:0043231,0.00308805132222807,0.00761595897540349,0.00155143598527707,0.080787730568895,0.0707494362944673,0.0611028260244633,0.0707494362944673,-3.8211375366488100,0.0667948488683057,0.0374825731951224,11.598414984737,0.00021066291641255,0.00801455361996225,-2.75347198541301,114743,2.0961206611808,9,0,0,0.00308805132222807,0.0707494362944673,22.9107061094505,4.51795001817003
145,149,226,226,226,Q6VAB6,KSR2,KSR2_HUMAN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; calcium-mediated signaling [GO:0019722]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0019722; GO:0043410; GO:0046872,0.00014799850572494,0.00015038488296896,0.00015491894511915,0.0278194246644628,0.0244298996698918,0.0331361030152054,0.0278194246644628,-5.1677636060667300,0.0283107083385823,0.0143064549472289,11.5776819228904,0.0002122453166413,0.0080390261524317,-2.76265145991724,107632,2.0947965584955,9,0,0,0.00015038488296896,0.0278194246644628,184.98817244952,7.53128922217087
146,150,227,227,227,Q96GS4,BORCS6,BORC6_HUMAN,BORC complex [GO:0099078]; lysosomal membrane [GO:0005765]; lysosome localization [GO:0032418],SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000305|PubMed:25898167}.,BLOC-1-related complex subunit 6 (Lysosome-dispersing protein) (Lyspersin),GO:0005765; GO:0032418; GO:0099078,3.28749386148508E-06,1E-07,1E-07,0.0124102840846815,0.015584900277588,0.0169414124799076,0.015584900277588,-6.003707266090850,0.0149777031161052,0.00749001405600645,11.5579025343325,0.00021376854057093,0.00806105157395256,-2.77142308168121,37226,2.0936083002575,5,2,0,1E-07,0.015584900277588,155849.00277588,17.2497893981207
147,151,228,228,228,Q96DE0,NUDT16,NUD16_HUMAN,"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; IDP phosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; negative regulation of rRNA processing [GO:2000233]; nucleobase-containing small molecule catabolic process [GO:0034656]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; snoRNA catabolic process [GO:0016077]; XDP catabolic process [GO:1901639]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20385596, ECO:0000269|PubMed:21337011}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q6TEC1}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q6TEC1}. Cytoplasm {ECO:0000269|PubMed:21070968, ECO:0000269|PubMed:21337011}. Note=Localized predominantly in the cytoplasm (PubMed:21070968). Localized in nucleolus, and in a minor proportion in distinct foci in the nucleoplasm (By similarity). {ECO:0000250|UniProtKB:Q6TEC1, ECO:0000269|PubMed:21070968}.",U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase),GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0008284; GO:0016077; GO:0030145; GO:0030515; GO:0034656; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0090068; GO:0097383; GO:0098519; GO:1901639; GO:1901640; GO:1901641; GO:1990003; GO:2000233; GO:2000781,1E-07,1E-07,1E-07,0.0315212253242049,0.0401604842815325,0.0429310163148207,0.0401604842815325,-4.6380795234155000,0.0382041419735194,0.0191021709867597,11.5213419995009,0.00021661955348397,0.00810016877888234,-2.78767380493672,21273,2.09150593186535,4,3,0,1E-07,0.0401604842815325,401604.842815325,18.615417140796
148,152,231,231,231,Q5T3F8,TMEM63B,CSCL2_HUMAN,actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion transport [GO:0006811],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,CSC1-like protein 2 (Transmembrane protein 63B),GO:0005886; GO:0006811; GO:0015629; GO:0016021,0.00290839866116431,0.00582150223364754,0.00767603217695318,0.050555698043387,0.0573206452428385,0.043963709307446,0.050555698043387,-4.305982484873760,0.0451447065073022,0.0280409976109061,11.4148456008562,0.00022519412914551,0.0083448560410631,-2.83528708182935,94958,2.07858115102922,7,0,0,0.00582150223364754,0.050555698043387,8.68430449982163,3.11841031239719
149,153,233,233,233,Q9HCN4,GPN1,GPN1_HUMAN,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11058119, ECO:0000269|PubMed:20855544}. Nucleus {ECO:0000269|PubMed:20855544}. Note=Shuttles between the nucleus and the cytoplasm. {ECO:0000269|PubMed:20855544}.",GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1),GO:0003924; GO:0005525; GO:0005654; GO:0005739; GO:0005829,1E-07,1E-07,1E-07,0.0164376333520069,0.0129144527472813,0.0123989525196309,0.0129144527472813,-6.2748696795368700,0.0139169128729731,0.00695855643648653,11.3620293458184,0.00022960095842559,0.00843512533958398,-2.85905511221149,41740,2.07390845973932,4,3,0,1E-07,0.0129144527472813,129144.527472813,16.9786269846747
150,154,234,234,234,Q9UI10,EIF2B4,EI2BD_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of translation [GO:0006417]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta),GO:0001541; GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0006417; GO:0009408; GO:0009749; GO:0014003; GO:0031369; GO:0042552; GO:0043434; GO:0050852,1E-07,1.92166474228777E-05,1E-07,0.0156795132153002,0.0197053366513908,0.0147210759096146,0.0156795132153002,-5.9949754194015600,0.0166955030429609,0.00835422373728808,11.3286612751735,0.00023243965773345,0.00850292081281356,-2.87412454219329,57557,2.07043186546282,16,2,0,1E-07,0.0156795132153002,156795.132153002,17.25852124481
151,155,236,236,236,Q8N158,GPC2,GPC2_HUMAN,anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuron differentiation [GO:0030182]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; smoothened signaling pathway [GO:0007224],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.; SUBCELLULAR LOCATION: Secreted glypican-2: Secreted, extracellular space {ECO:0000250}.",Glypican-2 [Cleaved into: Secreted glypican-2],GO:0001523; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0007224; GO:0009966; GO:0030182; GO:0043202; GO:0043395; GO:0046658,0.00014424352208074,2.65922863606958E-05,8.55327468534331E-06,0.0338826576504169,0.0302588536895993,0.0245416869484316,0.0302588536895993,-5.0464988554803300,0.029501269735107,0.0148104312285958,11.2411158565188,0.00024009453055797,0.00868768523765751,-2.91385930244828,62830,2.06109592233451,18,0,0,2.65922863606958E-05,0.0302588536895993,1137.88086060636,10.1521337959003
152,156,238,238,238,Q15262,PTPRK,PTPRK_HUMAN,"adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell membrane; Single-pass type I membrane protein.",Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),GO:0001750; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0030424; GO:0030425; GO:0031175; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043025; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041,4.38897270935312E-05,3.76956818934816E-05,4.46557130524784E-05,0.114696666636484,0.0942200399009525,0.0837772827093066,0.0942200399009525,-3.4078222468063100,0.0975225827082346,0.0488033717281305,11.1278033522021,0.00025046707341537,0.00900839558166234,-2.96572057196317,162102,2.04535255109386,5,0,0,4.38897270935312E-05,0.0942200399009525,2146.74472001534,11.0679349280876
153,158,244,244,244,Q14728,MFSD10,MFS10_HUMAN,brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252],SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane protein {ECO:0000255}.,Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein),GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252,6.7738305869013E-05,9.65065252411282E-06,6.58595202730473E-05,0.0115209166571554,0.0116789422672683,0.0151953272460345,0.0116789422672683,-6.4199465709392300,0.012750645897264,0.00642307244152072,11.0136046838839,0.00026148220583378,0.00917331017187385,-3.01848833068333,48339,2.03747392169399,4,0,0,6.58595202730473E-05,0.0116789422672683,177.331116577353,7.47030190025269
154,159,247,247,247,P57678,GEMIN4,GEMI4_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; import into nucleus [GO:0051170]; rRNA processing [GO:0006364]; spliceosomal snRNP assembly [GO:0000387],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus, nucleolus. Nucleus, gem. Note=Localized in subnuclear structures next to coiled bodies, called gems, which are highly enriched in spliceosomal snRNPs and in the nucleolus.",Gem-associated protein 4 (Gemin-4) (Component of gems 4) (p97),GO:0000387; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0016020; GO:0016604; GO:0030532; GO:0032797; GO:0034719; GO:0051170; GO:0070062; GO:0097504,0.00239084357730621,0.00168812810905215,0.00415615069608725,0.0219227748300437,0.0285515355219118,0.0239074486154251,0.0239074486154251,-5.3863960148183000,0.022048878861645,0.013769480224971,10.8949372092857,0.00027356443091602,0.00948061347628006,-3.07386379544202,120037,2.02316355920804,11,0,0,0.00239084357730621,0.0239074486154251,9.99958710906629,3.32186852608733
155,160,248,248,248,Q9P2G1,ANKIB1,AKIB1_HUMAN,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209],NA,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),GO:0000151; GO:0000209; GO:0005737; GO:0031624; GO:0032436; GO:0046872; GO:0061630,4.68975377316883E-06,8.57539230334542E-06,1.03181778942694E-05,0.0249003568520761,0.0178335513689614,0.0211888025472943,0.0211888025472943,-5.5605541314603200,0.0212997091481203,0.0106577156820504,10.8138102507365,0.00028221964351401,0.00974112963096762,-3.11204506928395,122002,2.0113906772026,4,0,0,8.57539230334542E-06,0.0211888025472943,2470.88433948709,11.2708117652787
156,161,251,251,251,O00264,PGRMC1,PGRC1_HUMAN,cell body [GO:0044297]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; heme binding [GO:0020037]; steroid binding [GO:0005496]; neutrophil degranulation [GO:0043312],SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:Q95250}; Single-pass membrane protein {ECO:0000255}. Smooth endoplasmic reticulum membrane {ECO:0000303|PubMed:28396637}; Single-pass membrane protein {ECO:0000255}.,Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA),GO:0005496; GO:0005783; GO:0005886; GO:0005887; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0043005; GO:0043025; GO:0043312; GO:0044297; GO:0045202,0.00026157681977765,0.00029672175613476,0.00031764956534235,0.0334551040274357,0.0262045014364683,0.0364954686782657,0.0334551040274357,-4.9016298595257300,0.0317597086669716,0.0161718370472374,10.7806654019242,0.0002858521775233,0.00974198215195206,-3.12772087852587,21671,2.01135267042385,5,0,0,0.00029672175613476,0.0334551040274357,112.749076654297,6.81697180851728
157,162,252,252,252,Q6PID6,TTC33,TTC33_HUMAN,NA,NA,Tetratricopeptide repeat protein 33 (TPR repeat protein 33) (Osmosis-responsive factor),NA,1E-07,1E-07,1E-07,0.0355044314035536,0.0409864811232231,0.0292376099040814,0.0355044314035536,-4.8158570872717600,0.035242740810286,0.017621470405143,10.7590278945993,0.00028825449659155,0.00974198215195206,-3.13797847437524,29411,2.01135267042385,3,3,0,1E-07,0.0355044314035536,355044.314035536,18.4376395769398
158,163,253,253,253,Q8IUL8,CILP2,CILP2_HUMAN,extracellular exosome [GO:0070062],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:21880736}.",Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2],GO:0070062,4.94911770050285E-05,6.2824187212559E-05,6.42338847790161E-05,0.0818641079920406,0.0623844969436496,0.0617152595971711,0.0623844969436496,-4.0026686376323100,0.0685957717612883,0.0343567356303097,10.7570034601293,0.00028848052448191,0.00974198215195206,-3.13893916862993,126291,2.01135267042385,4,0,0,6.2824187212559E-05,0.0623844969436496,993.001258139293,9.95565173543388
159,164,254,254,254,Q9P2R3,ANKFY1,ANFY1_HUMAN,"cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10940552}. Endosome membrane {ECO:0000269|PubMed:10940552}; Peripheral membrane protein {ECO:0000269|PubMed:10940552}. Early endosome {ECO:0000269|PubMed:15328530}. Note=Also associated with endosomal membranes. Localizes to macropinosomes. {ECO:0000269|PubMed:15328530}.,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0017137; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981,0.00025405500957897,0.00012282415791858,0.00010264782663239,0.0116139462381188,0.0161610919295316,0.0148847824398445,0.0148847824398445,-6.0700180548800800,0.0140600978711216,0.00718989126693746,10.751707600413,0.00028907283488269,0.00974198215195206,-3.141453110064,128399,2.01135267042385,24,0,0,0.00012282415791858,0.0148847824398445,121.187742640268,6.92109997665191
160,165,256,256,256,Q6YN16,HSDL2,HSDL2_HUMAN,membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491],SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:19703561}.,Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-) (Short chain dehydrogenase/reductase family 13C member 1),GO:0005739; GO:0005777; GO:0016020; GO:0016491,1E-07,0.0019339793865708,1E-07,2.90393125451213,2.24043186092712,2.16044869565573,2.24043186092712,1.16377684994617,2.4342925439028,1.21779099841359,10.7047369148302,0.00029439200764012,0.00976295949576005,-3.16380050776521,45395,2.01041851247168,3,2,0,1E-07,2.24043186092712,22404318.6092712,24.4172735141577
161,166,257,257,257,O43301,HSPA12A,HS12A_HUMAN,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,Heat shock 70 kDa protein 12A,GO:0005524; GO:0070062,0.00012653028035575,0.00012320176373781,0.0002374670338069,0.00223906496201323,0.00168786970020674,0.0018319227899835,0.0018319227899835,-9.0924255851875300,0.001757219458101,0.00104100942168399,10.7016125563004,0.00029475006166226,0.00976295949576005,-3.16529021978834,74978,2.01041851247168,27,0,0,0.00012653028035575,0.0018319227899835,14.4781374453048,3.85580411227692
162,167,258,258,258,P07741,APRT,APT_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; cellular response to insulin stimulus [GO:0032869]; grooming behavior [GO:0007625]; lactation [GO:0007595]; neutrophil degranulation [GO:0043312]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101],SUBCELLULAR LOCATION: Cytoplasm.,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),GO:0002055; GO:0003999; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0006166; GO:0006168; GO:0007595; GO:0007625; GO:0016208; GO:0032869; GO:0034774; GO:0043101; GO:0043312; GO:0044209; GO:0070062,1E-07,1E-07,1E-07,0.0139936795444516,0.0187076857062965,0.0192967767280789,0.0187076857062965,-5.7402250933318000,0.0173326139929423,0.00866640699647116,10.7015332153862,0.00029475916114223,0.00976295949576005,-3.16532805524333,19608,2.01041851247168,4,3,0,1E-07,0.0187076857062965,187076.857062965,17.5132715708797
163,168,259,259,259,P18669,PGAM1,PGAM1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]",NA,Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),GO:0004082; GO:0004619; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006094; GO:0006096; GO:0006110; GO:0016020; GO:0016787; GO:0019901; GO:0034774; GO:0043209; GO:0043312; GO:0043456; GO:0045730; GO:0046538; GO:0061621; GO:0070062; GO:1904813,0.00098647459235748,0.00127602103867613,0.00112344590059572,0.00260149489281437,0.00230182700582939,0.00261742630585947,0.00260149489281437,-8.58644340960526000,0.00137826889095797,0.00181778162268876,10.6959708682983,0.00029539795670582,0.00976295949576005,-3.16798123129738,28804,2.01041851247168,5,0,0,0.00112344590059572,0.00260149489281437,2.31563877836476,1.21141022167515
164,169,261,261,261,P56159,GFRA1,GFRA1_HUMAN,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; MAPK cascade [GO:0000165],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}.",GDNF family receptor alpha-1 (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1),GO:0000165; GO:0005088; GO:0005102; GO:0005622; GO:0005886; GO:0007166; GO:0007411; GO:0016167; GO:0019898; GO:0031225; GO:0070062,0.00108856425747171,0.00016035150349422,0.00033890948729386,0.0536343875825237,0.038237810660064,0.0468372679504048,0.0468372679504048,-4.4161992648612100,0.0457072136482442,0.0233828819068754,10.6099309497123,0.00030549854829575,0.0100194159900828,-3.2091850841596,51456,1.9991575918097,8,0,0,0.00033890948729386,0.0468372679504048,138.199931564009,7.11061309108491
165,170,264,264,264,Q9Y693,LHFPL6,LHPL6_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,LHFPL tetraspan subfamily member 6 protein (Lipoma HMGIC fusion partner),GO:0016021,0.0120605798535366,1E-07,5.37605238436754E-06,0.0657935941502434,0.0664437384793783,0.0538509416379246,0.0657935941502434,-3.9259090638318400,0.0580074061205418,0.0330257216955779,10.4771524707326,0.00032193054818918,0.0104383541382553,-3.27338309176282,21598,1.98136797307923,3,1,0,5.37605238436754E-06,0.0657935941502434,12238.2725178716,13.5791123096563
166,172,266,266,266,Q86UN3,RTN4RL2,R4RL2_HUMAN,anchored component of plasma membrane [GO:0046658]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; signaling receptor activity [GO:0038023]; axon regeneration [GO:0031103]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase activity [GO:0006469],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12694398, ECO:0000269|PubMed:12839991}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:12694398}. Membrane raft {ECO:0000269|PubMed:12694398}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q7M6Z0}. Perikaryon {ECO:0000250|UniProtKB:Q80WD1}. Cell projection, axon {ECO:0000250|UniProtKB:Q80WD1}. Note=Localized to the surface of neurons, including axons. Detected close to synapses, but is excluded from synapses. {ECO:0000250|UniProtKB:Q7M6Z0}.",Reticulon-4 receptor-like 2 (Nogo receptor-like 3) (Nogo-66 receptor homolog 1) (Nogo-66 receptor-related protein 2) (NgR2),GO:0004860; GO:0005576; GO:0005737; GO:0005886; GO:0006469; GO:0007166; GO:0009897; GO:0009986; GO:0010977; GO:0019221; GO:0022038; GO:0030424; GO:0030425; GO:0031103; GO:0038023; GO:0043005; GO:0043204; GO:0045121; GO:0046426; GO:0046658; GO:0070062,0.00011557421922933,3.48475088819734E-05,0.0002270045179534,0.0524416455070581,0.0740907367809189,0.0616773125228697,0.0616773125228697,-4.0191162859744100,0.0626107561882606,0.0314311868428186,10.3434249468027,0.00033958817311152,0.0108770640900113,-3.3388049223534,46106,1.96348831250283,9,0,0,0.00011557421922933,0.0616773125228697,533.6597809974,9.05977647720736
167,173,269,269,269,Q9H444,CHMP4B,CHM4B_HUMAN,cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; autophagy [GO:0006914]; cell separation after cytokinesis [GO:0000920]; endosomal transport [GO:0016197]; exit from mitosis [GO:0010458]; macroautophagy [GO:0016236]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear envelope reassembly [GO:0031468]; nucleus organization [GO:0006997]; positive regulation of viral release from host cell [GO:1902188]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of viral process [GO:0050792]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuolar transport [GO:0007034]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:15511219}. Late endosome membrane {ECO:0000269|PubMed:15511219, ECO:0000305|PubMed:12860994}; Peripheral membrane protein {ECO:0000305}. Midbody {ECO:0000269|PubMed:21310966, ECO:0000269|PubMed:22422861}. Nucleus envelope {ECO:0000269|PubMed:26040712}. Note=Recruited to the nuclear envelope by CHMP7 during late anaphase (PubMed:26040712). Localizes transiently to the midbody arms immediately before abscission (PubMed:22422861). {ECO:0000269|PubMed:22422861, ECO:0000269|PubMed:26040712}.",Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2),GO:0000281; GO:0000815; GO:0000920; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0006620; GO:0006914; GO:0006997; GO:0007034; GO:0007080; GO:0009898; GO:0010458; GO:0010824; GO:0016197; GO:0016236; GO:0019058; GO:0030117; GO:0030496; GO:0031468; GO:0031902; GO:0031982; GO:0036258; GO:0036438; GO:0039702; GO:0042802; GO:0042803; GO:0045296; GO:0046755; GO:0050792; GO:0051260; GO:0060548; GO:0070062; GO:0090148; GO:0090611; GO:1901215; GO:1901673; GO:1902188; GO:1902902,0.00281641692847688,0.00138130573439177,0.00254526311183992,0.0289184945141822,0.0325868156259897,0.0236595801892209,0.0289184945141822,-5.1118637416854900,0.0261406348515614,0.0153179793506836,10.3074528577569,0.00034453911825123,0.0109502967131745,-3.35653637250248,24950,1.96057411286509,4,0,0,0.00254526311183992,0.0289184945141822,11.3616915986645,3.50610574305038
168,174,270,270,270,Q7L775,EPM2AIP1,EPMIP_HUMAN,"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]",SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:12782127}.,EPM2A-interacting protein 1 (Laforin-interacting protein),GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0005783; GO:0032868; GO:0042802; GO:0045725; GO:2000467,1E-07,0.00190982198334158,1E-07,0.0326940898591361,0.0346631027970966,0.0249534201924458,0.0326940898591361,-4.9348263277988700,0.0301335302884457,0.01570343913867,10.3012993876734,0.00034539487296228,0.0109502967131745,-3.35957527218721,70370,1.96057411286509,9,2,0,1E-07,0.0326940898591361,326940.898591361,18.3186703364127
169,175,271,271,271,O75182,SIN3B,SIN3B_HUMAN,"autosome [GO:0030849]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; RNA polymerase II transcription corepressor activity [GO:0001106]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810}.,Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b),GO:0000122; GO:0000805; GO:0000806; GO:0001106; GO:0001741; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016575; GO:0016580; GO:0019216; GO:0030849,1.4858747767043E-06,1E-07,1E-07,0.0592793776311447,0.0711691908561486,0.0502124981618414,0.0592793776311447,-4.0763258887769700,0.0602197935914527,0.0301104587539852,10.2833156017266,0.00034791082113268,0.010989360254228,-3.36846619457072,133066,1.95902758930041,19,2,0,1E-07,0.0592793776311447,592793.776311447,19.1771707754346
170,177,273,273,273,P68106,FKBP1B,FKB1B_HUMAN,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; ion transmembrane transport [GO:0034220]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Sarcoplasmic reticulum {ECO:0000250}.,Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12),GO:0000413; GO:0003755; GO:0005102; GO:0005528; GO:0005737; GO:0005829; GO:0006458; GO:0006939; GO:0009749; GO:0010459; GO:0010880; GO:0010881; GO:0014808; GO:0016020; GO:0019227; GO:0019855; GO:0022417; GO:0030018; GO:0030073; GO:0030551; GO:0032515; GO:0033017; GO:0033197; GO:0034220; GO:0034704; GO:0035584; GO:0042026; GO:0042098; GO:0042542; GO:0044325; GO:0048680; GO:0051280; GO:0051284; GO:0051480; GO:0051775; GO:0060314; GO:0060315; GO:0061077; GO:0061179; GO:0086064; GO:1903779,0.00426073643034016,1E-07,1E-07,0.0261697380579614,0.0300277074107431,0.0228095115034587,0.0261697380579614,-5.2559567057545100,0.0249153401806077,0.0138779822337505,10.2322033228264,0.00035518505401551,0.0111369379574097,-3.39381384387973,11783,1.95323419973664,3,2,0,1E-07,0.0261697380579614,261697.380579614,17.997539958457
171,178,274,274,274,O60422,ONECUT3,ONEC3_HUMAN,"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; cell differentiation [GO:0030154]; system development [GO:0048731]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00374}.",One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3) (OC-3),GO:0000977; GO:0000981; GO:0001077; GO:0003677; GO:0005634; GO:0005667; GO:0030154; GO:0048731,0.0851073570504495,0.126629244868213,0.136344708142891,0.314962086407258,0.30069183262712,0.280268290479196,0.30069183262712,-1.73364241283635,0.182613633150674,0.207333919929188,10.1399771638673,0.00036878801574274,0.0115212606378025,-3.43984722236521,50037,1.93849999850937,4,0,0,0.126629244868213,0.30069183262712,2.37458442510701,1.24767505016044
172,179,275,275,275,O43639,NCK2,NCK2_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16835242}. Endoplasmic reticulum {ECO:0000269|PubMed:16835242}.,Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta),GO:0001771; GO:0001784; GO:0005070; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0007176; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0033137; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048010; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441,0.00043256697514652,0.00048135697076067,0.0117311998276384,0.0667649085543146,0.0727441863464138,0.0557554229163756,0.0667649085543146,-3.9047661642736800,0.0608731313478528,0.0346516069317749,10.1160450167623,0.00037242165617927,0.011592470461435,-3.45185556465635,42915,1.93582400204869,7,0,0,0.00048135697076067,0.0667649085543146,138.701447386975,7.11583903242626
173,180,276,276,276,Q53FT3,HIKESHI,HIKES_HUMAN,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; Golgi organization [GO:0007030]; lung development [GO:0030324]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031]; regulation of cellular response to heat [GO:1900034],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9DD02}. Cytoplasm, cytosol {ECO:0000269|PubMed:22541429}. Nucleus {ECO:0000269|PubMed:22541429}.",Protein Hikeshi,GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0007030; GO:0008565; GO:0015031; GO:0030324; GO:0030544; GO:0034605; GO:1900034,3.38632335412007E-05,3.07103054855247E-05,6.17661132840814E-05,0.0118946158367539,0.00833356319782271,0.0109550056816141,0.0109550056816141,-6.5122659572189000,0.01035228168796,0.00521825406141693,10.0655321985437,0.00038023609420993,0.0117928295885401,-3.47728716426167,21628,1.92838197715697,3,0,0,3.38632335412007E-05,0.0109550056816141,323.507371742435,8.33765477696957
174,182,278,278,278,Q12926,ELAVL2,ELAV2_HUMAN,"nucleoplasm [GO:0005654]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription, DNA-templated [GO:0006355]",NA,ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B) (HuB) (Nervous system-specific RNA-binding protein Hel-N1),GO:0000398; GO:0003723; GO:0003730; GO:0005654; GO:0006355,1E-07,1E-07,1E-07,0.0446300624032556,0.0320951386052823,0.0446969992849879,0.0446300624032556,-4.4858403659587800,0.0404739667645086,0.0202370833822543,10.0102792874505,0.00038901509811801,0.01197830661831,-3.50523986587684,39504,1.92160457412577,5,3,0,1E-07,0.0446300624032556,446300.624032556,18.7676562982528
175,183,279,279,279,Q06136,KDSR,KDSR_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15328338}; Multi-pass membrane protein {ECO:0000269|PubMed:15328338}.,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560,0.00018419618288138,0.00117117439172889,0.00023994754357895,0.00708695042487185,0.00685624116214267,0.00541354507321741,0.00685624116214267,-7.18836642881315000,0.00592047284734757,0.00349200912973686,9.99230026248692,0.00039192514385258,0.0120246567432909,-3.51436608486946,36187,1.91992731217845,4,0,0,0.00023994754357895,0.00685624116214267,28.5739168648199,4.83662690694498
176,184,280,280,280,Q13838,DDX39B,DX39B_HUMAN,"cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]",SUBCELLULAR LOCATION: Nucleus. Nucleus speckle. Cytoplasm. Note=Can translocate to the cytoplasm in the presence of MX1. TREX complex assembly seems to occur in regions surrounding nuclear speckles known as perispeckles.,Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein),GO:0000245; GO:0000346; GO:0000398; GO:0001889; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016363; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0031124; GO:0032786; GO:0042802; GO:0043008; GO:0044877; GO:0045727; GO:0046784; GO:0061051; GO:1904707; GO:2000002; GO:2000573,1E-07,4.03125678766398E-06,9.54200707721949E-06,0.00145987302490825,0.00206683790755326,0.00197988574642757,0.00197988574642757,-8.98036710578058000,0.00183097447167473,0.00092004499045899,9.96943830872238,0.00039566413194072,0.012063308487615,-3.52599268084719,48991,1.91853356608807,9,1,0,4.03125678766398E-06,0.00197988574642757,491.133621774283,8.93997177896787
177,185,281,281,281,Q9UHR5,SAP30BP,S30BP_HUMAN,"intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15496587}.,SAP30-binding protein (Transcriptional regulator protein HCNGP),GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006915; GO:0010942; GO:0045111,1E-07,1E-07,1E-07,0.035326453281954,0.0335315552925655,0.0248159183741763,0.0335315552925655,-4.8983367886342800,0.0312245423162319,0.015612371158116,9.96737654920184,0.00039600346787614,0.012063308487615,-3.52704240403496,33870,1.91853356608807,4,3,0,1E-07,0.0335315552925655,335315.552925655,18.3551598755773
178,186,282,282,282,Q8IXK0,PHC2,PHC2_HUMAN,heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}.,Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2),GO:0000792; GO:0003677; GO:0005634; GO:0005654; GO:0007275; GO:0007283; GO:0008270; GO:0031519; GO:0035102; GO:0042802,0.00417449421342641,0.0164399235909651,0.00764561459198376,0.074206193291935,0.0732631340415233,0.0929655781421868,0.074206193291935,-3.752316589738760,0.07072495769309,0.0447824896453367,9.92774059710069,0.00040259679081552,0.012220668543904,-3.54726143485423,90713,1.91290503492927,5,0,0,0.00764561459198376,0.074206193291935,9.70571984752388,3.2788352177756
179,187,283,283,283,Q9BU61,NDUFAF3,NDUF3_HUMAN,mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Mitochondrion inner membrane {ECO:0000269|PubMed:19463981}.,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,GO:0005634; GO:0005743; GO:0032981,8.17338737044296E-05,0.0426539770000768,6.54930325072459E-05,0.21421719333503,0.284694015070874,0.259116817885076,0.259116817885076,-1.948325438721010,0.238408940794897,0.133471538366211,9.87557856649251,0.00041147992566071,0.0124461772567341,-3.57398328888386,20350,1.90496401814559,5,0,0,8.17338737044296E-05,0.259116817885076,3170.25005840428,11.6303809243302
180,188,284,284,284,Q9BR01,SULT4A1,ST4A1_HUMAN,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; steroid metabolic process [GO:0008202],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST),GO:0004062; GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0050427,0.116353812393539,0.231747796991898,0.232260417354194,0.638256740039014,0.660135573714937,0.578431464124265,0.638256740039014,-0.647791227206761,0.432153917046195,0.409530967436308,9.81275023780424,0.00042250040051957,0.012734519114252,-3.60634143942753,33085,1.89501745038391,4,0,0,0.231747796991898,0.638256740039014,2.75410057106747,1.46158124310798
181,191,289,289,289,Q15257,PTPA,PTPA_HUMAN,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17333320}. Nucleus {ECO:0000269|PubMed:17333320}.,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",GO:0000159; GO:0003755; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008160; GO:0019888; GO:0032515; GO:0032516; GO:0034704; GO:0035307; GO:0035308; GO:0042803; GO:0043065; GO:0043666; GO:0046982; GO:0051721; GO:0070062,0.00066943259876321,0.00056562575736529,0.00045062843170067,0.012437622770834,0.0151155093166473,0.0178230130402137,0.0151155093166473,-6.0478265984226100,0.0145634861132886,0.00784363865258737,9.69814308545893,0.00044354961644899,0.0131376633799425,-3.66585800343695,40668,1.88148187004524,5,0,0,0.00056562575736529,0.0151155093166473,26.7235166005452,4.74003796229306
182,192,290,290,290,O00233,PSMD9,PSMD9_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]; bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]; negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]",NA,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0016579; GO:0032024; GO:0043425; GO:0043687; GO:0045893; GO:0046676; GO:0070682,1E-07,1E-07,0.00025341089431064,0.0139613602760713,0.018745858134721,0.0201940606351305,0.018745858134721,-5.737284319957250,0.017549222717204,0.00885914832337223,9.64598715712918,0.00045355300726473,0.0133876335937452,-3.69315595776665,24682,1.87329618236088,4,2,0,1E-07,0.018745858134721,187458.58134721,17.5162123442543
183,193,291,291,291,Q9ULK4,MED23,MED23_HUMAN,"nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130),GO:0003713; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367,0.00298834659095593,3.08041570672947E-05,3.2904701363941E-05,0.0233294410858547,0.017166133120597,0.0223044852554315,0.0223044852554315,-5.4865223359024400,0.0199160013374987,0.0109753524852117,9.61454192380493,0.00045971766059069,0.0134848674179758,-3.70967922523483,156474,1.87015331913505,15,0,0,3.2904701363941E-05,0.0223044852554315,677.851016143065,9.40482441020077
184,194,293,293,293,Q96FT7,ASIC4,ASIC4_HUMAN,integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; sodium channel activity [GO:0005272]; sodium ion transmembrane transporter activity [GO:0015081]; behavioral fear response [GO:0001662],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,"Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4) (Amiloride-sensitive cation channel 4, pituitary)",GO:0001662; GO:0005216; GO:0005272; GO:0005887; GO:0015081,1E-07,1E-07,1E-07,0.0159397538718181,0.0166645197913181,0.0221833532025319,0.0166645197913181,-5.9070764447637500,0.018262442288556,0.00913132114427801,9.59785481546997,0.00046303071887219,0.0135274503533993,-3.71846767441059,70105,1.86878405128075,7,3,0,1E-07,0.0166645197913181,166645.197913181,17.3464202194478
185,195,294,294,294,O43602,DCX,DCX_HUMAN,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Cell projection {ECO:0000250|UniProtKB:Q9ESI7}. Note=Localizes at neurite tips. {ECO:0000250|UniProtKB:Q9ESI7}.,Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X),GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035556; GO:0043005,0.00013147436341804,7.05740643627218E-05,0.00010321410481044,0.0434992816615348,0.0424197190873056,0.0585040713662691,0.0434992816615348,-4.5228646129949300,0.0480392698608395,0.0241213891079501,9.58930476223809,0.00046473956730633,0.0135311928440213,-3.72297604852126,40574,1.86866391642962,18,0,0,0.00010321410481044,0.0434992816615348,421.447066187556,8.71920762961496
186,196,295,295,295,Q9BX66,SORBS1,SRBS1_HUMAN,cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; SH3/SH2 adaptor activity [GO:0005070]; cell-matrix adhesion [GO:0007160]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; muscle contraction [GO:0006936]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose import in response to insulin stimulus [GO:2001275]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149],"SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell membrane. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Nucleus {ECO:0000250}. Nucleus matrix {ECO:0000250}. Note=Colocalizes with the Ten-1 ICD form of TENM1 in the nucleus (By similarity). Colocalizes with actin stress fibers. Also detected at the plasma membrane and in neuronal intranuclear inclusions. Colocalized with PXN at focal adhesions during myogenic differentiation. {ECO:0000250}.",Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP),GO:0001725; GO:0003779; GO:0005070; GO:0005158; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005913; GO:0005915; GO:0005924; GO:0005925; GO:0006936; GO:0007160; GO:0008092; GO:0008286; GO:0016363; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046889; GO:0048041; GO:1903078; GO:2001275,7.54426161252248E-06,6.5975053782391E-06,8.71207129658241E-06,0.029502061832358,0.0424493098420161,0.03371652676837,0.03371652676837,-4.89040026180222,0.0352150148681523,0.0176151253801719,9.57046000389951,0.00046853329149642,0.013595406695625,-3.73292567804323,142513,1.86660779631304,23,0,0,7.54426161252248E-06,0.03371652676837,4469.16192731241,12.1257886022745
187,198,299,299,299,Q9P0J7,KCMF1,KCMF1_HUMAN,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312],NA,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (RING-type E3 ubiquitin transferase KCMF1) (ZZ-type zinc finger-containing protein 1),GO:0003676; GO:0005576; GO:0005829; GO:0008270; GO:0016740; GO:0043312; GO:1904813,0.00014148227843341,0.00152335114328638,0.00022464304483378,0.0322189808745744,0.0462637121012256,0.0442863153744667,0.0442863153744667,-4.4969952199192000,0.0402931772945711,0.0207764141361367,9.46295716702503,0.00049091493817633,0.0140542871932756,-3.79002811983736,41945,1.85219117608836,5,0,0,0.00022464304483378,0.0442863153744667,197.140825825413,7.62308276431307
188,199,300,300,300,P52597,HNRNPF,HNRPF_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; fibroblast growth factor receptor signaling pathway [GO:0008543]; interleukin-12-mediated signaling pathway [GO:0035722]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm.","Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]",GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0008543; GO:0016020; GO:0016070; GO:0017025; GO:0035722; GO:0043484; GO:0071013,8.49517857443907E-05,0.00014759434674598,8.0252753523928E-05,0.00577062399259395,0.00541877789116985,0.00759726323675197,0.00577062399259395,-7.43705695498597000,0.00615795541150049,0.00318324400108835,9.44218810333807,0.00049538859593141,0.0140983741253709,-3.80112797624912,45672,1.85083096884062,10,0,0,8.49517857443907E-05,0.00577062399259395,67.9282247221622,6.08593924529033
189,200,301,301,301,Q5VTL8,PRPF38B,PR38B_HUMAN,precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),GO:0003723; GO:0006397; GO:0008380; GO:0071011,1E-07,1E-07,1E-07,0.0315326632565513,0.0225093751983833,0.0324019620908443,0.0315326632565513,-4.9870091642268300,0.028814566848593,0.0144073834242965,9.44052536024601,0.00049574890324026,0.0140983741253709,-3.80201757412463,64468,1.85083096884062,4,3,0,1E-07,0.0315326632565513,315326.632565513,18.2664874999847
190,201,302,302,302,O95248,SBF1,MTMR5_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; phosphatidylinositol biosynthetic process [GO:0006661]; protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatogenesis [GO:0007283],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9537414}.,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0006661; GO:0007283; GO:0008138; GO:0016021; GO:0016604; GO:0017112; GO:0019208; GO:0043087,1E-07,1E-07,1E-07,0.00037356857461415,0.00049840448557439,0.00053486568762062,0.00049840448557439,-10.97039532706470000,0.00046884624926972,0.00023452312463486,9.37856879246909,0.00050940609462665,0.0144387952649144,-3.83526727103848,208443,1.84046904164358,23,3,0,1E-07,0.00049840448557439,4984.0448557439,12.2831013371468
191,202,303,303,303,Q9P2G3,KLHL14,KLH14_HUMAN,actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; protein ubiquitination [GO:0016567],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:19535332}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:19535332}. Note=Colocalizes with TOR1A at the endoplasmic reticulum level.",Kelch-like protein 14 (Protein interactor of Torsin-1A) (Printor) (Protein interactor of torsinA),GO:0005783; GO:0005789; GO:0005829; GO:0015629; GO:0016235; GO:0016567; GO:0031463; GO:0043005; GO:0043025,0.00023632817015546,0.00029293085162572,0.00021442752303761,0.030700798226032,0.0372337203896772,0.0450572819591194,0.0372337203896772,-4.7472464124363800,0.0374160380100033,0.0189559145199412,9.34206067038649,0.00051766933027534,0.0145791462881395,-3.8549531809553,70714,1.83626790627904,9,0,0,0.00023632817015546,0.0372337203896772,157.550918983481,7.2996743592939
192,203,305,305,305,O95336,PGLS,6PGL_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,6-phosphogluconolactonase (6PGL) (EC 3.1.1.31),GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062,1E-07,1E-07,1E-07,0.0170840831993707,0.0117340567388155,0.013569915160383,0.013569915160383,-6.203444488773100,0.0141292516995231,0.00706472584976154,9.32730257760596,0.0005210561668679,0.014623740289801,-3.86293083593168,27547,1.83494153439114,8,3,0,1E-07,0.013569915160383,135699.15160383,17.0500521754384
193,204,307,307,307,O00451,GFRA2,GFRA2_HUMAN,anchored component of membrane [GO:0031225]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; axon guidance [GO:0007411]; MAPK cascade [GO:0000165]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}.",GDNF family receptor alpha-2 (GDNF receptor alpha-2) (GDNFR-alpha-2) (GFR-alpha-2) (GDNF receptor beta) (GDNFR-beta) (Neurturin receptor alpha) (NRTNR-alpha) (NTNR-alpha) (RET ligand 2) (TGF-beta-related neurotrophic factor receptor 2),GO:0000165; GO:0005088; GO:0005622; GO:0005886; GO:0007169; GO:0007411; GO:0016167; GO:0019898; GO:0031225; GO:0033141,1E-07,1E-07,1E-07,0.036653832170283,0.0249258917273259,0.0299818251246261,0.0299818251246261,-5.0597679806683600,0.030520416340745,0.0152603081703725,9.31152577150849,0.00052470681698569,0.0146302617374514,-3.87147182431295,51544,1.83474790421549,7,3,0,1E-07,0.0299818251246261,299818.251246261,18.1937286835432
194,205,309,309,309,A6NJT0,UNCX,UNC4_HUMAN,"nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1),GO:0000981; GO:0001502; GO:0005634; GO:0006351; GO:0007389; GO:0021516; GO:0021889; GO:0035726; GO:0043565; GO:0045595,0.00537803640388344,0.00041241547426931,0.00088714558675478,0.133035795234613,0.0946679477065674,0.135186367136796,0.133035795234613,-2.910113618639290,0.118737504204356,0.0615946179238141,9.28060755374268,0.00053195227043364,0.0147123074504376,-3.88824789387573,53690,1.83231920800643,4,0,0,0.00088714558675478,0.133035795234613,149.959372194212,7.22842788067479
195,207,312,312,312,Q8NI37,PPTC7,PPTC7_HUMAN,metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721],NA,Protein phosphatase PTC7 homolog (EC 3.1.3.16) (T-cell activation protein phosphatase 2C) (TA-PP2C) (T-cell activation protein phosphatase 2C-like),GO:0004721; GO:0046872,0.0108254130604558,0.167701517498395,0.0212718451358225,0.53211598421667,0.545143360286686,0.603912413505461,0.545143360286686,-0.875292419168215,0.493790994104714,0.313495088950582,9.26138012190296,0.00053651983093192,0.0147199030537733,-3.89870613047976,32646,1.83209505028045,6,0,0,0.0212718451358225,0.545143360286686,25.6274599972828,4.67961859142889
196,208,314,314,314,Q5K4L6,SLC27A3,S27A3_HUMAN,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; very long-chain fatty acid-CoA ligase activity [GO:0031957],SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,Long-chain fatty acid transport protein 3 (FATP-3) (Fatty acid transport protein 3) (EC 6.2.1.-) (Solute carrier family 27 member 3) (Very long-chain acyl-CoA synthetase homolog 3) (VLCS-3),GO:0000166; GO:0004467; GO:0005783; GO:0016020; GO:0016021; GO:0031957; GO:0031966,1E-07,6.26945857927277E-06,1E-07,0.00019217867370817,0.00022955426460555,0.00018365014475257,0.00019217867370817,-12.34526413210870000,0.00019963787482901,0.00010197542360759,9.24015104968738,0.0005416187450557,0.0147651479543849,-3.91027594455278,78644,1.83076219682278,3,2,0,1E-07,0.00019217867370817,1921.7867370817,10.9082325321029
197,209,316,316,316,Q06587,RING1,RING1_HUMAN,"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin-protein transferase activator activity [GO:0097027]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; histone H2A monoubiquitination [GO:0035518]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21282530}. Nucleus speckle {ECO:0000269|PubMed:21282530}.,E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein),GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0009952; GO:0016607; GO:0016740; GO:0031519; GO:0035102; GO:0035518; GO:0045892; GO:0046872; GO:0048593; GO:0070317; GO:0097027,1E-07,1E-07,1E-07,0.0404254564272654,0.059846295868141,0.0488321746971197,0.0488321746971197,-4.3560241612384700,0.0497012089975087,0.0248507044987543,9.15849115191683,0.00056179323484344,0.0152181964881643,-3.95500559164122,42429,1.81763681285115,5,3,0,1E-07,0.0488321746971197,488321.746971197,18.8974725029731
198,210,317,317,317,O75038,PLCH2,PLCH2_HUMAN,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488],SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Note=Localized predominantly at the plasma membrane. {ECO:0000250}.,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)",GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0035556; GO:0043647; GO:0046488,0.0765227672570909,0.0662888537931774,0.0336750390802427,0.205255451479631,0.177804802203531,0.196217702457178,0.196217702457178,-2.349472889746660,0.13426376533661,0.125960769378475,9.13098996239972,0.00056879369152747,0.015352549176757,-3.97015060121312,154668,1.81381950282643,7,0,0,0.0662888537931774,0.196217702457178,2.96004065886222,1.5656169927245
199,211,318,318,318,Q8TEW0,PARD3,PARD3_HUMAN,"adherens junction [GO:0005912]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell cycle [GO:0007049]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Endomembrane system {ECO:0000269|PubMed:20332120}. Cell junction {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cell junction, tight junction {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q99NH2}. Cell membrane {ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:27925688}. Cytoplasm, cell cortex {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:20332120}. Note=Localized along the cell-cell contact region. Colocalizes with PARD6A and PRKCI at epithelial tight junctions. Colocalizes with the cortical actin that overlays the meiotic spindle during metaphase I and metaphase II. Colocalized with SIRT2 in internode region of myelin sheat (By similarity). Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction. {ECO:0000250}.",Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),GO:0005546; GO:0005547; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007163; GO:0007179; GO:0007205; GO:0007409; GO:0008356; GO:0010801; GO:0012505; GO:0019903; GO:0022011; GO:0030054; GO:0031643; GO:0032266; GO:0032991; GO:0033269; GO:0042802; GO:0043025; GO:0044295; GO:0060341; GO:0065003; GO:0070830; GO:0090162,1E-07,1.59700826750727E-05,1.13998553537372E-05,0.0504437911538669,0.0364086189178282,0.0364475352740743,0.0364475352740743,-4.7780349326463200,0.0410908251359135,0.0205545692139664,9.11346748441692,0.00057330973016998,0.015352549176757,-3.97982177249458,151423,1.81381950282643,6,1,0,1.13998553537372E-05,0.0364475352740743,3197.19278386508,11.6425900228189
200,212,319,319,319,Q8IYB1,MB21D2,M21D2_HUMAN,cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877],NA,Protein MB21D2 (Mab-21 domain-containing protein 2),GO:0044877; GO:0045296,2.26384155758377E-05,1E-07,0.00065675739259015,0.0207736358450677,0.0296935597834889,0.0299328376793952,0.0296935597834889,-5.0737061299924000,0.0265735124999286,0.0135132548526863,9.11243238809042,0.00057357787292547,0.015352549176757,-3.98039359701434,55800,1.81381950282643,11,1,0,2.26384155758377E-05,0.0296935597834889,1311.64478733137,10.357161354511
201,214,322,322,322,Q13596,SNX1,SNX1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle organization [GO:0016050]","SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:15498486, ECO:0000269|PubMed:18088323, ECO:0000269|PubMed:22431521}; Peripheral membrane protein; Cytoplasmic side. Golgi apparatus, trans-Golgi network membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Early endosome membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, lamellipodium {ECO:0000269|PubMed:20604901}. Note=Enriched on tubular elements of the early endosome membrane. Binds preferentially to highly curved membranes enriched in phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) (PubMed:15498486). Colocalized with SORT1 to tubular endosomal membrane structures called endosome-to-TGN transport carriers (ETCs) which are budding from early endosome vacuoles just before maturing into late endosome vacuoles (PubMed:18088323). Colocalizes with DNAJC13 and Shiginella dysenteria toxin stxB on early endosomes (PubMed:19874558). Colocalized with F-actin at the leading edge of lamellipodia in a KALRN-dependent manner (PubMed:20604901). {ECO:0000269|PubMed:15498486, ECO:0000269|PubMed:18088323, ECO:0000269|PubMed:20604901}.",Sorting nexin-1,GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0016050; GO:0019898; GO:0030027; GO:0030904; GO:0030905; GO:0031623; GO:0031901; GO:0031982; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0043231; GO:0045296; GO:0045732; GO:0046982; GO:0072673; GO:1990459; GO:1990460,0.00031796841404613,0.00035591744542576,0.00064509823652352,0.0255960279428392,0.0182007870709599,0.0190592872531932,0.0190592872531932,-5.7133620209733700,0.0205123727236656,0.0106958477271646,9.09275456422338,0.00057870472639035,0.0153842001798181,-3.9912754894936,59070,1.81292507767592,15,0,0,0.00035591744542576,0.0190592872531932,53.5497416553826,5.7428077097621
202,215,323,323,323,Q16799,RTN1,RTN1_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuron differentiation [GO:0030182],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.,Reticulon-1 (Neuroendocrine-specific protein),GO:0005783; GO:0005789; GO:0030176; GO:0030182,1E-07,2.81966696359325E-05,2.86054607908048E-05,0.0114487359644346,0.0143521745852854,0.0171062040932564,0.0143521745852854,-6.1225868448094900,0.0142834041708499,0.00716066946223384,9.06056836828793,0.00058721187074813,0.0155620235715296,-4.00912037698278,83618,1.80793393120182,12,1,0,2.81966696359325E-05,0.0143521745852854,509.002473362871,8.99152885648764
203,216,324,324,324,O14628,ZNF195,ZN195_HUMAN,"nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Zinc finger protein 195,GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0008270,0.0397691952459066,0.0502812322983873,0.0539672915921693,0.0989077724947516,0.0884565871570681,0.0930929935285781,0.0930929935285781,-3.4251835996700600,0.0454798780146448,0.0707458453861435,9.03022983464474,0.00059537106488044,0.0157295565289402,-4.02599321629129,72332,1.80328352148028,4,0,0,0.0502812322983873,0.0930929935285781,1.85144614149729,0.88865258217229
204,217,326,326,326,Q9ULU4,ZMYND8,PKCB1_HUMAN,"cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription cofactor activity [GO:0003712]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription from RNA polymerase II promoter by histone modification [GO:1903758]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of filopodium assembly [GO:0051491]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27477906}.,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),GO:0000977; GO:0001106; GO:0003682; GO:0003712; GO:0005634; GO:0005737; GO:0006351; GO:0030336; GO:0035064; GO:0043197; GO:0043198; GO:0046872; GO:0047485; GO:0051491; GO:0060999; GO:0070491; GO:0070577; GO:0098815; GO:1902897; GO:1902952; GO:1903758,6.21985716145908E-05,0.00016789249227628,0.00011781226894855,0.00049377430628227,0.00045837151223993,0.00042827579787602,0.00045837151223993,-11.09119499607270000,0.00034417276118626,0.00028805415820627,8.94839313075342,0.00061808145117974,0.0161999954884952,-4.07176248602188,131692,1.79048510640317,18,0,0,0.00011781226894855,0.00045837151223993,3.89069420639124,1.96002759448207
205,218,327,327,327,P24928,POLR2A,RPB1_HUMAN,"cytoplasm [GO:0005737]; DNA-directed RNA polymerase II, core complex [GO:0005665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription, termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription, DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26566685, ECO:0000269|PubMed:9852112}. Cytoplasm {ECO:0000269|PubMed:26566685}. Note=Hypophosphorylated form is mainly found in the cytoplasm, while the hyperphosphorylated and active form is nuclear. {ECO:0000269|PubMed:26566685}.",DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),GO:0000398; GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0005737; GO:0006283; GO:0006353; GO:0006355; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016070; GO:0031625; GO:0033120; GO:0042795; GO:0046872; GO:0060964; GO:1990841,1.16860099114863E-05,4.42868486121641E-05,8.52219277889162E-06,0.00100538484290269,0.001318269345475,0.00092027935651736,0.00100538484290269,-9.95803644030129000,0.0010598128311975,0.00055140476603293,8.94567076275832,0.00061885496784321,0.0161999954884952,-4.07329149596256,217176,1.79048510640317,31,0,0,1.16860099114863E-05,0.00100538484290269,86.0332012823716,6.42682161611799
206,219,329,329,329,Q9HBE1,PATZ1,PATZ1_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10713105}.,"POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)",GO:0000978; GO:0000981; GO:0001077; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872,0.00015822748959571,0.00015977953885725,0.00016769049806011,0.14810696123874,0.222836851462164,0.1993738768198,0.1993738768198,-2.3264517034635,0.189943997331397,0.0951338978412028,8.91997136088135,0.00062621566738031,0.0162324844204844,-4.08774611571647,74060,1.78961500527953,9,0,0,0.00015977953885725,0.1993738768198,1247.80605981048,10.2851780054871
207,220,330,330,330,O43929,ORC4,ORC4_HUMAN,"cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]",SUBCELLULAR LOCATION: Nucleus.,Origin recognition complex subunit 4,GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006260; GO:0006270,0.0103976926483355,0.0150150671661777,0.00758952658206434,0.134475790554472,0.13636086432596,0.0970770073745306,0.134475790554472,-2.894581624638750,0.111637125286128,0.0668193247752567,8.91611291962657,0.00062733000386699,0.0162324844204844,-4.08991952181973,50377,1.78961500527953,5,0,0,0.0103976926483355,0.134475790554472,12.9332338531856,3.69301114966616
208,221,331,331,331,Q9HCJ2,LRRC4C,LRC4C_HUMAN,cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic membrane [GO:0045211]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; protein kinase inhibitor activity [GO:0004860]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560],"SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane {ECO:0000269|PubMed:14595443, ECO:0000269|PubMed:21946559}; Single-pass type I membrane protein {ECO:0000269|PubMed:14595443, ECO:0000269|PubMed:21946559}.",Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1),GO:0004860; GO:0005615; GO:0005737; GO:0006469; GO:0016020; GO:0016021; GO:0019221; GO:0030054; GO:0045211; GO:0046426; GO:0050770; GO:0050839; GO:0098632; GO:0099560,0.141966972430956,1E-07,1E-07,0.821786714148728,0.607487857775923,0.760500026888757,0.760500026888757,-0.394979795928681,0.682602475460817,0.388623628540727,8.91109370314385,0.00062878320787393,0.0162324844204844,-4.09274804001111,71950,1.78961500527953,4,2,0,1E-07,0.760500026888757,7605000.26888757,22.8585168682829
209,222,332,332,332,Q8N8L6,ARL 10.00,ARL10_HUMAN,intracellular [GO:0005622]; GTP binding [GO:0005525],NA,ADP-ribosylation factor-like protein 10,GO:0005525; GO:0005622,0.00021221414597868,0.00046882301559743,0.00013779481138195,0.0875179193995163,0.0725163904906683,0.058308009769638,0.0725163904906683,-3.7855490731704600,0.0725078292289549,0.0365268586054634,8.90835571571887,0.00062957766677579,0.0162324844204844,-4.09429160214899,27459,1.78961500527953,5,0,0,0.00021221414597868,0.0725163904906683,341.713273430668,8.4166424783399
210,223,337,337,337,Q9UQ03,CORO2B,COR2B_HUMAN,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.",Coronin-2B (Coronin-like protein C) (Clipin-C) (Protein FC96),GO:0003779; GO:0005737; GO:0015629; GO:0016020; GO:0030036; GO:0051015,0.00033068514051094,0.0001980185237703,0.00046416441640219,0.0138711607784898,0.018382726816465,0.0127795805050156,0.0138711607784898,-6.1717676682055600,0.014680200006429,0.00767105603010899,8.86037116646352,0.00064370220995075,0.0163504181518647,-4.12141258643606,54953,1.78647113604802,12,0,0,0.00033068514051094,0.0138711607784898,41.9467314347949,5.39048649252435
211,224,338,338,338,Q9P2N5,RBM27,RBM27_HUMAN,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],SUBCELLULAR LOCATION: Cytoplasm. Nucleus speckle. Note=Incorporated into the nuclear speckles and to speckles proximal to the nuclear periphery. Also localizes to punctate structures in the cytoplasm termed cytospeckles (By similarity). {ECO:0000250}.,RNA-binding protein 27 (RNA-binding motif protein 27),GO:0003723; GO:0005737; GO:0006397; GO:0016607; GO:0046872,1E-07,1E-07,1E-07,0.0557493531728189,0.0611492506019507,0.0812143275623632,0.0611492506019507,-4.0315213714713600,0.0660375437790443,0.0330188718895221,8.83293318867508,0.00065195287690608,0.0165109959358464,-4.13697982413391,118718,1.78222672949934,5,3,0,1E-07,0.0611492506019507,611492.506019507,19.2219752927402
212,225,339,339,339,Q9H6J7,C11orf49,CK049_HUMAN,NA,NA,UPF0705 protein C11orf49,NA,1.05749617831123,1.01373000052058,0.889859396913513,1.66970388297668,1.53233288650925,1.52275170381689,1.53233288650925,0.61572974474769,0.5879009658525,1.28097900817469,8.81724562585202,0.00065672825667149,0.0165828727938288,-4.14589980845047,37353,1.78034023069578,3,0,0,1.01373000052058,1.53233288650925,1.51157890732478,0.596056292385924
213,226,340,340,340,Q9NYQ7,CELSR3,CELR3_HUMAN,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:1904938,0.00029917241644901,0.00032728111383891,0.00024587141360904,0.0138867631410695,0.0209063894256879,0.0180959785766475,0.0180959785766475,-5.7881870633020100,0.017338935399836,0.00896024268121697,8.80715417971412,0.00065982275250918,0.0166120081219959,-4.15164534128741,358185,1.77957786522547,31,0,0,0.00029917241644901,0.0180959785766475,60.4867881585992,5.91854815066992
214,227,341,341,341,Q13501,SQSTM1,SQSTM_HUMAN,aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; immune system process [GO:0002376]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20168092, ECO:0000269|PubMed:22792322}. Late endosome. Lysosome. Cytoplasmic vesicle, autophagosome. Nucleus. Endoplasmic reticulum. Nucleus, PML body {ECO:0000269|PubMed:20168092}. Cytoplasm, myofibril, sarcomere {ECO:0000250}. Note=In cardiac muscle, localizes to the sarcomeric band (By similarity). Commonly found in inclusion bodies containing polyubiquitinated protein aggregates. In neurodegenerative diseases, detected in Lewy bodies in Parkinson disease, neurofibrillary tangles in Alzheimer disease, and HTT aggregates in Huntington disease. In protein aggregate diseases of the liver, found in large amounts in Mallory bodies of alcoholic and nonalcoholic steatohepatitis, hyaline bodies in hepatocellular carcinoma, and in SERPINA1 aggregates. Enriched in Rosenthal fibers of pilocytic astrocytoma. In the cytoplasm, observed in both membrane-free ubiquitin-containing protein aggregates (sequestosomes) and membrane-surrounded autophagosomes. Colocalizes with TRIM13 in the perinuclear endoplasmic reticulum. Co-localizes with TRIM5 in cytoplasmic bodies. When nuclear export is blocked by treatment with leptomycin B, accumulates in PML bodies. {ECO:0000269|PubMed:20168092}.",Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),GO:0000122; GO:0000407; GO:0000422; GO:0000423; GO:0000932; GO:0001934; GO:0002376; GO:0002931; GO:0004674; GO:0005080; GO:0005654; GO:0005737; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006511; GO:0006914; GO:0006915; GO:0007032; GO:0008104; GO:0008270; GO:0010821; GO:0016197; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030971; GO:0031625; GO:0035255; GO:0035556; GO:0035973; GO:0042169; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043122; GO:0043130; GO:0043231; GO:0044130; GO:0044753; GO:0044754; GO:0045944; GO:0046578; GO:0051291; GO:0061635; GO:0061912; GO:0070062; GO:0070498; GO:0070530; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719,0.0216075504319164,0.0132534023754922,0.0160925203527435,0.0423123742865427,0.0392476786534259,0.0385107814028444,0.0392476786534259,-4.6712488630119500,0.0230391203942203,0.0285040512504942,8.79362738720773,0.00066399868660234,0.016668119522921,-4.15935602756328,47687,1.77811339398636,4,0,0,0.0160925203527435,0.0392476786534259,2.43887705549708,1.28621703328979
215,228,342,342,342,P12270,TPR,TPR_HUMAN,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12802065}. Nucleus membrane {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}; Peripheral membrane protein {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}; Nucleoplasmic side {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Nucleus envelope {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:7798308}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:7798308, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Cytoplasm {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:12802065}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19273613}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:18981471}. Nucleus membrane {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}; Peripheral membrane protein {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}; Cytoplasmic side {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}. Note=Detected as discrete intranuclear foci with IFI204 (By similarity). In interphase, localizes to the nucleoplasmic side of the nuclear pore complex (NPC) core structure, forming a fibrous structure called the nuclear basket. Detected exclusively to the cytoplasmic margin of NPC (PubMed:7798308). Docking to the inner nucleoplasmic side of the NPC is mediated through binding to nucleoporins. Anchored by NUP153 to the NPC. The assembly of the NPC is a stepwise process in which Trp-containing peripheral structures assemble after other components, including p62. Detected as filaments that emanate from the nuclear basket of the NPC and extend to the nucleolus to delineate a chromatin-free network extending from the nuclear envelope to the perinucleolar region. Detected in diffuse and discrete spheroidal intranuclear foci. Nucleocytoplasmic shuttling protein imported into the nucleus in a XPO1/CRM1- and Importin alpha/Importin beta receptor-dependent manner. Remains localized to the nuclear membrane after poliovirus (PV) infection. During mitosis, remains associated with the nuclear envelope until prometaphase. Associated with the mitotic spindle from late prometaphase until anaphase. Reorganized during mitosis in a viscous and dynamic nuclear-derived spindle matrix that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner. Recruited to the reforming nuclear envelope during telophase and cytokinesis. Detected at kinetochores during prometaphase (PubMed:18981471). Colocalizes with MAD2L1 in the spindle matrix but not at kinetochore (PubMed:19273613). Colocalizes with dynein, dynactin, tubulin at kinetochore during the metaphase-anaphase transition. Colocalizes with DYNLL1 at the mitotic spindle. {ECO:0000250, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:7798308}.",Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein),GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0016032; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,6.90781279628288E-05,6.58356143329134E-05,4.18504147196662E-05,0.00025739119874675,0.00026034201642728,0.00030925450981156,0.00026034201642728,-11.90730421341040000,0.0002167411893234,0.0001672919803335,8.77651302075286,0.00066932855111189,0.0167166904166289,-4.16912696325625,267293,1.77684970034606,66,0,0,6.58356143329134E-05,0.00026034201642728,3.95442526154307,1.98346802780176
216,229,343,343,343,Q9NZ53,PODXL2,PDXL2_HUMAN,Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; glycosaminoglycan binding [GO:0005539]; leukocyte tethering or rolling [GO:0050901],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Podocalyxin-like protein 2 (Endoglycan),GO:0005539; GO:0005796; GO:0005887; GO:0050901,0.00012820479059713,0.00017134425725112,0.00010394979259001,0.0796364441307427,0.095169543325333,0.0628021299990194,0.0796364441307427,-3.6504273854600700,0.0790682062048856,0.0396686027159222,8.76603223130324,0.0006726183668465,0.0167166904166289,-4.17511907387126,65076,1.77684970034606,6,0,0,0.00012820479059713,0.0796364441307427,621.165899962286,9.27883482229191
217,230,344,344,344,P46379,BAG6,BAG6_HUMAN,BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; embryo development [GO:0009790]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of cell proliferation [GO:0042127]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Nucleus {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:29042515}. Secreted, exosome {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}. Note=Normally localized in cytosol and nucleus, it can also be released extracellularly, in exosomes, by tumor and myeloid dendritic cells (PubMed:18055229, PubMed:18852879). Cytoplasmic retention is due to interaction with GET4 (PubMed:29042515). {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879, ECO:0000269|PubMed:29042515}.",Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0009790; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0032435; GO:0042127; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381,0.00016111071642759,0.00845759005491993,7.57106147350154E-05,0.0402814070129712,0.055827817311745,0.0468961475390397,0.0468961475390397,-4.4143867777932400,0.0447703201592244,0.0252832972083064,8.76416076061941,0.00067320788050077,0.0167166904166289,-4.17618971114747,119409,1.77684970034606,20,0,0,0.00016111071642759,0.0468961475390397,291.080249525902,8.18527314233158
218,232,346,346,346,Q9H496,TOR1AIP2,IFG15_HUMAN,NA,NA,"Torsin-1A-interacting protein 2, isoform IFRG15 (15 kDa interferon-responsive protein) (IFRG15)",NA,4.25410831394109E-05,1.65021849828011E-05,2.25479390980297E-05,0.0451232843486204,0.0609091391263281,0.0420384107688394,0.0451232843486204,-4.4699841100473000,0.0493297476788559,0.0246920709085014,8.74597378039215,0.00067896979494765,0.016797634233387,-4.1866048378887,15348,1.77475187968688,7,0,0,2.25479390980297E-05,0.0451232843486204,2001.21546153029,10.9666607885109
219,233,348,348,348,P02786,TFRC,TFR1_HUMAN,basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; transferrin transmembrane transporter activity [GO:0033570]; virus receptor activity [GO:0001618]; cellular iron ion homeostasis [GO:0006879]; cellular response to drug [GO:0035690]; cellular response to leukemia inhibitory factor [GO:1990830]; iron ion import [GO:0097286]; membrane organization [GO:0061024]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of isotype switching [GO:0045830]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; transferrin transport [GO:0033572],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17081065}; Single-pass type II membrane protein {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. {ECO:0000269|PubMed:17081065}.; SUBCELLULAR LOCATION: Transferrin receptor protein 1, serum form: Secreted {ECO:0000269|PubMed:17081065}.","Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]",GO:0001618; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006879; GO:0009897; GO:0009986; GO:0010008; GO:0016020; GO:0016323; GO:0030316; GO:0030665; GO:0030890; GO:0031410; GO:0031623; GO:0033570; GO:0033572; GO:0035690; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0045780; GO:0045830; GO:0048471; GO:0055037; GO:0061024; GO:0070062; GO:0072562; GO:0097286; GO:1903561; GO:1990712; GO:1990830,1E-07,2.90158389694096E-05,2.52130234151806E-05,0.0365380976102888,0.0262724139048952,0.0397686833698585,0.0365380976102888,-4.7744546691002400,0.034174955340886,0.0171055872912378,8.70342073367883,0.00069268847496492,0.0170385440968383,-4.21104947680103,84871,1.76856751741688,17,1,0,2.52130234151806E-05,0.0365380976102888,1449.17557123631,10.5010166762496
220,234,349,349,349,Q8WUU5,GATAD1,GATD1_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin assembly [GO:0031497]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21965549}.,GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein),GO:0000981; GO:0005634; GO:0005654; GO:0008270; GO:0031497; GO:0043565,3.3912938354281E-05,0.00014372858414311,1E-07,0.0489740076181204,0.0482849693106693,0.0331095695576462,0.0482849693106693,-4.3722820291968500,0.0433969349879795,0.0217577146681555,8.68539649018988,0.00069860131995873,0.0171347487072972,-4.22143570767772,28690,1.76612226041033,3,1,0,3.3912938354281E-05,0.0482849693106693,1423.79197008077,10.4755226545217
221,235,350,350,350,A1L020,MEX3A,MEX3A_HUMAN,cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17267406}. Nucleus {ECO:0000269|PubMed:17267406}. Cytoplasm, P-body {ECO:0000269|PubMed:17267406}. Note=Predominantly expressed in the cytoplasm and shuttles between the cytoplasm and the nucleus through the CRM1 export pathway.",RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4),GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872,1.42456411352409E-05,8.33554979669808E-05,8.68072050233907E-05,0.0824712948438408,0.0866142264932969,0.0576993027862093,0.0824712948438408,-3.5999641309340800,0.0755334719264072,0.0378282054112454,8.66986032977316,0.00070374750697129,0.0172116533133551,-4.2304036587574,54173,1.76417741030115,9,0,0,8.33554979669808E-05,0.0824712948438408,989.39238388942,9.95039898378586
222,236,351,351,351,Q9ULI4,KIF26A,KI26A_HUMAN,"cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; enteric nervous system development [GO:0048484]; microtubule-based movement [GO:0007018]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.",Kinesin-like protein KIF26A,GO:0001560; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0009968; GO:0019886; GO:0048484,0.00021899555155734,4.0317354040151E-05,9.59695058546089E-05,0.0418117199410956,0.06388072649799,0.0545756639486956,0.0545756639486956,-4.1955984131218500,0.0533042759921097,0.0267705654665389,8.63415683867396,0.00071575054121117,0.0174553408340958,-4.25106724766013,194590,1.75807166670532,18,0,0,9.59695058546089E-05,0.0545756639486956,568.677138250313,9.15146599653389
223,237,352,352,352,Q9Y376,CAB39,CAB39_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine/threonine protein kinase complex [GO:1902554]; kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; cell cycle arrest [GO:0007050]; cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein heterooligomerization [GO:0051291]; signal transduction by protein phosphorylation [GO:0023014],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,Calcium-binding protein 39 (MO25alpha) (Protein Mo25),GO:0004674; GO:0005576; GO:0005829; GO:0007050; GO:0010800; GO:0018105; GO:0019900; GO:0023014; GO:0030295; GO:0034774; GO:0035556; GO:0043312; GO:0043539; GO:0051291; GO:0070062; GO:0071476; GO:0071902; GO:1901017; GO:1901380; GO:1902554; GO:1904813,0.00243626511391096,0.00010372558479511,7.14970073260723E-05,0.0357632496210587,0.0408132912610811,0.0526632321887976,0.0408132912610811,-4.6148171328278300,0.0422094284549684,0.0219752101294949,8.62765808539818,0.00071796216469081,0.0174595344595267,-4.25483662682953,39869,1.75796734049037,8,0,0,0.00010372558479511,0.0408132912610811,393.473715686443,8.62012345570992
224,238,353,353,353,P24666,ACP1,PPAC_HUMAN,cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; sarcolemma [GO:0042383]; acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726],SUBCELLULAR LOCATION: Cytoplasm.,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1),GO:0003993; GO:0004726; GO:0005737; GO:0005829; GO:0009898; GO:0042383; GO:0070062,0.00312098367556444,0.0104105615443324,0.0062262711219916,0.0309403228823784,0.0268281193919513,0.033486094343574,0.0309403228823784,-5.0143679374488100,0.0238322400920051,0.018502058826632,8.61165484875245,0.00072344400367345,0.0175430047349711,-4.26412955018352,18042,1.75589601940457,6,0,0,0.0062262711219916,0.0309403228823784,4.96931827672829,2.3130479471109
225,239,354,354,354,Q92558,WASF1,WASF1_HUMAN,actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; protein kinase A binding [GO:0051018]; protein-containing complex binding [GO:0044877]; actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; lamellipodium morphogenesis [GO:0072673]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:9889097}. Cell junction, synapse {ECO:0000250|UniProtKB:Q5BJU7}. Cell junction, focal adhesion {ECO:0000269|PubMed:18559503}. Note=Dot-like pattern in the cytoplasm. Concentrated in Rac-regulated membrane-ruffling areas (PubMed:9889097). Partial translocation to focal adhesion sites might be mediated by interaction with SORBS2 (PubMed:18559503). In neurons, colocalizes with activated NTRK2 after BDNF addition in endocytic sites through the association with TMEM108 (By similarity). {ECO:0000250|UniProtKB:Q8R5H6, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:9889097}.",Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1) (Verprolin homology domain-containing protein 1),GO:0003779; GO:0005741; GO:0005856; GO:0005925; GO:0006898; GO:0015629; GO:0016601; GO:0030027; GO:0030041; GO:0031209; GO:0032991; GO:0044877; GO:0045202; GO:0051018; GO:0051388; GO:0065003; GO:0072673; GO:0097484; GO:1990416; GO:2000601,0.00020082065048651,0.00010354759721506,0.00028274572292575,0.0102241419002451,0.014559096321786,0.015324517778437,0.014559096321786,-6.101935379055300,0.0131735473432803,0.00678247832851592,8.59077293939677,0.00073067412312812,0.0176546571791851,-4.27627862351707,61652,1.75314071121523,13,0,0,0.00020082065048651,0.014559096321786,72.4980039976715,6.17986937053492
226,240,355,355,355,Q9UP83,COG5,COG5_HUMAN,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:9792665}. Golgi apparatus membrane {ECO:0000269|PubMed:9792665}; Peripheral membrane protein {ECO:0000269|PubMed:9792665}.",Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1),GO:0000139; GO:0005654; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0015031; GO:0016020; GO:0017119; GO:0032588,0.00218074380435772,0.00092906913508571,0.00187072937414643,0.00697598254087708,0.00560444593095452,0.00690207699573185,0.00690207699573185,-7.17875371689548000,0.0048339877179912,0.00407717463019222,8.58647468313227,0.00073217328254798,0.0176546571791851,-4.27878260649367,92743,1.75314071121523,5,0,0,0.00187072937414643,0.00690207699573185,3.68951120943461,1.88342969909492
227,241,356,356,356,Q9Y4F3,MARF1,MARF1_HUMAN,Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; RNA binding [GO:0003723]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; negative regulation of phosphatase activity [GO:0010923]; oogenesis [GO:0048477]; regulation of gene expression [GO:0010468],SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:15932519}.,Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1),GO:0003723; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0010923; GO:0016020; GO:0043231; GO:0048477,8.96053813091854E-05,8.20247336842061E-05,0.0001039436283023,0.0452633435284153,0.0640093105561659,0.0686750123971565,0.0640093105561659,-3.9655744203456000,0.059224030912814,0.0297038733708389,8.57773597263952,0.0007352328007467,0.0176617170575026,-4.28387685204654,192859,1.75296707695614,7,0,0,8.96053813091854E-05,0.0640093105561659,714.34672361139,9.48048067722188
228,242,359,359,359,O94868,FCHSD2,FCSD2_HUMAN,neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; neuromuscular synaptic transmission [GO:0007274]; regulation of actin filament polymerization [GO:0030833],NA,F-BAR and double SH3 domains protein 2 (Carom) (SH3 multiple domains protein 3),GO:0007274; GO:0030833; GO:0031594; GO:0055037,0.0146050506055466,0.0226051480162605,0.0427280569112259,0.11936283191233,0.136585945385762,0.155733504761162,0.136585945385762,-2.872119056101590,0.110581342175407,0.0819367562653813,8.53268236535053,0.00075125670799142,0.0179129733158958,-4.31021440149434,84276,1.74683232104591,6,0,0,0.0226051480162605,0.136585945385762,6.0422495480902,2.59508576936171
229,243,360,360,360,Q8WUN7,UBTD2,UBTD2_HUMAN,cytoplasm [GO:0005737],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12507522}.,Ubiquitin domain-containing protein 2 (Dendritic cell-derived ubiquitin-like protein) (DC-UbP) (Ubiquitin-like protein SB72),GO:0005737,0.00140937837214967,0.0009917994851343,0.0599098906287866,0.232721989017393,0.208501793800348,0.19047744353051,0.208501793800348,-2.261868299247480,0.189796719287394,0.11566871580572,8.52029219199704,0.0007557380228829,0.017967113691887,-4.31747915006664,26190,1.74552168406884,3,0,0,0.00140937837214967,0.208501793800348,147.938834539037,7.20885700517765
230,244,361,361,361,Q16706,MAN2A1,MA2A1_HUMAN,"cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]",SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250|UniProtKB:P28494}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:P28494}.,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0030246; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062,0.0609360913753971,0.0574342724171181,0.065901299279838,0.271263741156324,0.228415530946693,0.199838075584406,0.228415530946693,-2.130267345859100,0.171748561538356,0.147298168459963,8.51482652253598,0.00075772523864149,0.017967113691887,-4.32068682761053,131141,1.74552168406884,3,0,0,0.0609360913753971,0.228415530946693,3.74844407954455,1.90629187973267
231,245,362,362,362,Q15126,PMVK,PMVK_HUMAN,"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; regulation of cholesterol biosynthetic process [GO:0045540]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10191291, ECO:0000269|PubMed:27052676}.",Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2),GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0019287; GO:0045540; GO:0070062; GO:0070723,1E-07,1E-07,0.00019012467848525,0.0179140979733034,0.0275515462958663,0.0237172853798193,0.0237172853798193,-5.3979172976476700,0.022997534990168,0.0115622090545791,8.50408358214307,0.00076164980744879,0.0180102827396732,-4.32699694894298,21995,1.74447946922844,4,2,0,1E-07,0.0237172853798193,237172.853798193,17.8555793665639
232,246,364,364,364,Q16555,DPYSL2,DPYL2_HUMAN,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; axon guidance [GO:0007411]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:20801876}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:20801876}. Membrane {ECO:0000269|PubMed:20801876}. Note=Tightly but non-covalently associated with membranes.",Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),GO:0004157; GO:0005829; GO:0005856; GO:0005886; GO:0006139; GO:0006897; GO:0007010; GO:0007165; GO:0007399; GO:0007411; GO:0007420; GO:0008017; GO:0030516; GO:0042802; GO:0070062,1E-07,0.0001655349178798,4.67960907035E-05,0.00164086337876987,0.00239964386310071,0.00185844048079829,0.00185844048079829,-9.07169180008477000,0.00189550557136186,0.00101856312187536,8.48269150787764,0.00076953888794265,0.0180554022974489,-4.33958319763035,62294,1.743392830493,28,1,0,4.67960907035E-05,0.00185844048079829,39.7135840378926,5.31156066074515
233,247,365,365,365,Q16718,NDUFA5,NDUA5_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}; Matrix side {ECO:0000305}.,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit),GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0032981,0.0148175377925867,0.0188069776364817,0.0174913455327015,0.0683590877608932,0.0583192899555012,0.0510419141365518,0.0583192899555012,-4.0998830349917900,0.0422014769637254,0.0381393588024527,8.48175716557805,0.00076988572880477,0.0180554022974489,-4.34013356943728,13459,1.743392830493,4,0,0,0.0174913455327015,0.0583192899555012,3.33417974314603,1.73733188103566
234,248,367,367,367,Q9BRD0,BUD13,BUD13_HUMAN,"nucleus [GO:0005634]; RES complex [GO:0070274]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]",NA,BUD13 homolog,GO:0000398; GO:0003723; GO:0005634; GO:0070274,0.0278791161533569,0.0304006265735806,0.0140187216522198,0.0721853953917298,0.0873561846090557,0.0780055412832431,0.0780055412832431,-3.6802795773652300,0.0550828856349571,0.0516409309438643,8.46512314426878,0.00077609258611539,0.0181017780303754,-4.34994080874081,70521,1.74227876486255,5,0,0,0.0278791161533569,0.0780055412832431,2.79799190383769,1.48439178798154
235,249,368,368,368,Q12797,ASPH,ASPH_HUMAN,"calcium channel complex [GO:0034704]; cell [GO:0005623]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; ion channel binding [GO:0044325]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; ion transmembrane transport [GO:0034220]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]",SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q28056}.; SUBCELLULAR LOCATION: Isoform 4: Sarcoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000305|PubMed:15485681}.; SUBCELLULAR LOCATION: Isoform 8: Endoplasmic reticulum membrane; Single-pass type II membrane protein {ECO:0000269|PubMed:22586105}.,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),GO:0004597; GO:0005198; GO:0005509; GO:0005513; GO:0005623; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034220; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879; GO:1903779,0.0839937799412359,0.0741895685486715,0.0755883500932516,0.248880723944016,0.241959956740786,0.191501127277089,0.241959956740786,-2.047159787022110,0.149523369792911,0.152685584424175,8.44734596858606,0.00078279370249333,0.0181915865578648,-4.36044095191019,85863,1.74012942280136,7,0,0,0.0755883500932516,0.241959956740786,3.20102180352244,1.67853250372716
236,250,369,369,369,Q86VW0,SESTD1,SESD1_HUMAN,"intermediate filament cytoskeleton [GO:0045111]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]",NA,SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein) (Protein Solo),GO:0005546; GO:0010314; GO:0032266; GO:0043325; GO:0045111; GO:0070273; GO:0070300; GO:0080025; GO:1904878,0.00281121707361476,0.0123464728589939,0.0031834373703855,0.0676705478090377,0.0525871836131565,0.0746705129633533,0.0676705478090377,-3.8853281222235000,0.0588623723608511,0.0355448952814236,8.44365623653358,0.00078419339250608,0.0181915865578648,-4.36262275825662,79348,1.74012942280136,13,0,0,0.0031834373703855,0.0676705478090377,21.2570689904426,4.40987078091608
237,252,371,371,371,O94953,KDM4B,KDM4B_HUMAN,"nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959}.",Lysine-specific demethylase 4B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B),GO:0005654; GO:0006351; GO:0006355; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544,3.64620111503343E-05,2.89017174544432E-05,3.96236606926757E-05,0.0848794136462142,0.0556867708672215,0.0668068582004959,0.0668068582004959,-3.9038599765369600,0.069089351774878,0.0345796716838715,8.41583963799677,0.00079484452111379,0.0183392698132995,-4.3790984728605,121897,1.73661795996195,8,0,0,3.64620111503343E-05,0.0668068582004959,1832.23185153031,10.8393863589969
238,253,372,372,372,P36954,POLR2I,RPB9_HUMAN,"DNA-directed RNA polymerase II, core complex [GO:0005665]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:9852112}.",DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),GO:0000398; GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006379; GO:0008270; GO:0008543; GO:0016070; GO:0042795; GO:0060964,0.00126121323641072,0.00062122665718834,0.00326499115263095,0.0289623419052227,0.0389352854599895,0.0273813241551908,0.0289623419052227,-5.1096779258050000,0.0300438401580577,0.0167377304277722,8.40605581143348,0.0007986327491363,0.0183771406790505,-4.38490488207474,14523,1.73572206008326,3,0,0,0.00126121323641072,0.0289623419052227,22.9638740453173,4.52129414258469
239,254,373,373,373,Q8NFP4,MDGA1,MDGA1_HUMAN,anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; brain development [GO:0007420]; neuron migration [GO:0001764]; spinal cord association neuron differentiation [GO:0021527],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15922729}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:15922729}. Note=Associated with lipid rafts.",MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein) (GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3),GO:0001764; GO:0005576; GO:0005615; GO:0005886; GO:0007420; GO:0021527; GO:0046658,5.67772885844096E-05,6.78960913219683E-05,8.32366234636109E-05,0.0161879514884989,0.0107673170616976,0.0123322334437978,0.0123322334437978,-6.3414220853709300,0.0130265306635414,0.00658256866622738,8.37952623784343,0.00080901631336196,0.0185303821599329,-4.40067955193946,105790,1.73211562394939,19,0,0,6.78960913219683E-05,0.0123322334437978,181.633923303735,7.50488986603513
240,255,375,375,375,Q02127,DHODH,PYRD_HUMAN,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:10727948}; Single-pass membrane protein {ECO:0000269|PubMed:10727948}.,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0010181; GO:0016021; GO:0031000; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0046134; GO:0048039; GO:0090140; GO:1903576,1E-07,1E-07,1E-07,0.00016108240570973,0.00020747673026981,0.00017066386538833,0.00017066386538833,-12.51655475026130000,0.00017964100045596,8.992050022798E-05,8.33939613088812,0.00082503826974227,0.0188313851816086,-4.42462535729883,42867,1.72511773337668,6,3,0,1E-07,0.00017066386538833,1706.6386538833,10.7369419139502
241,256,377,377,377,O15173,PGRMC2,PGRC2_HUMAN,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; heme binding [GO:0020037]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),GO:0003707; GO:0005496; GO:0005635; GO:0016020; GO:0016021; GO:0020037,0.00010550711453626,0.0004249719407362,0.00026894867214045,0.0273909059310439,0.0271498013349447,0.0183075850027028,0.0271498013349447,-5.2029145484352800,0.0240162881804262,0.0122746199993507,8.3232005396018,0.00083161395511051,0.0188313851816086,-4.43431819178712,23818,1.72511773337668,3,0,0,0.00026894867214045,0.0271498013349447,100.947891353658,6.65746696507617
242,257,378,378,378,P08243,ASNS,ASNS_HUMAN,cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; cofactor binding [GO:0048037]; protein homodimerization activity [GO:0042803]; asparagine biosynthetic process [GO:0006529]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to glucose starvation [GO:0042149]; cellular response to hormone stimulus [GO:0032870]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of mitotic cell cycle [GO:0045931]; response to amino acid [GO:0043200]; response to follicle-stimulating hormone [GO:0032354]; response to light stimulus [GO:0009416]; response to mechanical stimulus [GO:0009612]; response to methotrexate [GO:0031427]; response to toxic substance [GO:0009636],NA,Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase),GO:0001889; GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0008652; GO:0009416; GO:0009612; GO:0009636; GO:0031427; GO:0032354; GO:0032870; GO:0036499; GO:0042149; GO:0042803; GO:0043066; GO:0043200; GO:0045931; GO:0048037; GO:0070981,0.00034873468782658,0.00013664364530289,0.00022381923381879,0.00355863213391587,0.00247174498038007,0.00356472450417871,0.00355863213391587,-8.13446147966078000,0.00296196801717546,0.00171738319757049,8.31980921788585,0.00083299898179527,0.0188313851816086,-4.43634995976334,64370,1.72511773337668,15,0,0,0.00022381923381879,0.00355863213391587,15.8995814309553,3.99091688080997
243,258,379,379,379,Q13569,TDG,TDG_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; RNA polymerase II transcription cofactor activity [GO:0001104]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; embryo development [GO:0009790]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of gene expression, epigenetic [GO:0040029]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8662714}.,G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG),GO:0000122; GO:0000287; GO:0001104; GO:0003677; GO:0003684; GO:0003690; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0006351; GO:0008134; GO:0008263; GO:0009790; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0080111; GO:1902544,0.014080469523151,0.00215523083486056,0.0041968514244679,0.0861098975212962,0.125833014308425,0.120286830558405,0.120286830558405,-3.055449395250420,0.103932396868549,0.0587770490284344,8.31308068503357,0.00083575528307972,0.0188313851816086,-4.44038324371658,46053,1.72511773337668,4,0,0,0.0041968514244679,0.120286830558405,28.6612077466277,4.8410274990917
244,259,380,380,380,Q9C0I3,CCSER1,CCSE1_HUMAN,NA,NA,Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1),NA,0.402060563659314,0.40018366600985,0.296862977149747,0.995962451309469,0.880232807175636,0.803928870100635,0.880232807175636,-0.184042951435349,0.527005640588943,0.629871889234109,8.30411868906303,0.0008394438234383,0.0188313851816086,-4.44575981114037,99510,1.72511773337668,5,0,0,0.40018366600985,0.880232807175636,2.19957205138395,1.13722286038501
245,260,381,381,381,Q02543,RPL18A,RL18A_HUMAN,"cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",NA,60S ribosomal protein L18a (Large ribosomal subunit protein eL20),GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005829; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0042788; GO:0097327,0.00128737600769133,0.00513675885907952,0.00235790825988423,0.0148987910443423,0.0128313232134546,0.0129654298460577,0.0129654298460577,-6.2691861527701000,0.0106378336590665,0.00824626453841827,8.30328734279111,0.00083978699183691,0.0188313851816086,-4.44625882004852,20762,1.72511773337668,4,0,0,0.00235790825988423,0.0129654298460577,5.49869987167961,2.45909054401739
246,261,382,382,382,Q9NRW7,VPS45,VPS45_HUMAN,endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904],SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Associated with Golgi/endosomal vesicles and the trans-Golgi network. {ECO:0000250}.,Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45),GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021,0.00031015710868567,0.00046175754970963,0.00067415008323402,0.0401728861697747,0.0436444633718487,0.0284107407465521,0.0401728861697747,-4.6376340760825600,0.0369273418488487,0.0189456925049675,8.29866175200455,0.0008416995034144,0.0188313851816086,-4.4490360992865,65077,1.72511773337668,12,0,0,0.00046175754970963,0.0401728861697747,86.9999552688134,6.44294275408462
247,262,384,384,384,P16298,PPP3CB,PP2BB_HUMAN,"calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; social behavior [GO:0035176]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19154138}.,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta),GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0008144; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035176; GO:0035690; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796,1.3395282877886E-05,1E-07,1E-07,0.0184532848752234,0.014621937084901,0.0226597450338345,0.0184532848752234,-5.7599785360165500,0.0185737905703603,0.00929142704613945,8.29125642106273,0.00084477241936188,0.0188313851816086,-4.45348522515842,59024,1.72511773337668,9,2,0,1E-07,0.0184532848752234,184532.848752234,17.493518128195
248,263,385,385,385,P18074,ERCC2,ERCC2_HUMAN,"core TFIIH complex [GO:0000439]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; holo TFIIH complex [GO:0005675]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; 7-methylguanosine mRNA capping [GO:0006370]; aging [GO:0007568]; apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; global genome nucleotide-excision repair [GO:0070911]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; termination of RNA polymerase I transcription [GO:0006363]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20797633}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:20797633}.",General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 3.6.4.12) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),GO:0000439; GO:0001666; GO:0001701; GO:0003677; GO:0004003; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006283; GO:0006289; GO:0006293; GO:0006294; GO:0006296; GO:0006361; GO:0006363; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0006468; GO:0006915; GO:0006979; GO:0007059; GO:0007568; GO:0008022; GO:0008094; GO:0008283; GO:0009650; GO:0009791; GO:0016032; GO:0021510; GO:0030198; GO:0030282; GO:0032289; GO:0033683; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0043388; GO:0045893; GO:0045944; GO:0046872; GO:0047485; GO:0048568; GO:0048820; GO:0051539; GO:0060218; GO:0070911; GO:0071817; GO:1901990,0.00032537872352156,0.00215633786380897,0.00038983699738146,0.0534992921206415,0.0427340001426951,0.0351357532021828,0.0427340001426951,-4.5484718220671400,0.0428324972936025,0.0223734331750386,8.27874158037021,0.00084999677272964,0.0188986295443267,-4.46101212262548,86909,1.72356968804454,10,0,0,0.00038983699738146,0.0427340001426951,109.620175688146,6.77636954178168
249,264,386,386,386,Q96K37,SLC35E1,S35E1_HUMAN,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,Solute carrier family 35 member E1,GO:0005794; GO:0016021,0.00357174070822772,1E-07,1E-07,0.0427020592870577,0.0370059904598055,0.0282412966030778,0.0370059904598055,-4.7560973593815700,0.0347924685472378,0.0185868811763615,8.24791743506582,0.0008630335751066,0.0191126028938693,-4.47959380989404,44773,1.71868016352236,3,2,0,1E-07,0.0370059904598055,370059.904598055,18.49739930483
250,265,389,389,389,Q8WYK1,CNTNAP5,CNTP5_HUMAN,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),GO:0007155; GO:0016021,6.97168680854679E-05,0.00011078947285617,5.18008254725662E-05,0.0672182623393035,0.0556903875304898,0.0430999887609693,0.0556903875304898,-4.1664278578801400,0.0552587771547828,0.0277068242995295,8.22128576577352,0.00087449422666389,0.0192433691008816,-4.49569749658842,145623,1.71571888999943,17,0,0,6.97168680854679E-05,0.0556903875304898,798.807936441112,9.64170485631644
251,266,390,390,390,Q13825,AUH,AUHM_HUMAN,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q9JLZ3}.,"Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)",GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0009083; GO:0050011,0.00018757378220493,0.00028821191988196,0.00017695946387592,0.0371306863273459,0.0484289835832206,0.0317472177618172,0.0371306863273459,-4.7512442074151700,0.0388847141688069,0.0196599388063911,8.19665051865424,0.00088526155508264,0.0193052480030343,-4.51063493314552,35609,1.7143246148813,7,0,0,0.00018757378220493,0.0371306863273459,197.952431789105,7.62900998034826
252,267,391,391,391,Q86TN4,TRPT1,TRPT1_HUMAN,"tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",NA,tRNA 2'-phosphotransferase 1 (EC 2.7.1.160),GO:0000215; GO:0006388; GO:0045859,9.45344863038658E-05,0.00012831005431077,0.00012540126004199,0.00027258118982557,0.00028682599768443,0.00029310876926241,0.00028682599768443,-11.76753658483120000,0.00016809005203859,0.0002001269595715,8.19328037867506,0.00088674709546979,0.0193052480030343,-4.51268146885432,27742,1.7143246148813,3,0,0,0.00012540126004199,0.00028682599768443,2.28726567490939,1.19362395018912
253,268,393,393,393,Q6Y7W6,GIGYF2,GGYF2_HUMAN,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cellular protein metabolic process [GO:0044267]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing [GO:0016441]; spinal cord motor neuron differentiation [GO:0021522],NA,GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein),GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016021; GO:0016441; GO:0017148; GO:0021522; GO:0031571; GO:0032991; GO:0035264; GO:0043204; GO:0044267; GO:0045296; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635,1.1083218555429E-05,1E-07,1.99569898102302E-06,0.0404839198353928,0.0632111646487033,0.0519027997953641,0.0519027997953641,-4.2680438257206500,0.0518615684539746,0.0259351771994995,8.19074508622255,0.00088786664520143,0.0193052480030343,-4.51422152707155,150070,1.7143246148813,19,1,0,1.99569898102302E-06,0.0519027997953641,26007.3289052631,14.6666306137779
254,270,397,397,397,O15068,MCF2L,MCF2L_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G-protein coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],SUBCELLULAR LOCATION: Isoform 5: Cytoplasm {ECO:0000269|PubMed:15157669}. Cell membrane {ECO:0000269|PubMed:15157669}; Peripheral membrane protein {ECO:0000269|PubMed:15157669}; Cytoplasmic side {ECO:0000269|PubMed:15157669}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm {ECO:0000269|PubMed:15157669}. Endomembrane system {ECO:0000269|PubMed:15157669}. Note=Interaction with membranes enriched in phosphoinositides is mediated by the CRAL-TRIO domain. {ECO:0000269|PubMed:15157669}.; SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q64096}. Cell membrane {ECO:0000250|UniProtKB:Q64096}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q64096}; Cytoplasmic side {ECO:0000250|UniProtKB:Q64096}.,Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein),GO:0005085; GO:0005089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0012505; GO:0031234; GO:0035023; GO:0035025; GO:0035091; GO:0035556; GO:0043065; GO:0051056,6.34606732832394E-05,1E-07,1E-07,0.0511488208487143,0.0420657288797647,0.032679253136418,0.0420657288797647,-4.5712108474654000,0.0419433807305379,0.0209929105896967,8.1509703767149,0.00090565853555691,0.0195275492805219,-4.5384376308286,128109,1.7093522575176,13,2,0,1E-07,0.0420657288797647,420657.288797647,18.6822858167461
255,271,398,398,398,P16949,STMN1,STMN1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.",Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),GO:0000281; GO:0005622; GO:0005737; GO:0005829; GO:0005874; GO:0007019; GO:0007052; GO:0007165; GO:0007409; GO:0007420; GO:0009615; GO:0015631; GO:0016020; GO:0031110; GO:0031115; GO:0031175; GO:0035024; GO:0035556; GO:0043005; GO:0048012; GO:0051272; GO:0051497; GO:0061436; GO:0070062; GO:0070495; GO:1905098,0.00105623495775059,0.00160550093190265,0.00090458068229631,0.0122890142307896,0.0108346054112174,0.0158403577660905,0.0122890142307896,-6.3464869959022000,0.011799220278716,0.00708838233000785,8.14011070246984,0.00091059167813259,0.0195845848362187,-4.54506739149853,17303,1.70808563040922,8,0,0,0.00105623495775059,0.0122890142307896,11.6347353783489,3.54036649319528
256,272,399,399,399,Q15560,TCEA2,TCEA2_HUMAN,"transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]",SUBCELLULAR LOCATION: Nucleus.,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),GO:0003677; GO:0006354; GO:0008023; GO:0008270; GO:0032784; GO:0045944,6.94206743659341E-05,4.41748533559028E-05,0.0779097645307859,0.327821594901682,0.350451290352232,0.263521526671657,0.327821594901682,-1.609017201306010,0.287923683955688,0.169969628664013,8.11557724062298,0.00092185758189306,0.0197455298494759,-4.56007355103754,33601,1.70453120795852,5,0,0,6.94206743659341E-05,0.327821594901682,4722.24734052064,12.2052578932759
257,273,400,400,400,O15213,WDR46,WDR46_HUMAN,"90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:23848194}.",WD repeat-containing protein 46 (WD repeat-containing protein BING4),GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030686; GO:0032040,0.00153947877794083,0.00268733257873383,0.0022294163327824,0.0222003914113819,0.0191590962760625,0.0149681995773852,0.0191590962760625,-5.7058266782200600,0.0166238198584575,0.0104639858257144,8.11378268287033,0.00092268831072317,0.0197455298494759,-4.56117277409179,68071,1.70453120795852,5,0,0,0.0022294163327824,0.0191590962760625,8.59377227767556,3.10329154832189
258,274,401,401,401,P31930,UQCRC1,QCR1_HUMAN,"cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidation-reduction process [GO:0055114]; oxidative phosphorylation [GO:0006119]; protein processing [GO:0016485]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]",SUBCELLULAR LOCATION: Mitochondrion inner membrane.,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",GO:0004222; GO:0005739; GO:0005743; GO:0005746; GO:0005750; GO:0005829; GO:0006119; GO:0006122; GO:0008121; GO:0008270; GO:0009060; GO:0014823; GO:0016485; GO:0031625; GO:0043209; GO:0043279; GO:0044877; GO:0055114,0.00210245141739718,0.00203665324816618,0.00232571081074674,0.0111042514633387,0.0132423773517114,0.00924533332683899,0.0111042514633387,-6.4927440455640000,0.00904238222185966,0.0066761296030332,8.08962095202436,0.00093396260631464,0.0199369573816792,-4.57599340033264,52646,1.70034111950341,10,0,0,0.00210245141739718,0.0111042514633387,5.28157339163903,2.40096777544999
259,275,402,402,402,Q9Y496,KIF3A,KIF3A_HUMAN,"centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, plus-end-directed [GO:0008574]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; spectrin binding [GO:0030507]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; neurogenesis [GO:0022008]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}. Cell projection, cilium {ECO:0000250|UniProtKB:P28741}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:23386061}. Note=Localizes to the subdistal appendage region of the centriole. {ECO:0000269|PubMed:23386061}.",Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0006890; GO:0006996; GO:0007018; GO:0008017; GO:0008574; GO:0010457; GO:0015630; GO:0016939; GO:0017137; GO:0019886; GO:0022008; GO:0030507; GO:0034454; GO:0035735; GO:0060271; GO:0070062; GO:0072383; GO:0097542,2.8608098796857E-05,5.02619669528351E-05,4.22612713885229E-05,0.00028257630616943,0.00022861669537944,0.00022433829739993,0.00022861669537944,-12.09478161527260000,0.0002047999872702,0.0001427771060145,8.08218590585883,0.00093746571023818,0.0199619564170121,-4.58056181356781,80041,1.6997968969427,20,0,0,4.22612713885229E-05,0.00022861669537944,5.40960287913928,2.43552268918607
260,276,405,405,405,Q8N1G4,LRRC47,LRC47_HUMAN,RNA binding [GO:0003723],NA,Leucine-rich repeat-containing protein 47,GO:0003723,1E-07,1E-07,1E-07,0.00973346153358956,0.0150215032975638,0.0144996033923909,0.0144996033923909,-6.1078427510280500,0.0130847560745147,0.00654247803725737,8.05816453974633,0.00094889375502393,0.020051503016108,-4.59534679501929,63473,1.69785306807438,15,3,0,1E-07,0.0144996033923909,144996.033923909,17.1456539131835
261,277,406,406,406,P28799,GRN,GRN_HUMAN,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Secreted.,Granulins (Proepithelin) (PEPI) [Cleaved into: Acrogranin (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Progranulin); Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Granulin B); Granulin-4 (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],GO:0003723; GO:0005125; GO:0005576; GO:0005764; GO:0005768; GO:0005783; GO:0007165; GO:0008083; GO:0035578; GO:0043312; GO:0070062,0.551887537690189,0.518765937877066,0.536235375328771,0.721394426269823,0.685309743772408,0.761853377245302,0.721394426269823,-0.471139818454352,0.187222898797169,0.629241066363926,8.05331228587834,0.00095122278655525,0.020051503016108,-4.5983380099848,63544,1.69785306807438,3,0,0,0.536235375328771,0.721394426269823,1.34529436038704,0.427921879701234
262,278,407,407,407,O94952,FBXO21,FBX21_HUMAN,cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,F-box only protein 21,GO:0000151; GO:0000209; GO:0003677; GO:0004842; GO:0005829; GO:0006511; GO:0043687,0.00012034713949006,9.48139966258697E-05,0.00012012775657654,0.116011947822867,0.0759741333148193,0.114816752666974,0.114816752666974,-3.122594936965600,0.102155848303989,0.0511896871162255,8.04882389760488,0.00095338337938737,0.020051503016108,-4.60110632241818,72270,1.69785306807438,4,0,0,0.00012012775657654,0.114816752666974,955.788703119732,9.90054790562291
263,279,409,409,409,Q9UKE5,TNIK,TNIK_HUMAN,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of JNKK activity [GO:0007256]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; microvillus assembly [GO:0030033]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic cell cycle [GO:0007346]; Wnt signaling pathway [GO:0016055],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Recycling endosome. Cytoplasm, cytoskeleton. Note=Associated with recycling endosomes and the cytoskeletal fraction upon RAP2A overexpression.",TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0007256; GO:0007346; GO:0008349; GO:0016055; GO:0016324; GO:0030033; GO:0031532; GO:0035556; GO:0042981; GO:0046777; GO:0048814; GO:0055037; GO:0070062; GO:0072659,0.0153185816822587,0.0274465320308724,0.0360778574278475,0.105156386980839,0.0844156870578282,0.106586357710827,0.105156386980839,-3.249391615851970,0.0724384868695054,0.0625002338150789,8.02090544622629,0.00096695788819225,0.0202008211092838,-4.61835605279415,154943,1.69463097728687,14,0,0,0.0274465320308724,0.105156386980839,3.83131780957088,1.93784070294134
264,280,410,410,410,O75385,ULK1,ULK1_HUMAN,Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; macroautophagy [GO:0016236]; negative regulation of protein complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagosome assembly [GO:2000786]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to starvation [GO:0042594]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Preautophagosomal structure {ECO:0000250}. Note=Under starvation conditions, is localized to puncate structures primarily representing the isolation membrane that sequesters a portion of the cytoplasm resulting in the formation of an autophagosome. {ECO:0000250}.",Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1),GO:0004674; GO:0005524; GO:0005737; GO:0005741; GO:0005776; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007165; GO:0008104; GO:0016236; GO:0016241; GO:0016301; GO:0017137; GO:0018105; GO:0018107; GO:0030424; GO:0031102; GO:0031175; GO:0031333; GO:0031669; GO:0034045; GO:0042594; GO:0042802; GO:0044877; GO:0046777; GO:0048675; GO:0051020; GO:0055037; GO:0075044; GO:0097629; GO:0097632; GO:0097635; GO:1990316; GO:2000786,2.09231747395092E-05,0.0311301877415889,2.50638900949611E-05,0.212970986328138,0.169640954186675,0.148850094743852,0.169640954186675,-2.559443592029530,0.166761953484081,0.0937730350108481,8.01967269702492,0.00096756269331849,0.0202008211092838,-4.61911893138345,112631,1.69463097728687,10,0,0,2.50638900949611E-05,0.169640954186675,6768.34096957599,12.7245865337827
265,281,412,412,412,P25705,ATP5F1A,ATPA_HUMAN,"extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P19483}; Peripheral membrane protein {ECO:0000250|UniProtKB:P19483}; Matrix side {ECO:0000250|UniProtKB:P19483}. Cell membrane {ECO:0000269|PubMed:10077593}; Peripheral membrane protein {ECO:0000269|PubMed:10077593}; Extracellular side {ECO:0000269|PubMed:10077593}. Note=Colocalizes with HRG on the cell surface of T-cells (PubMed:19285951). {ECO:0000269|PubMed:19285951}.,"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)",GO:0001937; GO:0003723; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0016020; GO:0022857; GO:0042288; GO:0042407; GO:0042776; GO:0043209; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0070062,1E-07,1E-07,1E-07,0.00637384457350515,0.0087443036140654,0.0057851770327761,0.00637384457350515,-7.29362044530272000,0.00696767507344888,0.00348393753672444,7.9817522771632,0.00098639453073699,0.020431598892563,-4.6426359690326,59751,1.68969764594482,18,3,0,1E-07,0.00637384457350515,63738.4457350515,15.9598762189088
266,282,414,414,414,Q5JU85,IQSEC2,IQEC2_HUMAN,cytoplasm [GO:0005737]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,IQ motif and SEC7 domain-containing protein 2,GO:0005086; GO:0005737; GO:0030036; GO:0032012,0.0005160383476457,0.00019702006976553,0.00013436486646065,0.236506428990567,0.342866508261388,0.371849874674909,0.342866508261388,-1.544281108447110,0.316791796214331,0.158678372535123,7.97823510172588,0.00098816377821507,0.020431598892563,-4.6448221550901,162784,1.68969764594482,3,0,0,0.00019702006976553,0.342866508261388,1740.26183560602,10.7650886714897
267,284,418,418,418,Q9NQG5,RPRD1B,RPR1B_HUMAN,"centrosome [GO:0005813]; cytosol [GO:0005829]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II core binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22264791}.,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),GO:0000993; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0008284; GO:0010564; GO:0016591; GO:0042795; GO:0042802; GO:0045944; GO:0070940,1E-07,1E-07,1E-07,0.0326896232374111,0.0308129973575242,0.0459682618780052,0.0326896232374111,-4.9350234402819900,0.0364901941576468,0.0182451970788234,7.92694853126132,0.0010144076595618,0.0207735157077727,-4.6767965468542,36900,1.68248999728887,9,3,0,1E-07,0.0326896232374111,326896.232374111,18.3184732239295
268,285,419,419,419,Q6ZN54,DEF8,DEFI8_HUMAN,intracellular [GO:0005622]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029],NA,Differentially expressed in FDCP 8 homolog (DEF-8),GO:0005622; GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029,0.102644429714164,0.118895681223177,0.17717959065577,0.304365595874019,0.31610714622297,0.30359819218107,0.304365595874019,-1.716122802626300,0.175117077561649,0.220465105978528,7.89362598682118,0.00103191544148283,0.0210816137925848,-4.69766818670073,58710,1.67609614704638,4,0,0,0.118895681223177,0.304365595874019,2.55993819744133,1.35610898080294
269,286,422,422,422,P36639,NUDT1,8ODP_HUMAN,"acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity [GO:0044714]; 2-hydroxy-adenosine triphosphate pyrophosphatase activity [GO:0044713]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; nucleobase-containing small molecule catabolic process [GO:0034656]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]","SUBCELLULAR LOCATION: Isoform p18: Cytoplasm, cytosol {ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:7782328}. Mitochondrion matrix {ECO:0000269|PubMed:7782328, ECO:0000305|PubMed:12857738, ECO:0000305|PubMed:16607562}. Nucleus {ECO:0000269|PubMed:12857738, ECO:0000269|PubMed:7782328}. Note=Mostly present in cytosol (PubMed:7782328). A minor proportion is mitochondrial (PubMed:7782328). A very small amount of the protein is associated with nuclei (PubMed:7782328). Variant Met-124 has decreased efficiency in translocation to mitochondria (PubMed:16607562). {ECO:0000269|PubMed:16607562, ECO:0000269|PubMed:7782328}.; SUBCELLULAR LOCATION: Isoform p26: Mitochondrion matrix {ECO:0000269|PubMed:16607562}.","7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",GO:0001669; GO:0003924; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006195; GO:0006203; GO:0006281; GO:0006979; GO:0007568; GO:0008413; GO:0008584; GO:0030515; GO:0031965; GO:0034656; GO:0035539; GO:0036219; GO:0042262; GO:0044713; GO:0044714; GO:0046061; GO:0046686; GO:0046872; GO:0047693,1E-07,1E-07,1E-07,0.00029651212183257,0.00042017348036157,0.00045924362480227,0.00042017348036157,-11.21672727169890000,0.00039187640899881,0.0001960382044994,7.80905052915712,0.00107803406002436,0.0218672311701624,-4.75098861222361,22520,1.66020620386891,3,3,0,1E-07,0.00042017348036157,4201.7348036157,12.0367693925126
270,288,425,425,425,Q99873,PRMT1,ANM1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription, DNA-templated [GO:0006355]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19136629}. Nucleus, nucleoplasm {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:26876602}. Cytoplasm, cytosol {ECO:0000250}. Note=Mostly found in the cytoplasm. Colocalizes with CHTOP within the nucleus. Low levels detected also in the chromatin fraction (By similarity). {ECO:0000250}.",Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4),GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006479; GO:0006977; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0016274; GO:0016571; GO:0018216; GO:0019899; GO:0031175; GO:0034709; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046985; GO:0048273; GO:0051260; GO:1900745; GO:1904047,0.0004019758777002,0.00204887671044576,0.00064877683742694,0.00726437526903329,0.0103395061481065,0.00981493919869134,0.00981493919869134,-6.67080495410953000,0.00810639706341941,0.00508640834023401,7.78111576531966,0.00109381649295721,0.0220307510110911,-4.76871030029274,42462,1.65697069783728,11,0,0,0.00064877683742694,0.00981493919869134,15.1283748624836,3.9191851119356
271,289,426,426,426,P55011,SLC12A2,S12A2_HUMAN,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transport [GO:0015696]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; ion transport [GO:0006811]; positive regulation of cell volume [GO:0045795]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321],SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1),GO:0005886; GO:0005887; GO:0006811; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0015696; GO:0016020; GO:0016324; GO:0019901; GO:0030321; GO:0045795; GO:0070062; GO:0070634; GO:1903561,0.0248802046891445,0.0249110144722776,0.012541156581914,0.0575171161564634,0.0517000361064389,0.0595103564667302,0.0575171161564634,-4.1198648472914800,0.0354650443287655,0.0385099807454948,7.75600272213984,0.00110824580452121,0.0221403711704209,-4.78468907945498,131447,1.65481510270235,14,0,0,0.0248802046891445,0.0575171161564634,2.31176217700326,1.20899298793117
272,290,428,428,428,P43004,SLC1A2,EAA2_HUMAN,axolemma [GO:0030673]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14506254, ECO:0000269|PubMed:15265858, ECO:0000269|PubMed:26690923, ECO:0000269|PubMed:7521911}; Multi-pass membrane protein {ECO:0000305}.",Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0007632; GO:0009611; GO:0009986; GO:0010259; GO:0014047; GO:0015171; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0035264; GO:0043200; GO:0046326; GO:0046872; GO:0070207; GO:0070779; GO:0098712,0.00012292793654968,7.16966854941982E-05,7.55011198874967E-05,0.0221799842476736,0.0323182198825944,0.0220577189323686,0.0221799842476736,-5.4945978488833600,0.0254285991069017,0.012804341467428,7.74949699063074,0.00111202161193269,0.0221403711704209,-4.78883582216929,62104,1.65481510270235,8,0,0,7.55011198874967E-05,0.0221799842476736,293.770268318188,8.19854458185539
273,291,430,430,430,Q12765,SCRN1,SCRN1_HUMAN,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Secernin-1,GO:0005634; GO:0005737; GO:0006887; GO:0016805; GO:0031965,1E-07,1E-07,1E-07,0.0230461110312276,0.0159962266407334,0.0155208514663962,0.0159962266407334,-5.9661245627072300,0.0181876297127857,0.00909391485639287,7.74548978233128,0.00111435512864173,0.0221403711704209,-4.79139151179737,46382,1.65481510270235,11,3,0,1E-07,0.0159962266407334,159962.266407334,17.2873721015043
274,292,431,431,431,O75390,CS,CISY_HUMAN,extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; tricarboxylic acid cycle [GO:0006099],SUBCELLULAR LOCATION: Mitochondrion matrix.,"Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)",GO:0003723; GO:0004108; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0070062,2.10129780703334E-05,3.50238005326614E-06,1.41420016203052E-05,0.00281964173938584,0.00433759676464387,0.00437447432925569,0.00433759676464387,-7.84888834246060000,0.0038310184911805,0.00192839503217155,7.74476464667888,0.00111477803439853,0.0221403711704209,-4.79185410621057,51712,1.65481510270235,13,0,0,1.41420016203052E-05,0.00433759676464387,306.717314924919,8.26076580225904
275,293,433,433,433,Q86V97,KBTBD6,KBTB6_HUMAN,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],NA,Kelch repeat and BTB domain-containing protein 6,GO:0005829; GO:0016567; GO:0031463; GO:0043687,0.0013229527368861,0.00405216110322905,0.00065726022501118,0.0288447504342419,0.0443951092735746,0.0409793971274715,0.0409793971274715,-4.6089574296228500,0.0360622942567205,0.0200419384834024,7.73433813595951,0.00112088055942713,0.0221587473180052,-4.79850976599103,76138,1.65445479485766,7,0,0,0.0013229527368861,0.0409793971274715,30.9757075856895,4.9530653334665
276,294,434,434,434,O75093,SLIT1,SLIT1_HUMAN,extracellular space [GO:0005615]; intracellular [GO:0005622]; calcium ion binding [GO:0005509]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028],SUBCELLULAR LOCATION: Secreted {ECO:0000250}.,Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4),GO:0005509; GO:0005615; GO:0005622; GO:0007097; GO:0007411; GO:0008045; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964,1E-07,1E-07,1E-07,0.0586975190424523,0.0823591039345223,0.054199562260154,0.0586975190424523,-4.0905566632842300,0.0650852950790429,0.0325427475395214,7.7216553155355,0.0011283586761199,0.0222551849483557,-4.80661620112034,167926,1.65256879222772,13,3,0,1E-07,0.0586975190424523,586975.190424523,19.1629400009273
277,295,435,435,435,P62701,RPS4X,RS4X_HUMAN,"cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; multicellular organism development [GO:0007275]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.,"40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)",GO:0000184; GO:0003723; GO:0003735; GO:0005654; GO:0005829; GO:0005840; GO:0005844; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0007275; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022627; GO:0036464; GO:0045727; GO:0070062; GO:1990904,1E-07,1E-07,1E-07,0.00170899543821961,0.00255241042871803,0.00271606054631962,0.00255241042871803,-8.61392395090933000,0.00232572213775242,0.00116296106887621,7.71190249115716,0.00113415059035339,0.0223179978239656,-4.81285772393346,29598,1.65134476909852,8,3,0,1E-07,0.00255241042871803,25524.1042871803,14.6395727133022
278,296,436,436,436,P35222,CTNNB1,CTNB1_HUMAN,"adherens junction [GO:0005912]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intracellular [GO:0005622]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription factor complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; androgen receptor binding [GO:0050681]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; I-SMAD binding [GO:0070411]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; nuclear hormone receptor binding [GO:0035257]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; adherens junction assembly [GO:0034333]; androgen receptor signaling pathway [GO:0030521]; anterior/posterior axis specification [GO:0009948]; beta-catenin destruction complex disassembly [GO:1904886]; beta-catenin-TCF complex assembly [GO:1904837]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chromatin-mediated maintenance of transcription [GO:0048096]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; entry of bacterium into host cell [GO:0035635]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung cell differentiation [GO:0060479]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chromatin-mediated maintenance of transcription [GO:1904501]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; protein localization to cell surface [GO:0034394]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of euchromatin binding [GO:1904793]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25183871}. Nucleus {ECO:0000269|PubMed:24342833, ECO:0000269|PubMed:25183871, ECO:0000269|PubMed:29367600}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:B6V8E6}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q02248}. Cell junction {ECO:0000250|UniProtKB:B6V8E6}. Cell membrane {ECO:0000269|PubMed:24342833}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle pole. Cell junction, synapse {ECO:0000250|UniProtKB:Q02248}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:Q02248}. Note=Colocalized with RAPGEF2 and TJP1 at cell-cell contacts (By similarity). Cytoplasmic when it is unstabilized (high level of phosphorylation) or bound to CDH1. Translocates to the nucleus when it is stabilized (low level of phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear translocation. Interaction with EMD inhibits nuclear localization. The majority of beta-catenin is localized to the cell membrane. In interphase, colocalizes with CROCC between CEP250 puncta at the proximal end of centrioles, and this localization is dependent on CROCC and CEP250. In mitosis, when NEK2 activity increases, it localizes to centrosomes at spindle poles independent of CROCC. Colocalizes with CDK5 in the cell-cell contacts and plasma membrane of undifferentiated and differentiated neuroblastoma cells. Interaction with FAM53B promotes translocation to the nucleus (PubMed:25183871). {ECO:0000250|UniProtKB:B6V8E6, ECO:0000269|PubMed:25183871}.",Catenin beta-1 (Beta-catenin),GO:0000122; GO:0000578; GO:0000904; GO:0000922; GO:0001085; GO:0001102; GO:0001105; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003700; GO:0003713; GO:0005622; GO:0005634; GO:0005654; GO:0005667; GO:0005719; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007223; GO:0007268; GO:0007398; GO:0007403; GO:0008022; GO:0008134; GO:0008285; GO:0009948; GO:0009950; GO:0009954; GO:0010718; GO:0010909; GO:0016020; GO:0016055; GO:0016323; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030521; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032481; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035257; GO:0035315; GO:0035635; GO:0036023; GO:0042129; GO:0042475; GO:0042493; GO:0042733; GO:0043065; GO:0043123; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0045177; GO:0045202; GO:0045294; GO:0045296; GO:0045453; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0046982; GO:0048096; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048715; GO:0050681; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051149; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060479; GO:0060484; GO:0060492; GO:0060548; GO:0060742; GO:0060769; GO:0060789; GO:0060916; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0070062; GO:0070369; GO:0070411; GO:0070491; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072182; GO:0090279; GO:0097718; GO:0098609; GO:1903204; GO:1904501; GO:1904793; GO:1904798; GO:1904837; GO:1904886; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990403; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000144; GO:2001234,0.00013730302397182,6.75288996204814E-06,9.14572131986289E-06,0.0656364533738228,0.0639804981884354,0.0949571909257869,0.0656364533738228,-3.9293589039735900,0.0748069802842638,0.0374545573538831,7.70435645907093,0.00113865683951154,0.0223405524490373,-4.81769165279894,85497,1.65090609162319,17,0,0,9.14572131986289E-06,0.0656364533738228,7176.73883538,12.8091127060326
279,297,437,437,437,P48730,CSNK1D,KC1D_HUMAN,centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, perinuclear region. Cell membrane. Cytoplasm, cytoskeleton, spindle. Golgi apparatus. Note=Localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. Recruited to the spindle apparatus and the centrosomes in response to DNA-damage. Correct subcellular localization requires kinase activity.",Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26),GO:0000086; GO:0000139; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0006897; GO:0007020; GO:0007030; GO:0008360; GO:0010389; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0042277; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0097711; GO:1905426; GO:1905515; GO:1990090; GO:2000052,6.11939112675231E-05,7.04035533733228E-05,0.00011172437840527,0.0929802229306189,0.122121016549818,0.149594007696715,0.122121016549818,-3.033616591015510,0.121483975111369,0.0608230948366998,7.70125289582657,0.00114051652105483,0.0223405524490373,-4.81968095983579,47330,1.65090609162319,5,0,0,7.04035533733228E-05,0.122121016549818,1734.58597895276,10.7603756377306
280,299,439,439,439,Q99733,NAP1L4,NP1L4_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; nucleosome assembly [GO:0006334],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10764593, ECO:0000269|PubMed:9325046}. Cytoplasm {ECO:0000269|PubMed:10764593, ECO:0000269|PubMed:9325046}. Note=Present in the cytoplasm and excluded from the nucleus during G0/G1 phase, then relocates to the nucleus by the time cells are in S phase (PubMed:9325046). Phosphorylated form localizes in the cytoplasm during the G0/G1 transition, whereas dephosphorylation leads to relocalization into the nucleus at the G1/S-boundary (PubMed:10764593). {ECO:0000269|PubMed:10764593, ECO:0000269|PubMed:9325046}.",Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),GO:0003723; GO:0005634; GO:0005737; GO:0006334; GO:0031491; GO:0051082,0.00047072736862027,0.00041427067705893,0.00045123016141092,0.00284438231366813,0.00310481226140362,0.00209761031339875,0.00284438231366813,-8.45766889390881000,0.00223685889379345,0.00156383884926011,7.65485891711382,0.00116876255136288,0.022789538586939,-4.8495012677915,42823,1.64226446776279,9,0,0,0.00045123016141092,0.00284438231366813,6.30361743721703,2.6561799811494
281,300,441,441,441,Q96A35,MRPL24,RM24_HUMAN,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24) (Mitochondrial large ribosomal subunit protein uL24m)",GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126,8.70521774742656E-05,0.00021068381823073,0.00153054728450068,0.0177809522194915,0.0162324240649282,0.0244663803270406,0.0177809522194915,-5.8135236032024800,0.0188838244437516,0.0100513399819443,7.61850637591726,0.00119149256349406,0.023127383998887,-4.87297657072896,24915,1.63587348867772,5,0,0,0.00021068381823073,0.0177809522194915,84.3963830198802,6.39910926548927
282,301,443,443,443,Q9Y5R8,TRAPPC1,TPPC1_HUMAN,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; neutrophil degranulation [GO:0043312],"SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network {ECO:0000250}. Endoplasmic reticulum {ECO:0000250}.",Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2),GO:0000139; GO:0005576; GO:0005783; GO:0005829; GO:0006888; GO:0017112; GO:0030008; GO:0035578; GO:0043312; GO:0048208,2.55597803071783,2.18915380942764,2.29371171992328,3.25103417071937,3.13515961487924,3.3148824239808,3.25103417071937,1.70089871987579,0.887410883170217,2.78998662827469,7.59155293604136,0.00120869409042609,0.0233553530791137,-4.89044467679017,16832,1.63161356279488,3,0,0,2.29371171992328,3.25103417071937,1.41736825185168,0.503214639058988
283,302,444,444,444,Q9H4A3,WNK1,WNK1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; ion transport [GO:0006811]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of systemic arterial blood pressure [GO:0003084]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10660600}.,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),GO:0000287; GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0010766; GO:0010923; GO:0016020; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0023016; GO:0030291; GO:0030295; GO:0035556; GO:0046777; GO:0048666; GO:0050794; GO:0071277; GO:0090188; GO:0090263,0.00210144399949691,0.00982768599985317,0.00120620896070331,0.0377773101632169,0.0394568480439465,0.0521399147201504,0.0394568480439465,-4.6635804768199600,0.0387462446557535,0.0237515686478946,7.58131809452336,0.00121530509443269,0.0234302063250987,-4.89709171726338,250794,1.63022388701305,7,0,0,0.00210144399949691,0.0394568480439465,18.7760644839418,4.23082279661733
284,303,445,445,445,Q8WXI2,CNKSR2,CNKR2_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; identical protein binding [GO:0042802]; regulation of signal transduction [GO:0009966],SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein.,Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2),GO:0005737; GO:0009966; GO:0014069; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0070062,3.86937989147487E-05,4.89239101604722E-05,5.80291851518964E-05,0.00023282184658094,0.00021897954464041,0.00018775899633752,0.00021897954464041,-12.15691626873730000,0.00016463783111059,0.00013086788029766,7.5760497949307,0.00121872523066054,0.0234433437628184,-4.90051623874586,117535,1.62998044409709,12,0,0,4.89239101604722E-05,0.00021897954464041,4.47592074963242,2.16218449227398
285,304,446,446,446,Q9Y2B0,CNPY2,CNPY2_HUMAN,endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; enzyme linked receptor protein signaling pathway [GO:0007167]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]; tissue development [GO:0009888],SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000255|PROSITE-ProRule:PRU10138}.,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4),GO:0005783; GO:0005887; GO:0007167; GO:0009888; GO:0010629; GO:0010988; GO:0045716,0.00027366365865498,1E-07,1E-07,0.00510055281425112,0.00823015157309957,0.00682210284243567,0.00682210284243567,-7.19556778108081000,0.00662631452371046,0.00340444514807356,7.54769030390804,0.00123733879455158,0.0237480270882545,-4.9189858730448,20652,1.62437246436646,6,2,0,1E-07,0.00682210284243567,68221.0284243567,16.0579288831307
286,305,447,447,447,Q13492,PICALM,PICAL_HUMAN,"cell surface [GO:0009986]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; cadherin binding [GO:0045296]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; membrane organization [GO:0061024]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle maturation [GO:0016188]; transcytosis [GO:0045056]; vesicle organization [GO:0016050]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Membrane, clathrin-coated pit {ECO:0000269|PubMed:10436022}. Golgi apparatus {ECO:0000269|PubMed:10436022}. Cytoplasmic vesicle, clathrin-coated vesicle {ECO:0000269|PubMed:10436022}. Nucleus {ECO:0000269|PubMed:16491119}. Note=Colocalized with clathrin in the Golgi area (PubMed:10436022). Interaction with PIMREG may target PICALM to the nucleus in some cells (PubMed:16491119). {ECO:0000269|PubMed:10436022, ECO:0000269|PubMed:16491119}.",Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein),GO:0005545; GO:0005546; GO:0005634; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006898; GO:0007409; GO:0007611; GO:0008283; GO:0009986; GO:0010629; GO:0016020; GO:0016050; GO:0016188; GO:0016192; GO:0016197; GO:0017137; GO:0030097; GO:0030100; GO:0030136; GO:0030276; GO:0031224; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0035615; GO:0042734; GO:0043025; GO:0043231; GO:0043547; GO:0045056; GO:0045211; GO:0045296; GO:0045334; GO:0045893; GO:0048261; GO:0048268; GO:0048471; GO:0048813; GO:0050750; GO:0055072; GO:0061024; GO:0065003; GO:0070381; GO:0072583; GO:0090647; GO:0097418; GO:0097494; GO:0097753; GO:0098711; GO:1900223; GO:1901216; GO:1902004; GO:1902959; GO:1902961; GO:1902963; GO:1903077; GO:2000009; GO:2000370,0.0120024765956628,0.0100337549470452,0.0148551104827515,0.0459564164322909,0.0342146974266543,0.0379454332834943,0.0379454332834943,-4.7199299214118300,0.0270750683723267,0.0258346481946498,7.50948849195761,0.00126296310280243,0.0241602022501501,-4.94396003826354,70755,1.61689943446496,7,0,0,0.0120024765956628,0.0379454332834943,3.16146696734291,1.66059414555982
287,306,449,449,449,Q9NXG6,P4HTM,P4HTM_HUMAN,"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; regulation of erythrocyte differentiation [GO:0045646]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:12163023, ECO:0000269|PubMed:17726031}; Single-pass type II membrane protein {ECO:0000269|PubMed:12163023, ECO:0000269|PubMed:17726031}.",Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.-) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),GO:0005506; GO:0005509; GO:0005789; GO:0016021; GO:0016706; GO:0031418; GO:0045646,0.00012953475485544,0.00027884969409578,7.51939557272918E-05,0.0843644708169404,0.0536068190433981,0.0842205814840199,0.0842205814840199,-3.5696833534363700,0.0739027643132266,0.0371125749581728,7.48636699931839,0.00127878637688419,0.0243296713169465,-4.95912859466192,56661,1.61386375815511,8,0,0,0.00012953475485544,0.0842205814840199,650.177487717559,9.34468979360289
288,307,450,450,450,Q52WX2,SBK1,SBK1_HUMAN,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (SH3-binding kinase 1),GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107,1E-07,1E-07,1.75881143781795E-05,0.0352493375325,0.0566981529195232,0.0538580827903948,0.0538580827903948,-4.2146933152641300,0.0485959283760133,0.024303893559466,7.48603824792893,0.00127901309493294,0.0243296713169465,-4.95934455739628,46252,1.61386375815511,5,2,0,1E-07,0.0538580827903948,538580.827903948,19.0388033489474
289,309,454,454,454,Q9P2K5,MYEF2,MYEF2_HUMAN,"nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; single-stranded DNA binding [GO:0003697]; myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus.,Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156),GO:0000981; GO:0003697; GO:0003723; GO:0005634; GO:0006351; GO:0014902; GO:0030182,9.97986632770091E-05,9.96221480698904E-05,7.97127576863268E-05,0.00665688145905207,0.00816695318004403,0.00501850663757777,0.00665688145905207,-7.23093780665092000,0.00652106923588021,0.00335357914095118,7.43087801519275,0.00131775676032546,0.0247584961286867,-4.99569593009065,64122,1.60627573860379,19,0,0,9.96221480698904E-05,0.00665688145905207,66.8213001629106,6.06223614880141
290,311,456,456,456,P60510,PPP4C,PP4C_HUMAN,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569],"SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.",Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X),GO:0004704; GO:0004722; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0010569; GO:0030289; GO:0046872,0.00152654744672122,0.00012930155942225,0.00014664335284335,0.0480189016088041,0.0347155354260498,0.0309373846804071,0.0347155354260498,-4.8482747671320800,0.0372897764520914,0.0192457190123746,7.42926573970719,0.00131891054143471,0.0247584961286867,-4.99676191364588,35080,1.60627573860379,3,0,0,0.00014664335284335,0.0347155354260498,236.734463260222,7.88712593537146
291,312,457,457,457,Q9UNF1,MAGED2,MAGD2_HUMAN,cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; female pregnancy [GO:0007565]; platelet degranulation [GO:0002576]; renal sodium ion absorption [GO:0070294],NA,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),GO:0002576; GO:0005576; GO:0005634; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294,1E-07,1E-07,1E-07,0.0136996320846282,0.0111282604251222,0.00835438161954418,0.0111282604251222,-6.4896281022337700,0.0110606580430982,0.0055304290215491,7.42522607386205,0.00132180682668561,0.0247585698827765,-4.99943367742709,64954,1.60627444486825,6,3,0,1E-07,0.0111282604251222,111282.604251222,16.7638685619778
292,313,458,458,458,Q6ZVC0,NYAP1,NYAP1_HUMAN,intracellular [GO:0005622]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065],NA,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,GO:0005622; GO:0014065; GO:0048812,0.0575290404797689,0.0289381700268856,0.0509531057529044,0.166469467049012,0.151659896955553,0.127234941700967,0.151659896955553,-2.721088447088130,0.102647996481991,0.0971307703275154,7.41802431083092,0.00132698945477461,0.0248013749625997,-5.00419988241883,87928,1.60552424166906,6,0,0,0.0509531057529044,0.151659896955553,2.97646031021197,1.57359765679097
293,314,459,459,459,Q9BU76,MMTAG2,MMTA2_HUMAN,extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312],NA,Multiple myeloma tumor-associated protein 2 (hMMTAG2),GO:0003723; GO:0005576; GO:0034774; GO:0043312; GO:1904813,0.247891518363236,0.280748840231703,4.83538027578068,21.0692376938281,15.5332271039205,21.603712665947,21.0692376938281,4.3970662118319,17.61405227644,10.5950330163452,7.39737521785687,0.00134198704176989,0.0249863770132551,-5.01788764572586,29412,1.60229671134931,4,0,0,0.280748840231703,21.0692376938281,75.0465707229265,6.22971424382776
294,315,461,461,461,Q8NBI6,XXYLT1,XXLT1_HUMAN,integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22117070}; Single-pass type II membrane protein {ECO:0000269|PubMed:22117070}.,"Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)",GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252,0.00018127674933842,1E-07,1E-07,0.0563843209161787,0.0376565895439855,0.0381128286355788,0.0381128286355788,-4.7135795045560800,0.0439907541154682,0.0220558693075136,7.38985128674804,0.00134750299221299,0.0250208798554083,-5.02288318748057,43807,1.60169742247513,4,2,0,1E-07,0.0381128286355788,381128.286355788,18.5399171596555
295,316,462,462,462,Q96F07,CYFIP2,CYFP2_HUMAN,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10449408, ECO:0000269|PubMed:17245118}. Nucleus {ECO:0000269|PubMed:17245118}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q5SQX6}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:Q5SQX6}. Note=Highly expressed in the perinuclear regionand enriched in synaptosomes (By similarity). Treatment with leptomycin-B triggers translocation to the nucleus (PubMed:17245118). {ECO:0000250|UniProtKB:Q5SQX6, ECO:0000269|PubMed:17245118}.",Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030054; GO:0038096; GO:0043005; GO:0045202; GO:0045862; GO:0048010; GO:0048471; GO:0051388; GO:0070062; GO:0097202; GO:0097484; GO:0098609,8.34462984614931E-05,6.5479078535822E-05,0.00020430275993547,0.0045510387994292,0.00690773242465828,0.00732011607739186,0.00690773242465828,-7.17757208440889000,0.00614188638818219,0.00318868590640202,7.36739935144903,0.00136412789429954,0.0252747505956798,-5.03781609632199,148399,1.59731312121488,18,0,0,8.34462984614931E-05,0.00690773242465828,82.7805732790641,6.37122033456452
296,317,463,463,463,P84095,RHOG,RHOG_HUMAN,"cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; G-protein coupled receptor signaling pathway [GO:0007186]; neutrophil degranulation [GO:0043312]; positive regulation of cell proliferation [GO:0008284]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcription, DNA-templated [GO:0045893]; Rac protein signal transduction [GO:0016601]; regulation of ruffle assembly [GO:1900027]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]",SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.,Rho-related GTP-binding protein RhoG,GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0007186; GO:0007266; GO:0008284; GO:0016601; GO:0030036; GO:0030667; GO:0043312; GO:0045893; GO:0051056; GO:0060326; GO:0070062; GO:0090630; GO:1900027; GO:1903078,1.1120530254419E-05,3.04201521009856E-05,4.79080424230628E-05,0.132711890934747,0.165457953479516,0.21572045392855,0.165457953479516,-2.595463451954550,0.171266949872678,0.0856632911779319,7.35154957957261,0.00137601466501694,0.0254179357981254,-5.04838127295078,21309,1.59485972159807,3,0,0,3.04201521009856E-05,0.165457953479516,5439.09027575688,12.4091496559159
297,318,464,464,464,O43920,NDUFS5,NDUS5_HUMAN,"mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000305|PubMed:12611891}; Peripheral membrane protein {ECO:0000305}. Mitochondrion intermembrane space {ECO:0000305}.,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit),GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0032981,0.00734685218676935,0.00891160716657918,0.00634060853738699,0.0227255986466273,0.0172212376437546,0.0200241461482692,0.0200241461482692,-5.6421154639407900,0.0124573048493052,0.0137616750548978,7.34919050920289,0.00137779465073951,0.0254179357981254,-5.04995544811201,12518,1.59485972159807,4,0,0,0.00734685218676935,0.0200241461482692,2.72554090367163,1.44654257176315
298,319,465,465,465,P61086,UBE2K,UBE2K_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61085}.,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0010800; GO:0010994; GO:0016567; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0070059; GO:0070936,0.00343597270792946,0.00166141375650061,0.00338035632524764,0.0527849766372357,0.0418076555213426,0.0334543923946346,0.0418076555213426,-4.5800890471955600,0.0398564272545117,0.0227541278904818,7.33855647685897,0.00138585322163238,0.0254771119094532,-5.05705674389024,22407,1.59384980525654,6,0,0,0.00338035632524764,0.0418076555213426,12.3678250156897,3.62851990765356
299,320,467,467,467,P22695,UQCRC2,QCR2_HUMAN,mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627],SUBCELLULAR LOCATION: Mitochondrion inner membrane; Peripheral membrane protein; Matrix side.,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",GO:0004222; GO:0005654; GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006119; GO:0006627; GO:0008270; GO:0009060; GO:0043209; GO:0044877,1.55534467910947E-05,1E-07,1E-07,0.0101988145964869,0.0145853057792389,0.00940010317028991,0.0101988145964869,-6.6154547116125000,0.0113894900330749,0.0056999961654678,7.32128767240278,0.00139906233120185,0.0256444829873402,-5.06860737670792,48443,1.59100605222344,13,2,0,1E-07,0.0101988145964869,101988.145964869,16.638041952599
300,322,470,470,470,P42892,ECE1,ECE1_HUMAN,early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; endothelin maturation [GO:0034959]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; substance P catabolic process [GO:0010814],SUBCELLULAR LOCATION: Cell membrane; Single-pass type II membrane protein.,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0070062,1E-07,1E-07,5.32810966519796E-06,0.0411136083233431,0.033415836221014,0.0544172471032771,0.0411136083233431,-4.6042401946243300,0.0429803878459897,0.0214920366262166,7.26023948124188,0.00144700454147502,0.0263539550532471,-5.10962760671052,87164,1.57915419908877,3,2,0,1E-07,0.0411136083233431,411136.083233431,18.6492564695872
301,323,475,475,475,Q8N0Z6,TTC5,TTC5_HUMAN,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signal transduction by p53 class mediator [GO:1901796],"SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Phosphorylation at Ser-203 results in nuclear localization, while unphosphorylated protein localizes to the cytoplasm. {ECO:0000250}.",Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Strap),GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006281; GO:0045944; GO:1901796,0.00011855034230387,0.00011122684446078,0.00136085757224507,0.0324587290549643,0.020201032558986,0.0245128499337837,0.0245128499337837,-5.3503179639822500,0.0251939922629081,0.0131272077177906,7.22359140911142,0.0014767464704761,0.0266125258679482,-5.13439359915499,48928,1.57491390340983,13,0,0,0.00011855034230387,0.0245128499337837,206.771650401076,7.69189458708399
302,324,476,476,476,Q96NX9,DACH2,DACH2_HUMAN,"nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly [GO:0001075]; development of primary female sexual characteristics [GO:0046545]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Dachshund homolog 2 (Dach2),GO:0000981; GO:0001075; GO:0003677; GO:0005634; GO:0005667; GO:0006355; GO:0007275; GO:0046545,0.00040700314844374,0.0445446614671732,0.000325780862149,0.225710814192047,0.353237607021831,0.318234447470258,0.318234447470258,-1.651838085413670,0.283968474402124,0.157076719026984,7.21319891850983,0.00148531562791463,0.0267107180145993,-5.14143602021813,65323,1.57331443749015,5,0,0,0.00040700314844374,0.318234447470258,781.896770791805,9.61083433938233
303,325,479,479,479,Q00610,CLTC,CLH1_HUMAN,"clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; transferrin transport [GO:0033572]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}; Cytoplasmic side {ECO:0000269|PubMed:17081065}. Membrane, coated pit {ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000269|PubMed:17081065}; Cytoplasmic side {ECO:0000269|PubMed:17081065}. Melanosome {ECO:0000269|PubMed:17081065}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15858577, ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:23918938}. Note=Cytoplasmic face of coated pits and vesicles. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. In complex with TACC3 and CKAP5 (forming the TACC3/ch-TOG/clathrin complex) localized to inter-microtubule bridges in mitotic spindles. {ECO:0000269|PubMed:25596274}.",Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17),GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019886; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032802; GO:0032991; GO:0033572; GO:0034383; GO:0036020; GO:0042147; GO:0042470; GO:0043231; GO:0045056; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060071; GO:0060236; GO:0061024; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498,1E-07,1E-07,1E-07,0.00022329219870533,0.00035701712181053,0.00031324987507382,0.00031324987507382,-11.64039844535880000,0.00029775306519656,0.00014897653259828,7.17755929371199,0.00151516572691674,0.0270768656000153,-5.16565250622313,191615,1.56740161071818,55,3,0,1E-07,0.00031324987507382,3132.4987507382,11.6130982188527
304,326,481,481,481,Q15819,UBE2V2,UB2V2_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; cell proliferation [GO:0008283]; DNA double-strand break processing [GO:0000729]; double-strand break repair via nonhomologous end joining [GO:0006303]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA repair [GO:0006282],NA,Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein),GO:0000209; GO:0000729; GO:0005634; GO:0005654; GO:0005737; GO:0006282; GO:0006301; GO:0006303; GO:0008283; GO:0010976; GO:0016567; GO:0031372; GO:0031625; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0061630; GO:0061631; GO:0070062; GO:0070534,0.0045597431976651,0.00399910858319574,0.00334376577199245,0.0215266998372629,0.0217317892106403,0.0306085380620485,0.0217317892106403,-5.5240492311296900,0.0206548031856995,0.0142949407771342,7.10025902988322,0.00158245722484079,0.0281618167248174,-5.21852805914158,16363,1.55033933219634,6,0,0,0.00399910858319574,0.0217317892106403,5.43415832767265,2.44205660001343
305,327,482,482,482,Q9UBB9,TFIP11,TFP11_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear chromosome, telomeric region [GO:0000784]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=In the nucleus localizes to unique speckle domains in close proximity to nuclear speckles and not identical to paraspeckles. {ECO:0000250}.,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),GO:0000390; GO:0000398; GO:0000784; GO:0003676; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006396; GO:0016607; GO:0031214; GO:0031333; GO:0031848; GO:0032091; GO:0071008; GO:0071013; GO:1904876; GO:2001033,0.00037052816920907,0.00057191449845431,0.0131442159725392,0.0449270330742832,0.0346450807641469,0.043575405996632,0.043575405996632,-4.520342083620000,0.0363536203982865,0.0228723630792108,7.08671436381104,0.00159461964532347,0.0283023179986782,-5.22784296171973,96820,1.54817799370507,17,0,0,0.00057191449845431,0.043575405996632,76.1921687846723,6.25157081654142
306,328,483,483,483,P29401,TKT,TKT_HUMAN,"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; xylulose biosynthetic process [GO:0005999]",NA,Transketolase (TK) (EC 2.2.1.1),GO:0004802; GO:0005654; GO:0005777; GO:0005829; GO:0005999; GO:0006098; GO:0009052; GO:0016604; GO:0016607; GO:0031982; GO:0040008; GO:0042803; GO:0043209; GO:0046166; GO:0046872; GO:0048037; GO:0070062,1E-07,1.07815915949778E-05,1.12181091326502E-05,0.0007119206117282,0.00107388666154164,0.00118420143208726,0.00107388666154164,-9.86294254595712000,0.00098263633487649,0.00049868473434745,7.08411702030459,0.00159696490576654,0.0283023179986782,-5.22963091393743,67878,1.54817799370507,23,1,0,1.07815915949778E-05,0.00107388666154164,99.603722890215,6.63812776182805
307,329,484,484,484,Q5TGI0,FAXC,FAXC_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,Failed axon connections homolog,GO:0016021,5.49520806298503E-05,4.84174379819211E-05,3.98511667076823E-05,0.0366772988722171,0.045704007459029,0.06058891313455,0.045704007459029,-4.451535519288120,0.0476089995934922,0.0238522400251859,7.07627862264588,0.00160406803882291,0.0283640816440663,-5.23503003816952,46843,1.54723127320878,9,0,0,4.84174379819211E-05,0.045704007459029,943.957577352497,9.88257821427877
308,330,485,485,485,O43310,CTIF,CTIF_HUMAN,"cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:19648179}.",CBP80/20-dependent translation initiation factor,GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0048471,0.00156689402269719,0.00164863565379805,0.00153732300835655,0.0692035813559578,0.115786799701513,0.0964763655007064,0.0964763655007064,-3.3736806313434500,0.0922379646244417,0.0477032665405048,7.07297085672295,0.00160707705576777,0.0283640816440663,-5.23730995365404,67587,1.54723127320878,11,0,0,0.00156689402269719,0.0964763655007064,61.5717234881245,5.94419604727941
309,331,486,486,486,Q6ZNB6,NFXL1,NFXL1_HUMAN,"integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001078]; zinc ion binding [GO:0008270]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP),GO:0000977; GO:0000981; GO:0001078; GO:0005634; GO:0006366; GO:0008270; GO:0016020; GO:0016021,0.00011735057052881,0.00021465494817529,0.00021443830676242,0.00043661190192307,0.00046778242881794,0.0005100141748216,0.00046778242881794,-11.06187470839630000,0.00028932156003203,0.00032680872183819,7.06551444013743,0.00161388525242654,0.0284256332526155,-5.24245266809392,101339,1.54628985152842,12,0,0,0.00021443830676242,0.00046778242881794,2.18143127447935,1.12527502263504
310,332,487,487,487,Q719H9,KCTD1,KCTD1_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18358072}.,BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1),GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008134; GO:0042802; GO:0045892; GO:0051260,0.0550905731255052,0.0814253700099528,0.0507403315054204,0.159570291333362,0.133309119627072,0.159549045130823,0.159549045130823,-2.647928120486050,0.0883907271501259,0.106614121788689,7.05668587738374,0.00162199173239647,0.0285097520109113,-5.24854766490525,29405,1.54500656033913,3,0,0,0.0550905731255052,0.159549045130823,2.89612244126313,1.53412259747256
311,333,488,488,488,Q9H9T3,ELP3,ELP3_HUMAN,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; histone acetyltransferase complex [GO:0000123]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; central nervous system development [GO:0007417]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19185337}.; SUBCELLULAR LOCATION: Isoform 1: Nucleus.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.,Elongator complex protein 3 (hELP3) (EC 2.3.1.48),GO:0000123; GO:0001764; GO:0005730; GO:0005737; GO:0006357; GO:0006368; GO:0007417; GO:0008023; GO:0008607; GO:0010484; GO:0010485; GO:0030335; GO:0033588; GO:0043966; GO:0043967; GO:0046872; GO:0051536,1E-07,1E-07,1E-07,0.0237712323441057,0.0155432501141635,0.0157925618110922,0.0157925618110922,-5.9846109709278400,0.0183689147564538,0.0091845573782269,7.04394002727284,0.00163378267001419,0.0286581550313964,-5.25735837355216,62259,1.54275177225951,8,3,0,1E-07,0.0157925618110922,157925.618110922,17.2688856932837
312,334,489,489,489,Q12852,MAP3K12,M3K12_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase),GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0016572; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0046777; GO:2000672,1E-07,1E-07,1E-07,0.0418694731239513,0.0320490061897834,0.025103217998937,0.0320490061897834,-4.9635765688839300,0.0330071324375572,0.0165036662187786,7.03200757080272,0.00164491577457838,0.0287171092478525,-5.26561897064725,93219,1.54185927964186,5,3,0,1E-07,0.0320490061897834,320490.061897834,18.2899200953276
313,335,492,492,492,O75347,TBCA,TBCA_HUMAN,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.",Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA),GO:0003723; GO:0005730; GO:0005737; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0048487; GO:0051087,0.00077689484901718,0.00027480608106126,0.00019726269789131,0.00779875423946481,0.0055771722331438,0.00511507774374703,0.0055771722331438,-7.4862504599690600,0.00574734686279529,0.0032899946407209,7.02097085881262,0.00165529538843323,0.0287994482215213,-5.27326995301685,12855,1.54061583295758,6,0,0,0.00027480608106126,0.0055771722331438,20.2949374759306,4.34304799031574
314,336,493,493,493,Q86X27,RALGPS2,RGPS2_HUMAN,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Ral protein signal transduction [GO:0032485]; small GTPase mediated signal transduction [GO:0007264],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Associates with membranes through the PH domain. {ECO:0000250}.,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),GO:0005085; GO:0005737; GO:0005886; GO:0007264; GO:0032485,0.0687689270393778,0.0928518063310013,0.0568651653145843,0.164295197567772,0.144942100048213,0.152326402066565,0.152326402066565,-2.714762075391020,0.0810259336658622,0.113341599727919,7.00047041477332,0.00167478753646597,0.0290794752781921,-5.28750831854924,65167,1.5364134343275,6,0,0,0.0687689270393778,0.152326402066565,2.21504694961056,1.14733727812679
315,337,494,494,494,Q8N1B4,VPS52,VPS52_HUMAN,"cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:15878329, ECO:0000269|PubMed:18367545}; Peripheral membrane protein. Endosome membrane {ECO:0000269|PubMed:18367545}; Peripheral membrane protein. Recycling endosome {ECO:0000269|PubMed:25799061}. Note=Localizes to the trans-Golgi network as part of the GARP complex, while it localizes to recycling endosomes as part of the EARP complex (PubMed:25799061). {ECO:0000269|PubMed:25799061}.",Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein),GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0017137; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745,1E-07,0.0106275066251807,1E-07,0.0354068287654709,0.0281537030151029,0.0366494635318135,0.0354068287654709,-4.8198285561337100,0.0298607628957355,0.018472950322928,6.99468351528824,0.00168034026115936,0.0291168271974172,-5.29153387953909,82221,1.53585595098422,8,2,0,1E-07,0.0354068287654709,354068.287654709,18.4336681080778
316,338,495,495,495,Q12824,SMARCB1,SNF5_HUMAN,fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; p53 binding [GO:0002039]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; DNA integration [GO:0015074]; DNA repair [GO:0006281]; negative regulation of cell proliferation [GO:0008285]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of transcription by RNA polymerase II [GO:0006357]; single stranded viral RNA replication via double stranded DNA intermediate [GO:0039692],SUBCELLULAR LOCATION: Nucleus.,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5),GO:0000790; GO:0001164; GO:0001650; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006337; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0008285; GO:0015074; GO:0016514; GO:0030154; GO:0030957; GO:0032991; GO:0039692; GO:0043044; GO:0043231; GO:0043923; GO:0045944; GO:0051091; GO:0071564; GO:0071565; GO:0090240; GO:1900110; GO:1900113; GO:1901838; GO:1902661; GO:2000617,0.0136330150184738,0.0183447767899896,0.00679745198165231,0.0731021582468735,0.0816406054035142,0.055269599614858,0.0731021582468735,-3.7739421892591600,0.0570790398250433,0.0414646011758936,6.99020469987745,0.00168465321092797,0.0291325888596836,-5.29465141128167,44141,1.53562092019495,8,0,0,0.0136330150184738,0.0731021582468735,5.36214169410173,2.42280934290812
317,339,496,496,496,Q04656,ATP7A,ATP7A_HUMAN,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; copper-exporting ATPase activity [GO:0004008]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; superoxide dismutase copper chaperone activity [GO:0016532]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catalytic activity [GO:0043086]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; plasma membrane copper ion transport [GO:0015679]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568],"SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:10484781, ECO:0000269|PubMed:9147644, ECO:0000269|PubMed:9467005}; Multi-pass membrane protein {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:10484781, ECO:0000269|PubMed:9147644}; Multi-pass membrane protein {ECO:0000255}. Note=Cycles constitutively between the trans-Golgi network (TGN) and the plasma membrane (PubMed:9147644). Predominantly found in the TGN and relocalized to the plasma membrane in response to elevated copper levels. {ECO:0000269|PubMed:9147644}.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm, cytosol {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 5: Endoplasmic reticulum {ECO:0000269|PubMed:9467005}.",Copper-transporting ATPase 1 (EC 3.6.3.54) (Copper pump 1) (Menkes disease-associated protein),GO:0001568; GO:0001701; GO:0001889; GO:0001974; GO:0002082; GO:0004008; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010468; GO:0010592; GO:0015677; GO:0015679; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0030670; GO:0031069; GO:0031252; GO:0031526; GO:0032767; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043086; GO:0043204; GO:0043473; GO:0043588; GO:0045121; GO:0045793; GO:0048251; GO:0048286; GO:0048365; GO:0048471; GO:0048812; GO:0050679; GO:0051087; GO:0051216; GO:0051353; GO:0051542; GO:0060003; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:1903036; GO:1903136; GO:1904754; GO:1904959,5.3057836555269E-05,5.26611028065807E-05,0.00014616478387085,0.00037984600096315,0.00031804284462695,0.0003670723146476,0.0003670723146476,-11.4116480720496000,0.000271025812335,0.00021947414724507,6.97649616063464,0.00169793799924927,0.029303123535431,-5.30420381728194,163374,1.53308608401791,6,0,0,5.3057836555269E-05,0.0003670723146476,6.91834304750119,2.79042655182278
318,340,497,497,497,Q8WXF1,PSPC1,PSPC1_HUMAN,"cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; core promoter binding [GO:0001047]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus matrix {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus speckle. Note=In punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles. Colocalizes with NONO and SFPQ in paraspeckles and perinucleolar caps in an RNA-dependent manner. May cycle between paraspeckles and nucleolus. In telophase, when daughter nuclei form, localizes to perinucleolar caps.",Paraspeckle component 1 (Paraspeckle protein 1),GO:0000398; GO:0000976; GO:0000981; GO:0001047; GO:0001650; GO:0002218; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006355; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045087; GO:0045892; GO:0048511,8.76043047146617E-05,0.00012158694865849,0.00019783253655668,0.0135238310098637,0.0131145974207882,0.00821070508683408,0.0131145974207882,-6.2526826679474100,0.0114807032425187,0.00587602621790263,6.96768952748349,0.00170653964169252,0.0293769526833852,-5.31034876989423,58744,1.53199325624586,8,0,0,0.00012158694865849,0.0131145974207882,107.861884564799,6.75304133574991
319,341,498,498,498,P07738,BPGM,PMGE_HUMAN,"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; canonical glycolysis [GO:0061621]; carbohydrate metabolic process [GO:0005975]; erythrocyte development [GO:0048821]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory gaseous exchange [GO:0007585]",NA,"Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (2,3-diphosphoglycerate mutase) (DPGM) (BPG-dependent PGAM)",GO:0004082; GO:0005829; GO:0005975; GO:0006094; GO:0006096; GO:0007585; GO:0016787; GO:0043456; GO:0046538; GO:0048821; GO:0061621; GO:0070062,0.00081414603769189,0.00033512606950409,0.00017701412852793,0.00767301518816036,0.00753875735694809,0.0113087119918511,0.00767301518816036,-7.02599067405163000,0.00839806610041187,0.00464112846211391,6.96284113802312,0.00171129779307639,0.0293769526833852,-5.31373457894993,30005,1.53199325624586,8,0,0,0.00033512606950409,0.00767301518816036,22.8959066046836,4.51701778713994
320,342,499,499,499,O95782,AP2A1,AP2A1_HUMAN,"AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; ephrin receptor signaling pathway [GO:0048013]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; membrane organization [GO:0061024]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of defense response to virus by virus [GO:0050690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=AP-2 appears to be excluded from internalizing CCVs and to disengage from sites of endocytosis seconds before internalization of the nascent CCV. {ECO:0000250}.",AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit),GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0008022; GO:0010976; GO:0016020; GO:0016323; GO:0016324; GO:0019886; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0032802; GO:0034383; GO:0035615; GO:0036020; GO:0044877; GO:0045334; GO:0048013; GO:0048260; GO:0050690; GO:0050750; GO:0060071; GO:0061024; GO:0072583; GO:1900126,1E-07,1E-07,1E-07,0.00097673276527221,0.00113001609805668,0.00066608646878399,0.00097673276527221,-9.99974848568074000,0.00092417844403762,0.00046218922201881,6.96160692416724,0.00171251161086556,0.0293769526833852,-5.31459679118606,107546,1.53199325624586,20,3,0,1E-07,0.00097673276527221,9767.3276527221,13.2537481785308
321,343,500,500,500,P30153,PPP2R1A,2AAA_HUMAN,"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; female meiotic nuclear division [GO:0007143]; G2/M transition of mitotic cell cycle [GO:0000086]; inactivation of MAPK activity [GO:0000188]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q32PI5}. Chromosome, centromere {ECO:0000269|PubMed:16580887}. Lateral cell membrane {ECO:0000269|PubMed:15525651}. Cell projection, dendrite {ECO:0000269|PubMed:15525651}. Note=Centromeric localization requires the presence of BUB1. {ECO:0000269|PubMed:16580887}.",Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha),GO:0000086; GO:0000159; GO:0000184; GO:0000188; GO:0000775; GO:0004722; GO:0005634; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0010389; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0097711; GO:1903538; GO:1990405; GO:2001241,1E-07,1E-07,1E-07,0.00128963081202459,0.00081148612818054,0.0008929323225338,0.0008929323225338,-10.1291615453506000,0.00099791642091297,0.00049905821045648,6.95391525284982,0.00172009981138668,0.02944810877094,-5.31997301864818,65309,1.5309425914276,22,3,0,1E-07,0.0008929323225338,8929.323225338,13.1243351188609
322,344,501,501,501,P10586,PTPRF,PTPRF_HUMAN,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:1900121,0.00023190864602139,0.00041545716899777,0.00035716475015672,0.0511161898160915,0.0651225882378031,0.038578822501109,0.0511161898160915,-4.2900758874940100,0.0512710233299426,0.0259703551866966,6.92952958850634,0.00174442922447889,0.029757671415612,-5.33705075668599,212879,1.52640105601987,15,0,0,0.00035716475015672,0.0511161898160915,143.116558377226,7.16104678920976
323,345,503,503,503,Q99856,ARID3A,ARI3A_HUMAN,"cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:17400556}. Cytoplasm {ECO:0000269|PubMed:17400556}. Note=Shuttles between nucleus and cytoplasm.",AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),GO:0000977; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006977; GO:0042803; GO:0043231; GO:0045121,0.0020958246791695,1E-07,1E-07,0.0495565419917845,0.0747098821994249,0.0488189277706214,0.0495565419917845,-4.3347806686674500,0.0569964424275538,0.0291968961068334,6.91661790471024,0.0017574805245929,0.0299086148916804,-5.34611340353027,62889,1.52420369926654,8,2,0,1E-07,0.0495565419917845,495565.419917845,18.9187159955441
324,346,504,504,504,Q9BQ39,DDX50,DDX50_HUMAN,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.",ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2),GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0005886; GO:0010501; GO:0016020,0.0001097295302585,6.35956260735007E-05,7.13287578477646E-05,0.0233900334844177,0.0242532815172703,0.0145269347275149,0.0233900334844177,-5.4179622627672100,0.0206418652716744,0.0104024839405638,6.88112435892797,0.00179397442385735,0.0304265846179306,-5.37109913414176,82565,1.51674679443225,7,0,0,7.13287578477646E-05,0.0233900334844177,327.918699135888,8.3571943616534
325,348,507,507,507,O00116,AGPS,ADAS_HUMAN,"cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]; protein targeting to peroxisome [GO:0006625]",SUBCELLULAR LOCATION: Peroxisome membrane. Note=Localized to the inner aspect of the peroxisomal membrane.,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0016614; GO:0071949,4.62833103526395E-05,7.54075236541964E-05,8.14936877678012E-05,0.00022820622650311,0.00020750557631165,0.00020236601527768,0.00020750557631165,-12.23456227292570000,0.00014496443210594,0.00014021038997784,6.8656119172339,0.00181021304899134,0.0305629658764613,-5.38205290466573,72912,1.51480450345756,21,0,0,7.54075236541964E-05,0.00020750557631165,2.75178876398632,1.46036972845358
326,350,509,509,509,Q15717,ELAVL1,ELAV1_HUMAN,"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; multicellular organism development [GO:0007275]; negative regulation of gene silencing by miRNA [GO:0060965]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; regulation of mRNA stability [GO:0043488]; regulation of stem cell population maintenance [GO:2000036]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462, ECO:0000269|PubMed:19029303}. Nucleus {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:17632515, ECO:0000269|PubMed:18285462}. Note=Translocates into the cytoplasm following phosphorylation by MAPKAPK2 (PubMed:14517288). Likewise, phosphorylation by PRKCD promotes translocation from the nucleus into the cytoplasm, where it is associated with free and cytoskeleton-bound polysomes (PubMed:18285462). {ECO:0000269|PubMed:14517288, ECO:0000269|PubMed:18285462}.",ELAV-like protein 1 (Hu-antigen R) (HuR),GO:0000398; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007275; GO:0010494; GO:0016020; GO:0017091; GO:0019901; GO:0035198; GO:0035925; GO:0042803; GO:0043488; GO:0045727; GO:0048255; GO:0051260; GO:0060965; GO:0070935; GO:1990904; GO:2000036,0.00037868973042657,0.0007575359619204,0.0002149228768756,0.0164092461854927,0.0273864690069374,0.0259672855827297,0.0259672855827297,-5.2671609759511500,0.0228039507353124,0.0118523582240637,6.84750218673723,0.00182939720584715,0.0307481211844393,-5.39486680612431,36092,1.51218141595878,8,0,0,0.00037868973042657,0.0259672855827297,68.5714015890508,6.09953510586039
327,351,510,510,510,Q6P1X6,C8orf82,CH082_HUMAN,NA,NA,UPF0598 protein C8orf82,NA,0.00052520793880278,0.00025861652180091,0.00257072957831435,0.0202275806375014,0.012536053337527,0.0174153865168209,0.0174153865168209,-5.8434936973431900,0.0156081554843105,0.00892226242179458,6.84510432419382,0.00183195581823178,0.0307481211844393,-5.39656557592469,23889,1.51218141595878,5,0,0,0.00052520793880278,0.0174153865168209,33.1590313667374,5.05132995869283
328,352,511,511,511,Q9BXB4,OSBPL11,OSB11_HUMAN,Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890],"SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000269|PubMed:20599956}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:20599956}. Note=Localizes at the Golgi-late endosome interface.",Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),GO:0005654; GO:0005794; GO:0006869; GO:0008289; GO:0010890; GO:0031902; GO:0045444,0.00119967006539726,0.00235064540346926,0.00487840850732246,0.0585873816951604,0.0575391050360667,0.0875140267876258,0.0585873816951604,-4.0932662132853200,0.0650705965142213,0.0353448729158403,6.82336206476518,0.00185535530280809,0.0309626358907119,-5.4119915512324,83643,1.50916207434371,16,0,0,0.00235064540346926,0.0585873816951604,24.9239556118046,4.63946114754541
329,353,513,513,513,Q96CT7,CCDC124,CC124_HUMAN,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:23894443}. Midbody {ECO:0000269|PubMed:23894443}. Note=Colocalizes with gamma-tubulin at interphase, prophase, metaphase, and anaphase. Relocates from centrosome to midbody at telophase.",Coiled-coil domain-containing protein 124,GO:0003723; GO:0005815; GO:0005829; GO:0005886; GO:0007049; GO:0030496; GO:0051301,1E-07,1E-07,1E-07,0.00096891734994246,0.000946593828624,0.00058249816656671,0.000946593828624,-10.044966863180500,0.00083256978171106,0.00041638489085553,6.82314763917437,0.00185558787522608,0.0309626358907119,-5.41214388802143,25835,1.50916207434371,9,3,0,1E-07,0.000946593828624,9465.93828624,13.208529801031
330,355,515,515,515,Q9C0C2,TNKS1BP1,TB182_HUMAN,"CCR4-NOT complex [GO:0030014]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; cellular response to ionizing radiation [GO:0071479]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004]","SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton. Chromosome. Note=Colocalizes with chromosomes during mitosis, and in the cytoplasm with cortical actin.",182 kDa tankyrase-1-binding protein,GO:0000289; GO:0005634; GO:0005720; GO:0005737; GO:0005829; GO:0005856; GO:0005913; GO:0006302; GO:0006977; GO:0007004; GO:0010800; GO:0019899; GO:0030014; GO:0031954; GO:0033138; GO:0044877; GO:0045296; GO:0071479; GO:0071532,0.00020354968821493,0.0004102520931929,0.00037119345111258,0.0162471093419985,0.0274484196626546,0.0212204434032563,0.0212204434032563,-5.5584013879520300,0.0213103257251296,0.0109834946067383,6.81323848422438,0.00186637439940209,0.0310216793376348,-5.41918810414009,181796,1.50833469564792,41,0,0,0.00037119345111258,0.0212204434032563,57.168151376734,5.83713973407037
331,356,517,517,517,Q5JSZ5,PRRC2B,PRC2B_HUMAN,RNA binding [GO:0003723]; cell differentiation [GO:0030154],NA,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),GO:0003723; GO:0030154,0.00276222924459815,0.00010408446583021,9.25004015673208E-05,0.0648580242769161,0.0660698518705088,0.100307025012885,0.0660698518705088,-3.9198640795974800,0.0760920290161048,0.0390322858787176,6.76579944878614,0.00191908186061161,0.031774353436819,-5.4530298259148,242967,1.4979232779629,35,0,0,0.00010408446583021,0.0660698518705088,634.771493935384,9.31009353143007
332,357,518,518,518,Q15048,LRRC14,LRC14_HUMAN,cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27426725}.,Leucine-rich repeat-containing protein 14,GO:0005737; GO:0019900; GO:0032088; GO:0034122,0.00092194269649173,0.00085033578333437,0.00401540544760616,0.0389307284795992,0.0236913003420414,0.0317283955583399,0.0317283955583399,-4.9780816208844700,0.0295209134841827,0.0166896847179021,6.76236564428943,0.0019229667665649,0.0317772114320376,-5.45548703672376,54513,1.49788421640537,9,0,0,0.00092194269649173,0.0317283955583399,34.4147154471487,5.10495367618432
333,358,519,519,519,Q96GD3,SCMH1,SCMH1_HUMAN,"chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Polycomb protein SCMH1 (Sex comb on midleg homolog 1),GO:0005654; GO:0006338; GO:0006351; GO:0007283; GO:0009952; GO:0010369; GO:0016458; GO:0045892,7.74405820863913E-05,9.96019774287651E-05,0.00014541234332714,0.280529332172371,0.475433426075976,0.455872802322165,0.455872802322165,-1.133296755273180,0.403837701889223,0.202026335912226,6.7529319726695,0.00193368903818146,0.0318804180891646,-5.46224304132454,73354,1.49647599177321,4,0,0,9.96019774287651E-05,0.455872802322165,4576.94529858308,12.1601693343165
334,359,520,520,520,P59998,ARPC4,ARPC4_HUMAN,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:9359840}. Cell projection {ECO:0000269|PubMed:9359840}.",Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC),GO:0003779; GO:0005200; GO:0005829; GO:0005885; GO:0019899; GO:0030041; GO:0034314; GO:0038096; GO:0042995; GO:0045010; GO:0048013; GO:0061024; GO:0070062,0.00105106032835347,0.00151267883842099,0.00117617705796859,0.00951876268437814,0.015496635786045,0.0140844197855081,0.0140844197855081,-6.1497560573584200,0.0117866340103961,0.00713995574677905,6.75032850261885,0.0019366609119586,0.0318804180891646,-5.46410891448327,19667,1.49647599177321,8,0,0,0.00117617705796859,0.0140844197855081,11.9747445251429,3.58192297203955
335,360,521,521,521,Q6NUM9,RETSAT,RETST_HUMAN,"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; all-trans-retinol 13,14-reductase activity [GO:0051786]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114]; retinol metabolic process [GO:0042572]",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q64FW2}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q64FW2}.,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",GO:0005640; GO:0005789; GO:0016020; GO:0016491; GO:0031965; GO:0042572; GO:0051786; GO:0055114,0.00036468323647933,0.00024675310272191,0.00067091874023668,0.0147878686778458,0.024977464404337,0.0234920948932726,0.0234920948932726,-5.4116808192353400,0.0206583576320058,0.0107566305091489,6.73015944327873,0.0019598730041984,0.0322006006064076,-5.47858402799377,66820,1.49213602775709,5,0,0,0.00036468323647933,0.0234920948932726,64.4178085070936,6.00938767597867
336,361,522,522,522,P36578,RPL4,RL4_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]",NA,60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4),GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0022625; GO:0070062; GO:1990904,0.00038913723342996,0.00042211105926091,0.00027574545975291,0.00567273720836214,0.00937393423945753,0.00905595389865724,0.00905595389865724,-6.78691767083283000,0.00767187719801104,0.00419826984982012,6.70698949811776,0.00198695734419227,0.0325830552993982,-5.49525717638164,47697,1.48700819450707,17,0,0,0.00038913723342996,0.00905595389865724,23.2718771700041,4.54051568185015
337,362,523,523,523,Q8IXQ5,KLHL7,KLHL7_HUMAN,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16918702}. Cytoplasm {ECO:0000269|PubMed:27392078}. Note=Colocalizes with CUL3 in punctate structures at the perinuclear region of the cytoplasm. {ECO:0000269|PubMed:27392078}.,Kelch-like protein 7,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0016567; GO:0031463; GO:0042802; GO:0042803; GO:0048471,0.0180236217409076,0.0360069377631306,0.0399516514245392,0.143739290770048,0.149539919954644,0.20572091320643,0.149539919954644,-2.741397428974180,0.135005971000848,0.0988303891432833,6.69808646134055,0.00199748527648181,0.0326930668579049,-5.50167647667349,65992,1.48554433738871,6,0,0,0.0360069377631306,0.149539919954644,4.15308630071191,2.05418385113075
338,363,525,525,525,O00170,AIP,AIP_HUMAN,aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; interleukin-12-mediated signaling pathway [GO:0035722]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],SUBCELLULAR LOCATION: Cytoplasm.,AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9),GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0008134; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0035722; GO:0036004; GO:0051082; GO:0051344,0.00276318429817648,0.00101361834950774,0.00076512884017166,0.0356442045357794,0.043071038941786,0.0254588705677035,0.0356442045357794,-4.8101886647795300,0.0332107275191377,0.0181193409221875,6.69042400370983,0.00200660050883511,0.0327171435345305,-5.50720693085897,37636,1.48522462068972,10,0,0,0.00101361834950774,0.0356442045357794,35.1653110394952,5.1360810729824
339,365,527,527,527,Q9H4L4,SENP3,SENP3_HUMAN,cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protein desumoylation [GO:0016926]; rRNA processing [GO:0006364],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19680224}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19015314, ECO:0000269|PubMed:19680224}. Cytoplasm {ECO:0000250|UniProtKB:Q9EP97}. Note=Redistributes between the nucleolus and the nucleoplasm in response to mild oxidative stress (PubMed:19680224). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (By similarity). {ECO:0000250|UniProtKB:Q9EP97, ECO:0000269|PubMed:19680224}.",Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3),GO:0004175; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008234; GO:0016926; GO:0071339,0.00587899532767547,0.00121073997257914,0.00066352796166637,0.0617572255673335,0.0372011421901765,0.0570283017264512,0.0570283017264512,-4.1321781191450900,0.0494111354073467,0.0272899887909804,6.64748947816021,0.00205862029240898,0.0334379311252768,-5.53829229845647,65010,1.47576060110956,9,0,0,0.00121073997257914,0.0570283017264512,47.1020227447918,5.55771711101458
340,366,528,528,528,Q9BWE0,REPIN1,REPI1_HUMAN,nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10606657}.,Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464),GO:0003677; GO:0003723; GO:0005634; GO:0005664; GO:0006260; GO:0046872,1E-07,0.076484905757311,1E-07,0.226098576062516,0.28749206634726,0.332663824251062,0.28749206634726,-1.79840595100215,0.256589786967843,0.153789928736358,6.63929705625497,0.00206873155296938,0.0335385266920794,-5.5442425312326,63575,1.47445601935527,3,2,0,1E-07,0.28749206634726,2874920.6634726,21.4550907132094
341,368,530,530,530,P14416,DRD2,DRD2_HUMAN,"acrosomal vesicle [GO:0001669]; axon [GO:0030424]; axon terminus [GO:0043679]; ciliary membrane [GO:0060170]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; lateral plasma membrane [GO:0016328]; non-motile cilium [GO:0097730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; sperm flagellum [GO:0036126]; synaptic vesicle membrane [GO:0030672]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; drug binding [GO:0008144]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; potassium channel regulator activity [GO:0015459]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of protein kinase activity [GO:0032147]; adenohypophysis development [GO:0021984]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult walking behavior [GO:0007628]; arachidonic acid secretion [GO:0050482]; associative learning [GO:0008306]; auditory behavior [GO:0031223]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; branching morphogenesis of a nerve [GO:0048755]; cellular calcium ion homeostasis [GO:0006874]; cerebral cortex GABAergic interneuron migration [GO:0021853]; circadian regulation of gene expression [GO:0032922]; dopamine metabolic process [GO:0042417]; drinking behavior [GO:0042756]; excitatory postsynaptic potential [GO:0060079]; G-protein coupled receptor internalization [GO:0002031]; G-protein coupled receptor signaling pathway [GO:0007186]; grooming behavior [GO:0007625]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell death [GO:0060548]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, sleep [GO:0042321]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of innate immune response [GO:0045824]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein secretion [GO:0050709]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; neurological system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron-neuron synaptic transmission [GO:0007270]; orbitofrontal cortex development [GO:0021769]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; pigmentation [GO:0043473]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway [GO:0051482]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G-protein coupled receptor protein signaling pathway [GO:0045745]; positive regulation of glial cell-derived neurotrophic factor secretion [GO:1900168]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of receptor internalization [GO:0002092]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein localization [GO:0008104]; regulation of dopamine secretion [GO:0014059]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of heart rate [GO:0002027]; regulation of locomotion involved in locomotory behavior [GO:0090325]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of potassium ion transport [GO:0043266]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]; response to amphetamine [GO:0001975]; response to axon injury [GO:0048678]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to histamine [GO:0034776]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to iron ion [GO:0010039]; response to light stimulus [GO:0009416]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; temperature homeostasis [GO:0001659]; visual learning [GO:0008542]; Wnt signaling pathway [GO:0016055]",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21645528}; Multi-pass membrane protein {ECO:0000269|PubMed:21645528}.,D(2) dopamine receptor (Dopamine D2 receptor),GO:0001591; GO:0001659; GO:0001666; GO:0001669; GO:0001933; GO:0001963; GO:0001975; GO:0001976; GO:0002027; GO:0002028; GO:0002031; GO:0002052; GO:0002092; GO:0005622; GO:0005886; GO:0005887; GO:0006874; GO:0006914; GO:0007186; GO:0007194; GO:0007195; GO:0007270; GO:0007409; GO:0007416; GO:0007608; GO:0007616; GO:0007625; GO:0007626; GO:0007628; GO:0008104; GO:0008144; GO:0008285; GO:0008306; GO:0008542; GO:0009416; GO:0009636; GO:0010039; GO:0014059; GO:0014069; GO:0014854; GO:0015459; GO:0016055; GO:0016328; GO:0021756; GO:0021769; GO:0021853; GO:0021984; GO:0030139; GO:0030336; GO:0030424; GO:0030425; GO:0030432; GO:0030672; GO:0031223; GO:0032147; GO:0032228; GO:0032467; GO:0032922; GO:0033602; GO:0034776; GO:0035094; GO:0035240; GO:0035255; GO:0035556; GO:0035810; GO:0035815; GO:0036126; GO:0040018; GO:0042220; GO:0042321; GO:0042417; GO:0042493; GO:0042756; GO:0042802; GO:0042803; GO:0043197; GO:0043204; GO:0043266; GO:0043278; GO:0043473; GO:0043666; GO:0043679; GO:0045745; GO:0045776; GO:0045824; GO:0045944; GO:0046676; GO:0046982; GO:0048148; GO:0048149; GO:0048169; GO:0048678; GO:0048755; GO:0050482; GO:0050709; GO:0051209; GO:0051481; GO:0051482; GO:0051584; GO:0051586; GO:0051823; GO:0051898; GO:0051967; GO:0060079; GO:0060124; GO:0060134; GO:0060158; GO:0060160; GO:0060170; GO:0060548; GO:0070374; GO:0090325; GO:0097730; GO:1900168; GO:1900273; GO:1901386,0.00022447240637972,0.0107313127727462,0.00028184052300409,0.0519229095029622,0.040822103948549,0.034980094993693,0.040822103948549,-4.614505649787330,0.0388291609143581,0.0231604556912224,6.62436474574523,0.00208731693634774,0.033712137688937,-5.55510355761112,50619,1.47221370796333,3,0,0,0.00028184052300409,0.040822103948549,144.841144607004,7.17832767264265
342,369,532,532,532,P30876,POLR2B,RPB2_HUMAN,"DNA-directed RNA polymerase II, core complex [GO:0005665]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing, via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9852112}.,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2),GO:0000398; GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006283; GO:0006366; GO:0006367; GO:0006368; GO:0006370; GO:0008543; GO:0016020; GO:0016070; GO:0032549; GO:0042795; GO:0046872; GO:0060964,1E-07,2.00240781344121E-05,1E-07,0.0259989565881546,0.0177974368005964,0.0313140958267688,0.0259989565881546,-5.2654024648018000,0.0250300883791285,0.0125217855489424,6.59690470390171,0.00212202705358274,0.0341438939448651,-5.57512924885805,133897,1.46668695122562,31,2,0,1E-07,0.0259989565881546,259989.565881546,17.9880941994097
343,370,534,534,534,O00743,PPP6C,PPP6_HUMAN,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:29053956}. Cytoplasm {ECO:0000269|PubMed:16769727, ECO:0000269|PubMed:17568194}.","Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]",GO:0000082; GO:0000139; GO:0004722; GO:0005739; GO:0005829; GO:0006470; GO:0045087; GO:0046872; GO:0048208,1E-07,0.00523573000281798,1E-07,0.0132923216538096,0.0178758084353903,0.0159065388122405,0.0159065388122405,-5.9742362435872900,0.0139462462995408,0.00871843315070973,6.59019801141397,0.00213061069656784,0.0341536096678291,-5.58003060837658,35144,1.46656338931848,7,2,0,1E-07,0.0159065388122405,159065.388122405,17.2792604206242
344,371,536,536,536,Q9NXG2,THUMPD1,THUM1_HUMAN,nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA modification [GO:0000154]; tRNA modification [GO:0006400],NA,THUMP domain-containing protein 1,GO:0000154; GO:0003723; GO:0005654; GO:0006400,6.35229587695847E-05,1E-07,1E-07,0.00024471238223643,0.00028955708438577,0.00020988582295279,0.00024471238223643,-11.99662527715490000,0.00022681077693514,0.0001346463747241,6.57682940728484,0.00214784678370902,0.0343014337099799,-5.58981281456399,39315,1.46468772720737,10,2,0,1E-07,0.00024471238223643,2447.1238223643,11.2568713870567
345,372,539,539,539,Q9H3P7,ACBD3,GCP60_HUMAN,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694],SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:27009356}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Mitochondrion {ECO:0000250}. Note=Also mitochondrial (via its interaction with PBR). {ECO:0000250}.,"Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed]",GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0034237,1E-07,1E-07,1E-07,0.0144892827491609,0.00985016636212249,0.00879648909390332,0.00985016636212249,-6.66563619382076000,0.0110452127350622,0.00552270636753112,6.54468848244245,0.0021899836447741,0.0347797031526276,-5.61339810513372,60593,1.45867412905343,10,3,0,1E-07,0.00985016636212249,98501.6636212249,16.5878604703908
346,375,543,543,543,Q9HCM3,KIAA1549,K1549_HUMAN,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,UPF0606 protein KIAA1549,GO:0000981; GO:0005886; GO:0016021,7.17881382851845E-05,4.00922139049349E-05,4.28893282241362E-05,0.0521891466043512,0.0464724911670837,0.0767529849103648,0.0521891466043512,-4.2601063785374400,0.0584199510004618,0.0292615653937023,6.517064489386,0.00222700295214286,0.0351007430536128,-5.63374464563063,210755,1.45468368978295,9,0,0,4.28893282241362E-05,0.0521891466043512,1216.83292243737,10.248915376692
347,376,544,544,544,Q9HAT8,PELI2,PELI2_HUMAN,cytosol [GO:0005829]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; immune response [GO:0006955]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063],NA,E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2),GO:0000209; GO:0001934; GO:0004674; GO:0005829; GO:0006955; GO:0008063; GO:0034450; GO:0043123; GO:0043410; GO:0061630; GO:0070498,1.98075690794172E-06,1.55242091949406E-05,1.10261834899328E-05,0.0505270484507451,0.0775955578611121,0.0485667102839756,0.0505270484507451,-4.3068002827229200,0.05888692848208,0.0294529746242376,6.51433532140097,0.00223070142770624,0.0351007430536128,-5.63575864426191,46435,1.45468368978295,4,0,0,1.10261834899328E-05,0.0505270484507451,4582.4603315261,12.1619066766638
348,377,545,545,545,Q92845,KIFAP3,KIFA3_HUMAN,"axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intraciliary transport particle [GO:0030990]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; kinesin binding [GO:0019894]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; signal transduction [GO:0007165]",NA,Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein),GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0030990; GO:0032391; GO:0035735; GO:0036064; GO:0043066; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:1990075,7.4307694166774E-05,0.0155740512775207,7.96206183668932E-05,0.0671690666358859,0.0461704605538122,0.0677022609459428,0.0671690666358859,-3.8960592080438600,0.0551046028485288,0.0327949612876159,6.50893522821997,0.00223804144354549,0.0351516234068796,-5.6397456912564,91205,1.45405461316566,13,0,0,7.96206183668932E-05,0.0671690666358859,843.613978559795,9.72043919034945
349,378,546,546,546,O43854,EDIL3,EDIL3_HUMAN,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],SUBCELLULAR LOCATION: Secreted.,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),GO:0005178; GO:0005509; GO:0007155; GO:0007275; GO:0010811; GO:0062023; GO:0070062; GO:1903561,2.42238905334749E-06,3.18915633824691E-06,2.15181252794518E-05,0.0017561093545765,0.00099489641869075,0.00147177486777196,0.00147177486777196,-9.40822728037940000,0.00139855032345606,0.00070831838528504,6.50335885192906,0.00224565185726319,0.0352065565900603,-5.64386572676853,53765,1.45337644942756,22,0,0,3.18915633824691E-06,0.00147177486777196,461.493483439887,8.85016646608492
350,379,547,547,547,Q15643,TRIP11,TRIPB_HUMAN,cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi organization [GO:0007030]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281],"SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane {ECO:0000269|PubMed:10189370}; Peripheral membrane protein {ECO:0000269|PubMed:10189370}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10189370}. Note=Associates with the ends of centrosome-nucleated microtubules.",Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005634; GO:0005794; GO:0005801; GO:0005856; GO:0005929; GO:0006366; GO:0006486; GO:0007030; GO:0016607; GO:0030133; GO:0035735; GO:0060122,0.00036054128374206,0.00030250480784088,0.00531244087348309,0.0270807021448464,0.0391436447920259,0.0257077212059708,0.0270807021448464,-5.2065910443715800,0.0286521937259257,0.0163179258513182,6.48249591650648,0.00227440475785497,0.0355919868453691,-5.65930563813636,227586,1.44864776777318,13,0,0,0.00036054128374206,0.0270807021448464,75.1112379247548,6.23095687060813
351,380,549,549,549,O94766,B3GAT3,B3GA3_HUMAN,cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486],"SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:21763480}; Single-pass type II membrane protein {ECO:0000269|PubMed:21763480}. Golgi apparatus, cis-Golgi network {ECO:0000269|PubMed:21763480, ECO:0000269|PubMed:25893793}.","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)",GO:0000139; GO:0005794; GO:0005801; GO:0005975; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0030203; GO:0030204; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316,0.00010087287244757,0.0130178854633714,3.13982325829858E-05,0.0516664819734306,0.0562014732931221,0.0780514238185355,0.0562014732931221,-4.1532482393139100,0.0575897408388954,0.0331782559422484,6.47323151429612,0.00228731593249636,0.0356637966888321,-5.66617487433808,37122,1.44777242467053,4,0,0,0.00010087287244757,0.0562014732931221,557.151510901343,9.12192589490308
352,381,550,550,550,O00429,DNM1L,DNM1L_HUMAN,cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; BH2 domain binding [GO:0051433]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase binding [GO:0031625]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to thapsigargin [GO:1904579]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; execution phase of apoptosis [GO:0097194]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; negative regulation of mitochondrial fusion [GO:0010637]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; protein complex oligomerization [GO:0051259]; protein homotetramerization [GO:0051289]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of protein oligomerization [GO:0032459]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; synaptic vesicle recycling via endosome [GO:0036466],"SUBCELLULAR LOCATION: Cytoplasm, cytosol. Golgi apparatus. Endomembrane system; Peripheral membrane protein. Mitochondrion outer membrane {ECO:0000269|PubMed:26122121, ECO:0000269|PubMed:27145208}; Peripheral membrane protein. Peroxisome. Membrane, clathrin-coated pit {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}. Note=Mainly cytosolic. Translocated to the mitochondrial membrane through O-GlcNAcylation and interaction with FIS1. Recruited to the mitochondrial outer membrane by interaction with MIEF1. Colocalized with MARCH5 at mitochondrial membrane. Localizes to mitochondria at sites of division. Localizes to mitochondria following necrosis induction. Associated with peroxisomal membranes, partly recruited there by PEX11B. May also be associated with endoplasmic reticulum tubules and cytoplasmic vesicles and found to be perinuclear. In some cell types, localizes to the Golgi complex. Binds to phospholipid membranes.",Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),GO:0000139; GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010637; GO:0010821; GO:0016020; GO:0016559; GO:0017137; GO:0030054; GO:0030276; GO:0030672; GO:0030742; GO:0031625; GO:0032459; GO:0032991; GO:0036466; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0044877; GO:0048312; GO:0048471; GO:0050714; GO:0051259; GO:0051289; GO:0051433; GO:0061003; GO:0061025; GO:0070266; GO:0070584; GO:0090141; GO:0090149; GO:0090200; GO:0090650; GO:0097194; GO:0098794; GO:1900063; GO:1900244; GO:1903146; GO:1904579; GO:1905395; GO:1990910; GO:2000302; GO:2001244,2.37892253868734E-05,1.07979705352905E-05,8.67744412057365E-06,0.00013668687485054,0.00012741476850071,0.00012292471675597,0.00012741476850071,-12.93817987112410000,0.0001145872400215,7.17151666916623E-05,6.46804401476505,0.00229458424626781,0.0356990265908716,-5.67002472350988,81877,1.44734362567987,30,0,0,1.07979705352905E-05,0.00012741476850071,11.7998811058325,3.56070041812786
353,385,555,555,555,Q9NR28,DIABLO,DBLOH_HUMAN,CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065],SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:14523016}. Note=Released into the cytosol when cells undergo apoptosis.,"Diablo homolog, mitochondrial (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)",GO:0005739; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0008625; GO:0008635; GO:0009898; GO:0035631; GO:0043065; GO:0097193,7.38817101231269E-05,8.08872917274359E-05,0.00040538406310884,0.016943632652842,0.0165254838282619,0.0262746279000645,0.016943632652842,-5.883112973404790,0.0197278637720696,0.0100506495743546,6.41965490952487,0.0023637512595313,0.0364571365434017,-5.70605765528681,27131,1.43821744517737,4,0,0,8.08872917274359E-05,0.016943632652842,209.47212214666,7.71061444364227
354,386,557,557,557,P31150,GDI1,GDIA_HUMAN,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; Rab GTPase binding [GO:0017137]; negative regulation of axonogenesis [GO:0050771]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of axon extension [GO:0045773]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19570034}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:19570034}.",Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4),GO:0005092; GO:0005093; GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0007165; GO:0015031; GO:0017137; GO:0030424; GO:0030496; GO:0032482; GO:0032991; GO:0043025; GO:0043209; GO:0045773; GO:0050771; GO:0051056; GO:0051592; GO:0090315,1E-07,1E-07,1E-07,0.00363222335566164,0.00358787463936259,0.0020956991945207,0.00358787463936259,-8.12265480140866000,0.00310516572984831,0.00155268286492416,6.36830053109458,0.00243994373227175,0.0374971604097776,-5.74454047523802,50583,1.42600161934049,23,3,0,1E-07,0.00358787463936259,35878.7463936259,15.1308418628029
355,387,558,558,558,Q59EK9,RUNDC3A,RUN3A_HUMAN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanylate cyclase activator activity [GO:0030250]; peptide hormone receptor binding [GO:0051428]; small GTPase mediated signal transduction [GO:0007264],NA,RUN domain-containing protein 3A (Rap2-interacting protein 8) (RPIP-8),GO:0005829; GO:0005886; GO:0007264; GO:0030250; GO:0030695; GO:0051428,1E-07,1.10663303668247E-05,5.9564336588315E-06,0.0321624775208689,0.0382899092479218,0.0212387484735864,0.0321624775208689,-4.9584776461496500,0.0305580041594505,0.0152847096677338,6.34955456978531,0.00246849644592183,0.0378679741524926,-5.75865047848531,49747,1.42172792799053,6,1,0,5.9564336588315E-06,0.0321624775208689,5399.61986702935,12.3986421298539
356,388,561,561,561,Q5JRA6,MIA3,TGO1_HUMAN,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; lipoprotein transporter activity [GO:0042954]; cargo loading into COPII-coated vesicle [GO:0090110]; cellular protein metabolic process [GO:0044267]; ER to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; positive regulation of leukocyte migration [GO:0002687]; post-translational protein modification [GO:0043687]; protein transport [GO:0015031]; wound healing [GO:0042060],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:21525241}; Single-pass membrane protein {ECO:0000269|PubMed:19269366}. Note=Localizes at endoplasmic reticulum exit sites. After loading of COL7A1 into transport carriers, it is not incorporated into COPII carriers and remains in the endoplasmic reticulum membrane. {ECO:0000269|PubMed:19269366, ECO:0000269|PubMed:21525241}.",Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3),GO:0000139; GO:0002687; GO:0005788; GO:0005789; GO:0006887; GO:0006888; GO:0007162; GO:0015031; GO:0016020; GO:0016021; GO:0030336; GO:0042060; GO:0042953; GO:0042954; GO:0043231; GO:0043687; GO:0044267; GO:0070971; GO:0090110,0.0001034362802986,1E-07,4.69239648649544E-06,0.027023862186066,0.0353069631821645,0.0198200992032268,0.027023862186066,-5.209622313834290,0.0273475652982241,0.0137098588747071,6.33309729672734,0.00249389780078828,0.0379852253539405,-5.77106555218953,213702,1.42038529272468,27,1,0,4.69239648649544E-06,0.027023862186066,5759.07476357545,12.491621335701
357,389,562,562,562,Q15067,ACOX1,ACOX1_HUMAN,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; protein targeting to peroxisome [GO:0006625]; regulation of lipid metabolic process [GO:0019216]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038],SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:P07872}.,Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX),GO:0000038; GO:0003995; GO:0003997; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0005886; GO:0006091; GO:0006625; GO:0006629; GO:0006693; GO:0007283; GO:0016020; GO:0016401; GO:0016559; GO:0019216; GO:0019395; GO:0030165; GO:0033539; GO:0033540; GO:0036109; GO:0042632; GO:0043231; GO:0047485; GO:0050660; GO:0055088; GO:0071949,9.36408603173253E-05,0.00430368344250786,2.37179812619406E-05,0.0246751665464883,0.0197792766524785,0.0324689259420947,0.0246751665464883,-5.3407963675051300,0.0241674422856581,0.0135574019041914,6.32906382967956,0.00250017163862316,0.0379852253539405,-5.77411229876576,74424,1.42038529272468,12,0,0,9.36408603173253E-05,0.0246751665464883,263.508541707865,8.04170591778464
358,390,563,563,563,P30040,ERP29,ERP29_HUMAN,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],SUBCELLULAR LOCATION: Endoplasmic reticulum lumen. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.,Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31),GO:0000187; GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0030133; GO:0042470; GO:0042803; GO:0043335; GO:0050709; GO:0051087; GO:1902235,1E-07,1E-07,1E-07,0.0168075190074043,0.0270451798303405,0.0301956773086518,0.0270451798303405,-5.2084846994019000,0.0246826920487989,0.0123414460243994,6.32855435797494,0.002500965454757,0.0379852253539405,-5.77449724808046,28993,1.42038529272468,7,3,0,1E-07,0.0270451798303405,270451.798303405,18.0450119648096
359,391,564,564,564,P0CK96,SLC35E2B,S352B_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.,Solute carrier family 35 member E2B,GO:0016021,0.254018421523396,0.278771809029365,0.229409245896164,0.586106979003611,0.492139842484799,0.452964962616216,0.492139842484799,-1.022859776492000,0.256337435885234,0.382235210092259,6.32468547398021,0.00250700360913501,0.0379852253539405,-5.77742133541701,43777,1.42038529272468,3,0,0,0.254018421523396,0.492139842484799,1.9374179224221,0.954135192749292
360,393,566,566,566,Q9UPV7,PHF24,PHF24_HUMAN,"calcium ion binding [GO:0005509]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G-protein coupled receptor protein signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",NA,PHD finger protein 24,GO:0005509; GO:0007214; GO:0008277; GO:0032228; GO:0050966,0.00011885802874007,0.00014709297640897,0.00014352991391923,0.0003327467341476,0.0004177430572296,0.00046922139223334,0.0004177430572296,-11.2250965282436000,0.00027007675484742,0.00027153201711313,6.32054789566149,0.00251348068690653,0.0380130648055123,-5.78055009684598,45192,1.42006711396797,4,0,0,0.00014352991391923,0.0004177430572296,2.91049472421951,1.54126440245123
361,394,568,568,568,P09874,PARP1,PARP1_HUMAN,"membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA damage response, detection of DNA damage [GO:0042769]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; global genome nucleotide-excision repair [GO:0070911]; lagging strand elongation [GO:0006273]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; nucleotide-excision repair, preincision complex stabilization [GO:0006293]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:21799911, ECO:0000269|PubMed:23230272}. Nucleus, nucleolus {ECO:0000269|PubMed:9518481}. Note=Localizes at sites of DNA damage. {ECO:0000269|PubMed:23230272}.",Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1),GO:0000122; GO:0000715; GO:0000723; GO:0000724; GO:0000784; GO:0000977; GO:0001228; GO:0003677; GO:0003723; GO:0003910; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006273; GO:0006281; GO:0006293; GO:0006294; GO:0006296; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008134; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0018312; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0032042; GO:0032869; GO:0032991; GO:0032993; GO:0033148; GO:0033683; GO:0034599; GO:0034644; GO:0036211; GO:0042769; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051103; GO:0051287; GO:0051901; GO:0060391; GO:0070212; GO:0070412; GO:0070911; GO:0071294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1903827; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1990404; GO:1990966; GO:2000679; GO:2001170,2.11143870597019E-05,2.50631931761752E-05,5.25633538042314E-05,0.00032272539424042,0.00038746857810314,0.00052234659976777,0.00038746857810314,-11.33363306026670000,0.00037793321269041,0.00022188025102524,6.30853663002368,0.00253239873210916,0.0381643189205184,-5.78964215567446,113084,1.4183424836217,30,0,0,2.50631931761752E-05,0.00038746857810314,15.4596653099839,3.95043718123594
362,395,569,569,569,Q9NS86,LANCL2,LANC2_HUMAN,"cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12566319}. Cytoplasm {ECO:0000269|PubMed:12566319}. Cell membrane {ECO:0000269|PubMed:12566319, ECO:0000269|PubMed:16979580}. Note=Localizes to the juxta-nuclear vesicles (PubMed:16979580). Associates with the cortical actin cytoskeleton (PubMed:16979580). Cholesterol depletion by methyl-beta-cyclodextrin causes partial dissociation from the cell membrane in vitro and an enhanced cell detachment from the matrix in vivo (PubMed:16979580). Membrane-association is important for the increased cellular sensitivity to an anticancer drug (adriamycin) (PubMed:16979580). {ECO:0000269|PubMed:16979580}.",LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),GO:0003824; GO:0005524; GO:0005525; GO:0005634; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273,7.79709993965729E-05,0.00012261785241419,0.00012205563702402,0.00927761556413614,0.0107023551892279,0.0156687751085748,0.0107023551892279,-6.5459278748375300,0.011775367124368,0.00599523172512894,6.29840554752967,0.00254848980514386,0.038339319388456,-5.79732183291018,50854,1.41635560112049,14,0,0,0.00012205563702402,0.0107023551892279,87.6842352403742,6.45424557854984
363,397,571,571,571,Q9BSV6,TSEN34,SEN34_HUMAN,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15109492}. Nucleus, nucleolus {ECO:0000269|PubMed:15109492}. Note=May be transiently localized in the nucleolus.",tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34),GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0016829,0.00287028846383489,0.00572209051316637,0.00754586944486633,0.0501227947768281,0.0525799523793486,0.0781563785056791,0.0525799523793486,-4.2493433544393200,0.0549069590799961,0.0328328956806206,6.27564369807756,0.00258509660878865,0.0386869736466313,-5.81461233534682,33652,1.41243524236391,4,0,0,0.00572209051316637,0.0525799523793486,9.18894104494915,3.19989861154394
364,398,572,572,572,Q7Z7L7,ZER1,ZER1_HUMAN,Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein),GO:0004842; GO:0031462; GO:0051438,8.21379012046107E-05,0.00010980331975567,0.0104544090777233,0.0611314924763215,0.0941453575888696,0.0621249403154012,0.0621249403154012,-4.0086836291234000,0.0689184800273029,0.038008023446546,6.27560611022493,0.00258515758479826,0.0386869736466313,-5.81464092973223,88169,1.41243524236391,5,0,0,0.00010980331975567,0.0621249403154012,565.783807389787,9.14410707747965
365,399,574,574,574,Q86WA8,LONP2,LONP2_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; peroxisome organization [GO:0007031]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070],"SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000255|HAMAP-Rule:MF_03121, ECO:0000269|PubMed:14561759, ECO:0000269|PubMed:18281296, ECO:0000269|PubMed:22002062}.","Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)",GO:0002020; GO:0004176; GO:0004252; GO:0005102; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0019899; GO:0031998,1E-07,1E-07,1E-07,0.0190890125959652,0.0227569042009501,0.0328837828815543,0.0227569042009501,-5.4575518798330200,0.0249097998928232,0.0124549999464116,6.2569749276299,0.00261559739505707,0.0390061214315131,-5.82883127646561,94617,1.40886723155529,11,3,0,1E-07,0.0227569042009501,227569.042009501,17.7959447843785
366,401,576,576,576,Q13310,PABPC4,PABP4_HUMAN,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904,0.00011053923820697,2.44677624900385E-05,1.89584361833852E-05,0.00112045543653788,0.00147609631880736,0.00085734621047727,0.00112045543653788,-9.80169901445217000,0.00109997750964737,0.00060131056711715,6.24411865563267,0.00263685563518407,0.0391866045784299,-5.83864297411057,70783,1.40686236542559,6,0,0,2.44677624900385E-05,0.00112045543653788,45.7931303278773,5.51705928305115
367,402,577,577,577,P49458,SRP9,SRP09_HUMAN,"cytosol [GO:0005829]; signal recognition particle receptor complex [GO:0005785]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",SUBCELLULAR LOCATION: Cytoplasm.,Signal recognition particle 9 kDa protein (SRP9),GO:0003723; GO:0005047; GO:0005785; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0008312; GO:0045900,0.0235942118977978,1E-07,1E-07,0.0558117901757232,0.054358149222685,0.0557841146256261,0.0557841146256261,-4.1640018385735100,0.0474532140420788,0.031591410986972,6.24039465108633,0.00264305246836354,0.0392106224076116,-5.84148809889168,10112,1.40659626389602,3,2,0,1E-07,0.0557841146256261,557841.146256261,19.089494825638
368,403,578,578,578,Q13242,SRSF9,SRSF9_HUMAN,"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA export from nucleus [GO:0006405]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10196175, ECO:0000269|PubMed:11694584, ECO:0000269|PubMed:12024014, ECO:0000269|PubMed:12604611}. Note=Cellular stresses such as heat shock may induce localization to discrete nuclear bodies termed SAM68 nuclear bodies (SNBs), HAP bodies, or stress bodies. Numerous splicing factors including SRSF1/SFRS1/SF2, SRSF7/SFRS7, SAFB and KHDRBS1/SAM68 accumulate at these structures, which may participate in the post-transcriptional regulation of mRNAs in stressed cells.","Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0006405; GO:0006406; GO:0009636; GO:0019904; GO:0031124; GO:0043279; GO:0048025,1.07370546629767E-05,1E-07,1E-07,0.00437670286003786,0.00273586968485528,0.00274598317721112,0.00274598317721112,-8.50846149757053000,0.00328253955581376,0.00164491546279454,6.23463976969799,0.00265266348316653,0.0392678954339899,-5.84588748246815,25542,1.40596237415351,10,2,0,1E-07,0.00274598317721112,27459.8317721112,14.745035166641
369,404,580,580,580,P53990,IST1,IST1_HUMAN,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; neutrophil degranulation [GO:0043312]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],"SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:20719964}. Midbody {ECO:0000269|PubMed:20719964}. Nucleus envelope {ECO:0000269|PubMed:26040712}. Note=Localizes to centrosome and midbody of dividing cells (PubMed:19129480, PubMed:19129479, PubMed:20719964). Colocalized with SPART to the ends of Flemming bodies during cytokinesis (PubMed:20719964). Localizes to the nuclear envelope during late anaphase (PubMed:26040712). {ECO:0000269|PubMed:19129479, ECO:0000269|PubMed:19129480, ECO:0000269|PubMed:20719964, ECO:0000269|PubMed:26040712}.",IST1 homolog (hIST1) (Putative MAPK-activating protein PM28),GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0043312; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903,2.23340462176039E-05,1.49558041044595E-05,1.55287307678643E-05,0.00023545979673793,0.00036412584393944,0.00039747671256758,0.00036412584393944,-11.42327523942600000,0.00031474792405168,0.00017498015572248,6.22634844758904,0.00266658510519534,0.0393378789839146,-5.85223159900276,39751,1.40518906003475,6,0,0,1.55287307678643E-05,0.00036412584393944,23.4485257927824,4.55142531834027
370,405,581,581,581,Q96A83,COL26A1,COQA1_HUMAN,collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; positive regulation of cell-substrate adhesion [GO:0010811],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.",Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2) (Emu2),GO:0005576; GO:0005581; GO:0005788; GO:0005794; GO:0005886; GO:0010811; GO:0031012,1E-07,1E-07,1E-07,0.00017575723368497,0.00011802485549829,0.00014064333848646,0.00014064333848646,-12.79567115793230000,0.00014470847588991,7.24542379449558E-05,6.22431518682441,0.0026700125805671,0.0393378789839146,-5.85378838396346,45381,1.40518906003475,5,3,0,1E-07,0.00014064333848646,1406.4333848646,10.4578255062792
371,406,582,582,582,Q15631,TSN,TSN_HUMAN,cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; DNA recombination [GO:0006310]; RNA metabolic process [GO:0016070],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11801738}. Nucleus {ECO:0000269|PubMed:11801738}.,Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO),GO:0003677; GO:0003697; GO:0003729; GO:0004519; GO:0005634; GO:0005829; GO:0006310; GO:0016070; GO:0042802; GO:0043565,0.00075441843699905,0.00175885965850061,0.00154233673257976,0.0268103450127088,0.0156508796292224,0.0201935757938021,0.0201935757938021,-5.6299597900904300,0.019533061869218,0.0111184025439688,6.21934046614219,0.00267842102462968,0.0393939587127665,-5.85759904188873,26183,1.40457037459266,6,0,0,0.00154233673257976,0.0201935757938021,13.0928450105871,3.71070671674584
372,407,583,583,583,Q9UKG1,APPL1,DP13A_HUMAN,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; vesicle membrane [GO:0012506]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; regulation of glucose import [GO:0046324]; regulation of protein localization to plasma membrane [GO:1903076]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000269|PubMed:15016378, ECO:0000269|PubMed:20133602}; Peripheral membrane protein {ECO:0000269|PubMed:15016378}. Nucleus {ECO:0000269|PubMed:15016378}. Note=Early endosomal membrane-bound and nuclear. Translocated into the nucleus upon release from endosomal membranes following internalization of EGF. {ECO:0000269|PubMed:15016378}.","DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",GO:0005634; GO:0005769; GO:0005829; GO:0007049; GO:0007165; GO:0008283; GO:0008286; GO:0010008; GO:0012506; GO:0031901; GO:0042802; GO:0043422; GO:0046324; GO:0070062; GO:0097192; GO:1903076,0.00356807069960031,0.00537119098359598,0.00183592119445526,0.0171285084660343,0.0233819029838227,0.0158809739926198,0.0171285084660343,-5.8674566613733900,0.0152054008549417,0.0111944280533547,6.21500689720607,0.00268577193868177,0.0394343186880205,-5.86092056293495,79663,1.40412565813678,15,0,0,0.00356807069960031,0.0171285084660343,4.8004958163954,2.26318342144073
373,408,585,585,585,Q8TBP6,SLC25A40,S2540_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.,Solute carrier family 25 member 40 (Mitochondrial carrier family protein),GO:0005743; GO:0006839; GO:0016021; GO:0022857,0.00220862757039687,0.00011255250270592,0.00023204377888555,0.00965408398714341,0.0133932577552668,0.00854807307663341,0.00965408398714341,-6.69464490688431000,0.00968073032235176,0.00569143977850533,6.20769086069389,0.00269823749235868,0.0394819024522911,-5.86653224138536,38125,1.40360192883356,5,0,0,0.00023204377888555,0.00965408398714341,41.6045801077264,5.37867045342153
374,409,586,586,586,O14576,DYNC1I1,DC1I1_HUMAN,"condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; motor activity [GO:0003774]; spectrin binding [GO:0030507]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; ER to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of ATP-dependent microtubule motor activity, plus-end-directed [GO:2000582]; vesicle transport along microtubule [GO:0047496]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:19229290}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:19229290}.","Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)",GO:0000776; GO:0000777; GO:0000922; GO:0003774; GO:0003777; GO:0005634; GO:0005737; GO:0005829; GO:0005868; GO:0005874; GO:0006888; GO:0008017; GO:0019886; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037; GO:2000582,0.00172007277496573,0.0002276010687354,0.00051240544579659,0.013492621469913,0.0177851714709092,0.0234155722377885,0.0177851714709092,-5.8131813059547900,0.017411095296371,0.00952557407801806,6.20093639887781,0.00270980849569324,0.0395452839243548,-5.87171786681274,72955,1.40290530199573,5,0,0,0.00051240544579659,0.0177851714709092,34.7091773063813,5.11724526500725
375,411,589,589,589,O60299,LZTS3,LZTS3_HUMAN,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; regulation of dendritic spine morphogenesis [GO:0061001],"SUBCELLULAR LOCATION: Cell junction, synapse {ECO:0000250|UniProtKB:Q8K1Q4}. Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250|UniProtKB:Q8K1Q4}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q8K1Q4}. Note=Detected at synapses, postsynaptic density, synaptic spines and dendrites. Rather found at excitatory than inhibitory synapses. {ECO:0000250|UniProtKB:Q8K1Q4}.",Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1) (ProSAPiP1),GO:0005737; GO:0005856; GO:0014069; GO:0030054; GO:0045202; GO:0045211; GO:0061001,0.0137934651419326,0.000176533319628,0.00011229946070446,0.163204449849668,0.219366091594073,0.1256552349352,0.163204449849668,-2.615247701251180,0.164714492818892,0.0870513457168678,6.18234866661115,0.00274196277058,0.0398477146294256,-5.88601161958596,71791,1.39959658147718,6,0,0,0.000176533319628,0.163204449849668,924.496577720176,9.8525241688793
376,412,591,591,591,Q15120,PDK3,PDK3_HUMAN,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377],SUBCELLULAR LOCATION: Mitochondrion matrix.,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)",GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377,0.00026993791269992,0.00025265776795435,0.00019639091086863,0.0339790379978482,0.0486082827797735,0.0618058454627126,0.0486082827797735,-4.3626540218869700,0.0478913932162705,0.0241853588053095,6.17486884776145,0.00275503219046026,0.0398477146294256,-5.891773194785,46939,1.39959658147718,7,0,0,0.00025265776795435,0.0486082827797735,192.387842152377,7.58787382141553
377,414,593,593,593,Q9Y5X1,SNX9,SNX9_HUMAN,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein oligomerization [GO:0032461]; receptor-mediated endocytosis [GO:0006898],"SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle, clathrin-coated vesicle. Golgi apparatus, trans-Golgi network. Cell projection, ruffle. Cytoplasm. Note=Localized at sites of endocytosis at the cell membrane. Detected on newly formed macropinosomes. Transiently recruited to clathrin-coated pits at a late stage of clathrin-coated vesicle formation. Colocalizes with the actin cytoskeleton at the cell membrane.",Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A),GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0031234; GO:0031410; GO:0031625; GO:0032461; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045296; GO:0045860; GO:0051044; GO:0060988; GO:0061024; GO:0070062; GO:0071933; GO:0097320,1E-07,0.00155118849561768,1E-07,0.0187939587509508,0.0162692094449452,0.0106164346531342,0.0162692094449452,-5.9417120406430200,0.0147094047844708,0.00787183189077465,6.16507237980196,0.00277226382977015,0.0399286766909726,-5.89932766931938,66592,1.39871508287683,8,2,0,1E-07,0.0162692094449452,162692.094449452,17.3117846235685
378,416,595,595,595,O43155,FLRT2,FLRT2_HUMAN,"cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein binding, bridging [GO:0030674]; protein kinase inhibitor activity [GO:0004860]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; cytokine-mediated signaling pathway [GO:0019221]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8BLU0}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q8BLU0}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q8BLU0}. Cell junction, focal adhesion {ECO:0000250|UniProtKB:Q8BLU0}. Secreted, extracellular space, extracellular matrix {ECO:0000250|UniProtKB:Q8BLU0}. Microsome membrane {ECO:0000250|UniProtKB:Q8BLU0}. Secreted {ECO:0000250|UniProtKB:Q8BLU0}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:D3ZTV3}. Note=Proteolytic cleavage gives rise to a shedded ectodomain. {ECO:0000250|UniProtKB:Q8BLU0}.",Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2),GO:0003007; GO:0004860; GO:0005104; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006469; GO:0007411; GO:0008543; GO:0019221; GO:0030674; GO:0031012; GO:0031090; GO:0043005; GO:0045202; GO:0045499; GO:0046426; GO:0051965; GO:0061343; GO:0070062; GO:0071711; GO:2001222,1E-07,1E-07,6.50068233840537E-05,0.138962285642643,0.158464621579847,0.0864162785275901,0.138962285642643,-2.847234706177000,0.127925992975565,0.0639847320955774,6.16094254956587,0.00277956716641538,0.0399286766909726,-5.90251522493404,74049,1.39871508287683,3,2,0,1E-07,0.138962285642643,1389622.85642643,20.4062619580345
379,417,596,596,596,Q9UBI9,HECA,HDC_HUMAN,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],NA,Headcase protein homolog (hHDC),GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930,7.20395133730241E-05,0.00027796172257744,2.64078092979973E-05,0.0341233638912322,0.0621916969948589,0.0485977483479759,0.0485977483479759,-4.3629667179696400,0.0481788000629395,0.0242148697132192,6.15992176741638,0.00278137594491495,0.0399286766909726,-5.90330336472415,58837,1.39871508287683,5,0,0,7.20395133730241E-05,0.0485977483479759,674.59850951983,9.39788532059634
380,418,597,597,597,Q8IYT2,CMTR2,CMTR2_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap2 mRNA methylation [GO:0097310],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21310715}. Cytoplasm {ECO:0000269|PubMed:21310715}.,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097310,9.57829918284438E-05,0.16072707127155,0.00011578846803758,0.368388409330374,0.452921287989584,0.490232808849269,0.452921287989584,-1.142667745043970,0.383534621145937,0.245413524816774,6.15741345337326,0.00278582662160763,0.0399286766909726,-5.90524046102407,88120,1.39871508287683,3,0,0,0.00011578846803758,0.452921287989584,3911.62691471646,11.9335530593601
381,419,599,599,599,O00213,APBB1,APBB1_HUMAN,"cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; main axon [GO:0044304]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; proline-rich region binding [GO:0070064]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; histone H4 acetylation [GO:0043967]; negative regulation of cell growth [GO:0030308]; negative regulation of thymidylate synthase biosynthetic process [GO:0050760]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA repair [GO:0045739]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to iron ion [GO:0010039]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Nucleus. Cell projection, growth cone {ECO:0000250}. Nucleus speckle. Note=Colocalizes with TSHZ3 in axonal growth cone (By similarity). In normal conditions, it mainly localizes to the cytoplasm, while a small fraction is tethered to the cell membrane via its interaction with APP. Following exposure to DNA damaging agents, it is released from cell membrane and translocates to the nucleus. Nuclear translocation is under the regulation of APP. Colocalizes with TSHZ3 in the nucleus. Colocalizes with NEK6 at the nuclear speckles. Phosphorylation at Ser-610 by SGK1 promotes its localization to the nucleus (By similarity). {ECO:0000250}.",Amyloid-beta A4 precursor protein-binding family B member 1 (Protein Fe65),GO:0000122; GO:0001540; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006302; GO:0006351; GO:0006355; GO:0006915; GO:0006974; GO:0007050; GO:0007165; GO:0007409; GO:0008134; GO:0010039; GO:0010976; GO:0016607; GO:0030027; GO:0030308; GO:0030426; GO:0032991; GO:0042393; GO:0042734; GO:0043025; GO:0043065; GO:0043197; GO:0043967; GO:0044304; GO:0044877; GO:0045202; GO:0045211; GO:0045739; GO:0045893; GO:0045944; GO:0048156; GO:0048471; GO:0050714; GO:0050760; GO:0070064; GO:1990761; GO:1990812,6.2986912932481E-05,0.00637523684948906,0.00012036389857363,0.142608666203717,0.079476853362929,0.11101984201223,0.11101984201223,-3.17111054971373,0.108848924639294,0.0566106582066452,6.14828353478483,0.00280209950254428,0.0399387820446852,-5.91229653632653,77244,1.39860518331453,10,0,0,0.00012036389857363,0.11101984201223,922.368279258718,9.84919908855903
382,420,600,600,600,P04843,RPN1,RPN1_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; RNA binding [GO:0003723]; cellular protein modification process [GO:0006464]; protein N-linked glycosylation via asparagine [GO:0018279],"SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250|UniProtKB:E2RQ08, ECO:0000250|UniProtKB:Q9GMB0}. Endoplasmic reticulum membrane; Single-pass type I membrane protein {ECO:0000305}. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV.",Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),GO:0003723; GO:0004579; GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006464; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0042470,0.00052957679497513,0.00030845316993582,0.00018977161995428,0.0124173621778248,0.0179685006961043,0.0224826745482984,0.0179685006961043,-5.7983861553584400,0.0172802452791208,0.0089827231678488,6.14783205003138,0.0028029071987878,0.0399387820446852,-5.91264568359676,68569,1.39860518331453,15,0,0,0.00030845316993582,0.0179685006961043,58.2535776819639,5.86427475144442
383,421,603,603,603,P17612,PRKACA,KAPCA_HUMAN,acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; blood coagulation [GO:0007596]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; ciliary basal body-plasma membrane docking [GO:0097711]; cytokine-mediated signaling pathway [GO:0019221]; G2/M transition of mitotic cell cycle [GO:0000086]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],"SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Nucleus {ECO:0000250}. Mitochondrion {ECO:0000250}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. Distributed throughout the cytoplasm in meiotically incompetent oocytes. Associated to mitochondrion as meiotic competence is acquired. Aggregates around the germinal vesicles (GV) at the immature GV stage oocytes (By similarity). Colocalizes with HSF1 in nuclear stress bodies (nSBs) upon heat shock (PubMed:21085490). {ECO:0000250, ECO:0000269|PubMed:21085490}.; SUBCELLULAR LOCATION: Isoform 2: Cell projection, cilium, flagellum {ECO:0000269|PubMed:10906071}. Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250|UniProtKB:P05132}. Note=Expressed in the midpiece region of the sperm flagellum (PubMed:10906071). Colocalizes with MROH2B and TCP11 on the acrosome and tail regions in round spermatids and spermatozoa regardless of the capacitation status of the sperm (By similarity). {ECO:0000250|UniProtKB:P05132, ECO:0000269|PubMed:10906071}.",cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11),GO:0000086; GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0002223; GO:0003091; GO:0004672; GO:0004674; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0007596; GO:0010389; GO:0010881; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034199; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045171; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070613; GO:0071158; GO:0071333; GO:0071374; GO:0071377; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0097711; GO:1901621; GO:1903779; GO:2000810,1E-07,1E-07,3.00160512116756E-06,0.00131664313143302,0.00201971763486013,0.00120584983105174,0.00131664313143302,-9.56891992029730000,0.00151300299740791,0.000757568700411,6.13781150878039,0.00282090653787136,0.0400447097250063,-5.92040013819727,40590,1.39745485009145,3,2,0,1E-07,0.00131664313143302,13166.4313143302,13.6845767439142
384,422,604,604,604,Q08629,SPOCK1,TICN1_HUMAN,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.",Testican-1 (Protein SPOCK),GO:0001558; GO:0001764; GO:0004867; GO:0004869; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0007165; GO:0007399; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0014069; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268,0.00011162813538108,8.34881965487815E-05,0.0232929921606829,0.140980214163099,0.128084476282086,0.206643948627186,0.140980214163099,-2.826435392772150,0.15074017685992,0.0831994579274974,6.11974695177266,0.00285370997263764,0.0404170459920792,-5.93440497025673,49124,1.39343543144964,6,0,0,0.00011162813538108,0.140980214163099,1262.94516773765,10.3025762888309
385,423,605,605,605,P61916,NPC2,NPC2_HUMAN,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; low-density lipoprotein particle clearance [GO:0034383]; neutrophil degranulation [GO:0043312]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615],SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19723497}. Endoplasmic reticulum {ECO:0000269|PubMed:19723497}. Lysosome {ECO:0000269|PubMed:19723497}.,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein),GO:0005576; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015914; GO:0017127; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0033344; GO:0034383; GO:0035578; GO:0042632; GO:0043202; GO:0043312; GO:0046836; GO:0070062,0.0001010829300095,0.00011637142582556,0.00013700459706454,0.0015164575698794,0.00266363656281542,0.00205494584606532,0.00205494584606532,-8.92668390955924000,0.00196019367528685,0.00109824982194329,6.11817919295422,0.00285657860107569,0.0404170459920792,-5.9356219483614,16570,1.39343543144964,5,0,0,0.00011637142582556,0.00205494584606532,17.6585087918891,4.14229161174793
386,424,606,606,606,P78344,EIF4G2,IF4G2_HUMAN,"cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of translational initiation [GO:0006446]",NA,Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97),GO:0003723; GO:0003743; GO:0005829; GO:0005913; GO:0006446; GO:0007050; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0034645; GO:0045296,2.45484613005565E-05,7.40100436488216E-06,1.79569537483308E-05,0.00015239134782931,0.00018980529585817,0.00023451862957533,0.00018980529585817,-12.36319213322980000,0.00017560295128302,0.00010443694877943,6.11041742978002,0.00287083235476088,0.0405516913477775,-5.94165069357616,102362,1.39199102732981,33,0,0,1.79569537483308E-05,0.00018980529585817,10.5700164136032,3.40190571189231
387,425,607,607,607,Q8NEY1,NAV1,NAV1_HUMAN,axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule bundle formation [GO:0001578]; neuron migration [GO:0001764],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associates with a subset of microtubule plus ends. Enriched in neuronal growth cones (By similarity). {ECO:0000250}.",Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0043194,0.00024684328305591,0.00037582096286843,0.00028156498416616,0.0525707141188955,0.0299511957604037,0.0531081208241526,0.0525707141188955,-4.2495968572086400,0.0449086004911204,0.0227557099889237,6.09788899724303,0.00289402185134741,0.0407411307857085,-5.95139465790292,202472,1.38996692115868,41,0,0,0.00028156498416616,0.0525707141188955,186.708991086306,7.54464759287873
388,426,610,610,610,Q8IXT5,RBM12B,RB12B_HUMAN,RNA binding [GO:0003723],NA,RNA-binding protein 12B (RNA-binding motif protein 12B),GO:0003723,8.94849876578147E-05,4.80180123826498E-05,8.67106696559639E-05,0.00030098133486608,0.00033882022026599,0.00023658413057663,0.00030098133486608,-11.69803835745180000,0.00021739067200409,0.00018343322590085,6.09027892834988,0.00290821848105078,0.0407472334146245,-5.95732112750352,118103,1.3899018729007,11,0,0,8.67106696559639E-05,0.00030098133486608,3.4710991860663,1.79539259051991
389,427,611,611,611,P98172,EFNB1,EFNB1_HUMAN,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ephrin receptor binding [GO:0046875]; protein tyrosine kinase activity [GO:0004713]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),GO:0001755; GO:0004713; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0007411; GO:0009880; GO:0031295; GO:0042102; GO:0045121; GO:0045202; GO:0046875; GO:0048013; GO:0070062,1E-07,1E-07,1E-07,0.0121487375251876,0.00684839251984475,0.0121443387329593,0.0121443387329593,-6.3635722533335100,0.0103803895926639,0.00519029479633194,6.09014098596634,0.00290847659069341,0.0407472334146245,-5.95742860661167,38007,1.3899018729007,7,3,0,1E-07,0.0121443387329593,121443.387329593,16.889924410878
390,429,613,613,613,Q99567,NUP88,NUP88_HUMAN,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Nucleus, nuclear pore complex.",Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),GO:0000055; GO:0000056; GO:0000278; GO:0005215; GO:0005643; GO:0005654; GO:0005829; GO:0006406; GO:0006606; GO:0016032; GO:0017056,0.00023386772646439,0.00032515950323587,0.00012912257778195,0.0118036112030986,0.00654603280544131,0.00909099472425337,0.00909099472425337,-6.78134612388054000,0.00891749630843703,0.00468813142337925,6.08248848179534,0.00292283906460181,0.040814848928208,-5.96339415113479,83542,1.3891818066561,10,0,0,0.00023386772646439,0.00909099472425337,38.8723782528309,5.28067347085889
391,430,615,615,615,Q6F5E8,CARMIL2,CARL2_HUMAN,"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]","SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}. Cell membrane {ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cell projection, lamellipodium {ECO:0000269|PubMed:26578515}. Cell projection, ruffle {ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}. Note=Colocalizes to dynamic vimentin filaments both in the central cytoplasm and at leading edges of migrating cells (PubMed:26578515, PubMed:26466680, PubMed:19846667). Colocalizes with F-actin, Arp2/3 complex and cortactin to leading edge lamellipodia, ruffles and macropinosomes of migrating cells (PubMed:26578515). {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}.","Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)",GO:0001726; GO:0005543; GO:0005737; GO:0005886; GO:0007163; GO:0010592; GO:0015629; GO:0016020; GO:0030011; GO:0030027; GO:0030335; GO:0031234; GO:0031252; GO:0044319; GO:0044354; GO:0044877; GO:0045111; GO:0051639; GO:0061339; GO:0090091; GO:1900029; GO:1902745; GO:2000813,1E-07,1E-07,1E-07,0.00716388128244591,0.00397541716047585,0.00697259437106995,0.00697259437106995,-7.16408872901865000,0.0060371976046639,0.00301869880233195,6.05837662210256,0.0029686580767774,0.0413198587596985,-5.98222959795708,154689,1.38384117166327,6,3,0,1E-07,0.00697259437106995,69725.9437106995,16.0894079351929
392,431,617,617,617,Q6KCM7,SLC25A25,SCMC2_HUMAN,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; mitochondrial transport [GO:0006839]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094],"SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600}; Multi-pass membrane protein {ECO:0000269|PubMed:15054102, ECO:0000269|PubMed:15123600}.",Calcium-binding mitochondrial carrier protein SCaMC-2 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25),GO:0002021; GO:0005347; GO:0005509; GO:0005743; GO:0006839; GO:0014823; GO:0015217; GO:0016021; GO:0032094; GO:0035264; GO:0043010; GO:0045333; GO:0046034; GO:0060612; GO:0070588,5.81685661484281,5.07250782047066,7.92143487776382,11.6681407912814,14.3322930062067,14.2807791788998,14.2807791788998,3.8360027918221,7.15680455443684,9.84866871491085,6.05204694678899,0.0029808299768724,0.0413547886580677,-5.98718396934506,52663,1.38347419427681,3,0,0,5.81685661484281,14.2807791788998,2.45506811057706,1.29576304956184
393,432,619,619,619,P54756,EPHA5,EPHA5_HUMAN,axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P54757}; Single-pass type I membrane protein {ECO:0000255}. Cell projection, axon {ECO:0000250|UniProtKB:P54757}. Cell projection, dendrite {ECO:0000250|UniProtKB:P54756}.",Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7),GO:0005003; GO:0005004; GO:0005005; GO:0005524; GO:0005791; GO:0005886; GO:0005887; GO:0007411; GO:0009897; GO:0019933; GO:0021766; GO:0030424; GO:0030425; GO:0032793; GO:0032956; GO:0043025; GO:0043087; GO:0048013; GO:0048471; GO:0048666; GO:0061178,0.107805118460222,0.229290376492226,0.150658500765125,0.59399545831929,0.701402959091614,0.906355335548228,0.701402959091614,-0.511684577815611,0.571333252413853,0.448251291446118,6.02320167121402,0.00303707024229102,0.041973255592208,-6.00981372628172,114803,1.37702734408618,4,0,0,0.150658500765125,0.701402959091614,4.65558169986766,2.21896143912318
394,433,620,620,620,Q92997,DVL3,DVL3_HUMAN,"cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; Rac GTPase binding [GO:0048365]; signaling receptor binding [GO:0005102]; beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of cellular protein localization [GO:1903827]; response to drug [GO:0042493]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O14641}.,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),GO:0000790; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0016055; GO:0035556; GO:0035567; GO:0038031; GO:0042493; GO:0043507; GO:0043547; GO:0045893; GO:0046982; GO:0048365; GO:0050821; GO:0060070; GO:0060071; GO:0090090; GO:0090179; GO:0150012; GO:1903827; GO:1904886,4.92959183150311E-05,3.92081828381659E-05,4.2736507548343E-05,0.00028629512608088,0.000463439866739,0.00046785508157995,0.000463439866739,-11.075330224270500,0.0003621164885661,0.00022480511385023,6.02165650300353,0.00304011897980946,0.041973255592208,-6.01102835548773,78055,1.37702734408618,7,0,0,4.2736507548343E-05,0.000463439866739,10.8441211817499,3.43884123520926
395,434,621,621,621,Q96SU4,OSBPL9,OSBL9_HUMAN,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid binding [GO:0008289]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699],"SUBCELLULAR LOCATION: Late endosome membrane {ECO:0000269|PubMed:20599956}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:20599956}. Note=Localizes at the Golgi-late endosome interface.",Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),GO:0005794; GO:0005829; GO:0006699; GO:0008289; GO:0015248; GO:0031902; GO:0043231,0.0001188530486215,0.00016350366699057,0.00017609625221383,0.042884641099585,0.0309276687721088,0.0567788139877471,0.042884641099585,-4.543395142910270,0.0433775569638717,0.0218415961378778,6.01734219070109,0.00304865108979076,0.0420232742811738,-6.01442106050245,83185,1.37651011216695,11,0,0,0.00016350366699057,0.042884641099585,262.285500312714,8.03499424440338
396,435,622,622,622,O95373,IPO7,IPO7_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; transporter activity [GO:0005215]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165]; viral process [GO:0016032],SUBCELLULAR LOCATION: Cytoplasm. Nucleus.,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),GO:0005215; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0008536; GO:0008565; GO:0016020; GO:0016032; GO:0030695; GO:0042393; GO:0045087; GO:0045736; GO:0046332,4.03353703845423E-05,2.95074288410443E-05,3.04336482350892E-05,0.00017512984699132,0.00019988000993731,0.00014315569121911,0.00017512984699132,-12.47928739950820000,0.00013929636689569,0.00010307366593473,5.99407845313153,0.00309516091763249,0.0425022586163966,-6.03274837203269,119517,1.37158799045383,23,0,0,3.04336482350892E-05,0.00017512984699132,5.75448088374104,2.52468578757001
397,436,623,623,623,Q9NW61,PLEKHJ1,PKHJ1_HUMAN,"cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]",NA,Pleckstrin homology domain-containing family J member 1 (PH domain-containing family J member 1) (Guanine nucleotide-releasing protein x),GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0042147; GO:0055037,1.06953953364443,1.02591799603504,1.05801774691574,2.24311558916182,2.10772199618765,1.69154450418974,2.10772199618765,1.07568459127746,0.962968937648,1.53264289435574,5.99388874316053,0.00309554371028062,0.0425022586163966,-6.03289805660391,17551,1.37158799045383,3,0,0,1.05801774691574,2.10772199618765,1.99214238355825,0.994320764229491
398,437,624,624,624,Q9UBF2,COPG2,COPG2_HUMAN,"COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; ER to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cytoplasmic vesicle, COPI-coated vesicle membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=The coatomer is cytoplasmic or polymerized on the cytoplasmic side of the Golgi, as well as on the vesicles/buds originating from it. Tends to be more abundant in the trans-Golgi network compared to the cis-Golgi. {ECO:0000250}.",Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP),GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133,0.00228666849694695,0.00017461026364156,0.00010461641983553,0.0146874553608979,0.00878984648423032,0.0112552714687414,0.0112552714687414,-6.4732553358361600,0.0107222260444818,0.00621641141571561,5.9925258122217,0.00309829548792424,0.0425022586163966,-6.03397354311964,97622,1.37158799045383,21,0,0,0.00017461026364156,0.0112552714687414,64.459392214459,6.0103186802237
399,438,625,625,625,Q9GZT9,EGLN1,EGLN1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cAMP catabolic process [GO:0030821]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Nucleus {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Note=Mainly cytoplasmic. Shuttles between the nucleus and cytoplasm (PubMed:19631610). Nuclear export requires functional XPO1. {ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}.",Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20),GO:0001666; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0016706; GO:0018401; GO:0019899; GO:0030821; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043433; GO:0045765; GO:0045944; GO:0051344; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0061418; GO:0071731; GO:1901214,1E-07,1E-07,0.00023423038288962,0.0333393824789884,0.0399285378008417,0.0213108329850187,0.0333393824789884,-4.9066288071886000,0.0314481076273197,0.0158021972746231,5.9780189842874,0.00312776923909472,0.0428379274986413,-6.04543278862587,46021,1.36817154852357,8,2,0,1E-07,0.0333393824789884,333393.824789884,18.3468678570229
400,439,626,626,626,Q14108,SCARB2,SCRB2_HUMAN,"cell surface [GO:0009986]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; action potential [GO:0001508]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; phagocytosis, engulfment [GO:0006911]; positive regulation of neuron projection development [GO:0010976]; production of molecular mediator involved in inflammatory response [GO:0002532]; protein targeting to lysosome [GO:0006622]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of lysosome organization [GO:1905671]","SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18022370, ECO:0000269|PubMed:7509809}; Multi-pass membrane protein {ECO:0000269|PubMed:17897319, ECO:0000269|PubMed:18022370, ECO:0000269|PubMed:7509809}.",Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),GO:0000139; GO:0001508; GO:0001618; GO:0002532; GO:0004888; GO:0005044; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006631; GO:0006911; GO:0009986; GO:0010008; GO:0010976; GO:0016020; GO:0016021; GO:0019899; GO:0030665; GO:0031664; GO:0031902; GO:0043202; GO:0061024; GO:0070062; GO:1904978; GO:1905123; GO:1905671,1E-07,1E-07,1.47727419415309E-05,0.0220775375369982,0.0235275891044204,0.0371241361936118,0.0235275891044204,-5.4095026960419800,0.0275714300310296,0.0137907059294953,5.96157231901137,0.00316159569179185,0.043174825928488,-6.05845079875171,54290,1.36476940473791,11,2,0,1E-07,0.0235275891044204,235275.891044204,17.8439939681696
401,440,627,627,627,Q9NUM4,TMEM106B,T106B_HUMAN,endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; dendrite morphogenesis [GO:0048813]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of dendrite development [GO:1900006],SUBCELLULAR LOCATION: Late endosome membrane; Single-pass type II membrane protein. Lysosome membrane; Single-pass type II membrane protein. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.,Transmembrane protein 106B,GO:0005764; GO:0005765; GO:0005768; GO:0007040; GO:0007041; GO:0016021; GO:0031902; GO:0032418; GO:0048813; GO:1900006,0.0261166645231321,0.049471929470666,0.0518948197653879,0.151856165723562,0.125034705737009,0.185868168931957,0.151856165723562,-2.719222608323250,0.111758542211114,0.0983737423586191,5.96115723447225,0.00316245512350023,0.043174825928488,-6.0587797145669,31127,1.36476940473791,4,0,0,0.049471929470666,0.151856165723562,3.06954200793005,1.6180234138434
402,441,628,628,628,Q9UNF0,PACSIN2,PACN2_HUMAN,caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; transporter activity [GO:0005215]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; membrane organization [GO:0061024]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Early endosome. Recycling endosome membrane. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection {ECO:0000250}. Membrane, caveola. Note=Detected at the neck of flask-shaped caveolae. Localization to tubular recycling endosomes probably requires interaction with MICALL1 and EHD1.",Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II),GO:0005215; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0005925; GO:0008092; GO:0016607; GO:0019898; GO:0030036; GO:0030100; GO:0030659; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045296; GO:0045806; GO:0048858; GO:0055038; GO:0061024; GO:0070062; GO:0070300; GO:0070836; GO:0072584; GO:0097320,1E-07,3.26404428810728E-05,1.04887312649358E-05,0.0208291419494268,0.0163457956386646,0.0111314220928523,0.0163457956386646,-5.9349365871560000,0.0160877101689326,0.00805826480918162,5.94881850419255,0.00318813203411688,0.0434560672166251,-6.06856521948336,55739,1.36194957998058,11,1,0,1.04887312649358E-05,0.0163457956386646,1558.41495275117,10.6058637096978
403,442,629,629,629,Q8NEZ5,FBXO22,FBX22_HUMAN,cytosol [GO:0005829]; nucleus [GO:0005634]; Z disc [GO:0030018]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; cellular response to starvation [GO:0009267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of skeletal muscle fiber development [GO:0048742]; ubiquitin-dependent protein catabolic process [GO:0006511],"SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250}.",F-box only protein 22 (F-box protein FBX22p44),GO:0000209; GO:0004842; GO:0005634; GO:0005829; GO:0006464; GO:0006511; GO:0006913; GO:0009267; GO:0030018; GO:0032436; GO:0043687; GO:0048742,6.7720395963925E-05,1E-07,1E-07,0.0161734105479541,0.010877063971877,0.0203877802030927,0.0161734105479541,-5.9502322523488000,0.01579011144232,0.00791769585314796,5.94623262798964,0.00319354517819848,0.0434566726436629,-6.07061802215957,44508,1.36194352946089,6,2,0,1E-07,0.0161734105479541,161734.105479541,17.3032644118627
404,446,636,636,636,Q9BW62,KATNAL1,KATL1_HUMAN,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; microtubule severing [GO:0051013],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000255|HAMAP-Rule:MF_03024, ECO:0000269|PubMed:22654668}. Cytoplasm {ECO:0000269|PubMed:26929214}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:26929214}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:26929214}. Note=Colocalizes with microtubules throughout the basal and adluminal compartments of Sertoli cells (By similarity). Localizes within the cytoplasm, partially overlapping with microtubules, in interphase and to the mitotic spindle and spindle poles during mitosis (PubMed:26929214). {ECO:0000250|UniProtKB:Q8K0T4, ECO:0000269|PubMed:26929214}.",Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1),GO:0000922; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0042802; GO:0051013,1E-07,5.5849394714794E-05,1E-07,0.00073058213382051,0.00116617799970621,0.00135652699570093,0.00116617799970621,-9.74399627340143000,0.00106574591150429,0.00055155608732374,5.90574703952716,0.00327976348554418,0.0439871324869701,-6.10284903599108,55392,1.3566743486773,10,2,0,1E-07,0.00116617799970621,11661.7799970621,13.5095003908101
405,449,639,639,639,Q12955,ANK3,ANK3_HUMAN,"axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; ER to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:21223964}. Cell projection, axon {ECO:0000250}. Cell membrane, sarcolemma {ECO:0000269|PubMed:21223964}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}. Lysosome {ECO:0000250}. Note=In skeletal muscle, localized at costameres and neuromuscular junctions. In macrophages, associated with lysosomes. {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 5: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:8666667}. Golgi apparatus {ECO:0000269|PubMed:8666667}.",Ankyrin-3 (ANK-3) (Ankyrin-G),GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:1900827; GO:1902260; GO:2000651; GO:2001259,9.74813920089555E-05,0.00010640405336722,0.0001010120758649,0.00045169642450429,0.00035236312450465,0.00055780874732796,0.00045169642450429,-11.11235888567740000,0.0003523235916986,0.00027779430292966,5.90396681238647,0.00328361888541751,0.0439871324869701,-6.10427025300534,480410,1.3566743486773,67,0,0,0.0001010120758649,0.00045169642450429,4.47170717596595,2.16082571823176
406,450,640,640,640,Q9UQ80,PA2G4,PA2G4_HUMAN,"azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Isoform 1: Cytoplasm {ECO:0000269|PubMed:16832058, ECO:0000269|PubMed:19037095}. Nucleus, nucleolus {ECO:0000269|PubMed:16832058, ECO:0000269|PubMed:19037095}. Note=Translocates to the nucleus upon treatment with HRG. Phosphorylation at Ser-361 by PKC/PRKCD regulates its nucleolar localization. {ECO:0000269|PubMed:16832058}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm {ECO:0000269|PubMed:16832058, ECO:0000269|PubMed:19037095}.",Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1),GO:0003677; GO:0003700; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006351; GO:0006364; GO:0006417; GO:0007050; GO:0008283; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0043312; GO:0045597; GO:0045892; GO:0070062,1.21960275573888E-05,1E-07,1E-07,0.00018532451207042,0.0001898448628911,0.00012139606053569,0.00018532451207042,-12.39765866654020000,0.00016138980264661,8.48269105091014E-05,5.90149247975801,0.00328898660467646,0.0439901958375476,-6.10624615417526,43787,1.35664410460697,17,2,0,1E-07,0.00018532451207042,1853.2451207042,10.8558379976714
407,451,641,641,641,Q14576,ELAVL3,ELAV3_HUMAN,AU-rich element binding [GO:0017091]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,ELAV-like protein 3 (Hu-antigen C) (HuC) (Paraneoplastic cerebellar degeneration-associated antigen) (Paraneoplastic limbic encephalitis antigen 21),GO:0007399; GO:0017091; GO:0030154,0.00017811968262625,1E-07,1E-07,0.00362812674313073,0.00555949724866292,0.00680818508578703,0.00555949724866292,-7.49082986028442000,0.0052724964649848,0.00269568812670115,5.89293261686287,0.00330763809389923,0.0441706428764078,-6.1130867020968,39547,1.35486627980784,4,2,0,1E-07,0.00555949724866292,55594.9724866292,15.7626668039271
408,453,647,647,647,A8MW92,PHF20L1,P20L1_HUMAN,"nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]",NA,PHD finger protein 20-like protein 1,GO:0005634; GO:0006355; GO:0046872,0.00013362835689411,0.00017230082323404,5.55134156656227E-05,0.0450089161103948,0.0241794833385877,0.0335625161022598,0.0335625161022598,-4.8970053145159400,0.0341298243184828,0.017185393024506,5.87173524104722,0.00335437961254425,0.0443794273313428,-6.1300598252336,115010,1.35281830616986,8,0,0,0.00013362835689411,0.0335625161022598,251.16312796434,7.97248087451597
409,454,649,649,649,Q9P2Q2,FRMD4A,FRM4A_HUMAN,"adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding, bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cell junction, adherens junction {ECO:0000250|UniProtKB:Q8BIE6}. Cell junction, tight junction {ECO:0000250|UniProtKB:Q8BIE6}. Note=Colocalized with CYTH1 at adherens junction and tight junction. Colocalized with PARD3 during the process of epithelial polarization. {ECO:0000250|UniProtKB:Q8BIE6}.",FERM domain-containing protein 4A,GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0090162,1E-07,1E-07,6.74407398331917E-05,0.00761183946574201,0.00441622031671195,0.00490176074643057,0.00490176074643057,-7.67248421627982000,0.00562072659635045,0.00283291021145295,5.85563835022467,0.0033904086529358,0.0447178706766262,-6.14298079524538,115458,1.34951888435705,12,2,0,1E-07,0.00490176074643057,49017.6074643057,15.5810124479317
410,455,651,651,651,Q8IVU1,IGDCC3,IGDC3_HUMAN,integral component of plasma membrane [GO:0005887]; neuromuscular process controlling balance [GO:0050885],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule),GO:0005887; GO:0050885,8.52905447622209E-06,8.30925063834818E-05,6.35141566997862E-05,0.0324054110416665,0.0250586234671639,0.0459043501196357,0.0324054110416665,-4.9476214559493800,0.0344044163036355,0.0172539200576709,5.839902477774,0.0034260829844298,0.0450495704250677,-6.15563869386689,86724,1.34630934592603,5,0,0,6.35141566997862E-05,0.0324054110416665,510.207687946451,8.99494082779519
411,456,652,652,652,Q2NKJ3,CTC1,CTC1_HUMAN,"CST complex [GO:1990879]; nuclear chromosome, telomeric region [GO:0000784]; nucleus [GO:0005634]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19854130}. Chromosome, telomere {ECO:0000269|PubMed:19854130}. Note=A transmembrane region is predicted by sequence analysis tools (ESKW, MEMSAT and Phobius); however, given the telomeric localization of the protein, the relevance of the transmembrane region is unsure in vivo. {ECO:0000305}.",CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B),GO:0000723; GO:0000784; GO:0003697; GO:0005634; GO:0006974; GO:0010389; GO:0010833; GO:0016233; GO:0032211; GO:0035264; GO:0042162; GO:0045740; GO:0048146; GO:0048536; GO:0048538; GO:0048539; GO:0071425; GO:0090399; GO:0098505; GO:1990879,0.459903887779021,0.441085928234819,0.475436170729363,0.891431900969006,0.705980031201161,0.745761014070744,0.745761014070744,-0.423214715148996,0.322248986499236,0.619933155497352,5.83376005368784,0.00344013136572248,0.0451649148628596,-6.16058683285616,134609,1.34519880408816,3,0,0,0.459903887779021,0.745761014070744,1.62155840358774,0.697380986204459
412,457,653,653,653,Q99569,PKP4,PKP4_HUMAN,cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; cornification [GO:0070268]; keratinization [GO:0031424]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155],"SUBCELLULAR LOCATION: Cell junction, desmosome {ECO:0000269|PubMed:17115030}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:17115030}. Midbody {ECO:0000269|PubMed:17115030}. Cell membrane {ECO:0000269|PubMed:17115030}; Peripheral membrane protein {ECO:0000269|PubMed:17115030}. Note=Associated with the pericentrosomal region in interphase and with spindle poles during mitosis. In anaphase, during chromosome segregation, is recruited to the central microtubule bundle, focussed at the spindle midzone and ultimately localizes to the midbody at cytokinesis. Constituent of the midbody cytoskeletal matrix. Colocalized with desmoplakin at desmosomal junctional plaques in cultured epithelial cells.",Plakophilin-4 (p0071),GO:0000922; GO:0001533; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007043; GO:0007267; GO:0009898; GO:0014069; GO:0030054; GO:0030057; GO:0030155; GO:0030496; GO:0031424; GO:0032467; GO:0043547; GO:0048471; GO:0051233; GO:0070268; GO:0072686; GO:0098609,0.00685952929201213,0.00026172587513799,0.00020274488261766,0.0657302477239382,0.115011604205087,0.119405278700756,0.115011604205087,-3.120148664286950,0.0976077101933379,0.0512451884465916,5.83022690051155,0.00344824362229486,0.0452020909752588,-6.16343485898994,131868,1.3448414749671,11,0,0,0.00026172587513799,0.115011604205087,439.435360162419,8.77950715393381
413,458,655,655,655,P63151,PPP2R2A,2ABA_HUMAN,"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; developmental process [GO:0032502]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine dephosphorylation [GO:0070262]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278]",NA,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha),GO:0000086; GO:0000159; GO:0000184; GO:0000278; GO:0004722; GO:0005654; GO:0005829; GO:0006470; GO:0019888; GO:0032502; GO:0043278; GO:0044877; GO:0048156; GO:0051721; GO:0070262,0.0001578797592608,0.00032298939477542,0.00051853809880216,0.0369201333945323,0.025765812620198,0.0484047876302691,0.0369201333945323,-4.7594484242427600,0.0366971087973871,0.0186816901496397,5.81742456101568,0.00347783270827189,0.0453978051917936,-6.17376587269096,51692,1.34296514309299,7,0,0,0.00032298939477542,0.0369201333945323,114.307571678022,6.836777159911
414,459,656,656,656,Q6N022,TENM4,TEN4_HUMAN,cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell proliferation [GO:0060038]; cell morphogenesis [GO:0000902]; central nervous system myelin formation [GO:0032289]; gastrulation with mouth forming second [GO:0001702]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron development [GO:0048666]; positive regulation of gastrulation [GO:2000543]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; self proteolysis [GO:0097264]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26188006}; Single-pass membrane protein {ECO:0000255}. Cell projection {ECO:0000250|UniProtKB:Q3UHK6}. Nucleus {ECO:0000250|UniProtKB:Q3UHK6}. Cytoplasm {ECO:0000250|UniProtKB:Q3UHK6}.,Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4),GO:0000902; GO:0001702; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007157; GO:0007165; GO:0031641; GO:0031643; GO:0032289; GO:0042803; GO:0043005; GO:0046982; GO:0048666; GO:0048714; GO:0050839; GO:0060038; GO:0060912; GO:0097264; GO:2000543,2.16108933472159E-05,2.37025502292672E-05,2.13417734237328E-05,0.00052729716927578,0.00072811726772899,0.00096591125727471,0.00072811726772899,-10.42354155557260000,0.00071822349242642,0.00038133015187995,5.81688600967804,0.00347908413619353,0.0453978051917936,-6.17420084974292,307957,1.34296514309299,36,0,0,2.16108933472159E-05,0.00072811726772899,33.6921410897061,5.07434020756639
415,460,657,657,657,Q9UPU3,SORCS3,SORC3_HUMAN,integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; neuropeptide receptor activity [GO:0008188]; learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long term synaptic depression [GO:1900452],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,VPS10 domain-containing receptor SorCS3,GO:0007218; GO:0007612; GO:0007613; GO:0008188; GO:0014069; GO:0016020; GO:0016021; GO:1900452,0.0143589680030575,0.0286692414857313,0.0428389994919556,0.0756764288833989,0.0973141477551628,0.08652375103852,0.08652375103852,-3.53075997838878,0.0578823728987791,0.057563589442971,5.8087879735132,0.00349796728934124,0.0455747336328174,-6.18074523421927,135755,1.34127586095353,3,0,0,0.0286692414857313,0.08652375103852,3.01799931057063,1.59359247629652
416,461,658,658,658,P17706,PTPN2,PTN2_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217],"SUBCELLULAR LOCATION: Isoform 1: Endoplasmic reticulum {ECO:0000269|PubMed:7593185}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000269|PubMed:7593185}. Note=Targeted to the endoplasmic reticulum by its C-terminal hydrophobic region. {ECO:0000269|PubMed:7593185}.; SUBCELLULAR LOCATION: Isoform 2: Nucleus. Cytoplasm. Cell membrane. Note=Predominantly localizes to chromatin (By similarity). Able to shuttle between the nucleus and the cytoplasm and to dephosphorylate plasma membrane receptors (PubMed:9488479). Recruited by activated ITGA1 at the plasma membrane. {ECO:0000250, ECO:0000269|PubMed:9488479}.",Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0071345; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587,0.0234434998798996,0.0269377242550567,0.0118036222275902,0.166864118937582,0.0984458445508385,0.148363154558612,0.148363154558612,-2.752795246430420,0.117162757228162,0.0793096607349299,5.79794744031976,0.00352343979905639,0.0458368460181196,-6.18951701760153,48473,1.338785273328,3,0,0,0.0234434998798996,0.148363154558612,6.3285411870528,2.66187297757501
417,462,660,660,660,Q96EZ8,MCRS1,MCRS1_HUMAN,"cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; cellular protein modification process [GO:0006464]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; protein deubiquitination [GO:0016579]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15044100, ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:18922472, ECO:0000269|PubMed:20018852}. Nucleus, nucleolus {ECO:0000269|PubMed:16571602, ECO:0000269|PubMed:9654073}. Cytoplasm {ECO:0000269|PubMed:16571602}. Note=In microspherules in the nucleolus. {ECO:0000269|PubMed:9654073}.",Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),GO:0000123; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006281; GO:0006310; GO:0006351; GO:0006355; GO:0006464; GO:0008266; GO:0010521; GO:0016579; GO:0030425; GO:0031011; GO:0034046; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0051974; GO:0071339; GO:1904357; GO:1904751,8.02792322301168E-05,6.89267431150948E-05,8.24776007766798E-05,0.0587119104027501,0.104376519465907,0.110616158714346,0.104376519465907,-3.260130895049440,0.0911576350022937,0.0456560453598541,5.77327184766581,0.00358226228738844,0.0464178752894961,-6.20953103155207,51803,1.33331474262129,3,0,0,8.02792322301168E-05,0.104376519465907,1300.1683818639,10.3444827601844
418,463,664,664,664,P09001,MRPL3,RM03_HUMAN,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3) (Mitochondrial large ribosomal subunit protein uL3m)",GO:0003723; GO:0003735; GO:0005743; GO:0005762; GO:0006412; GO:0070125; GO:0070126,0.00567557424879144,0.00296891937957513,0.0158096655795802,0.110141570840184,0.0648160593080866,0.110758125212056,0.110141570840184,-3.182569005408120,0.0870871987174602,0.051694985761379,5.74537163194711,0.00365020799217433,0.0470568982123678,-6.23224015837944,38633,1.32737670303439,3,0,0,0.00567557424879144,0.110141570840184,19.4062426130074,4.27844890905825
419,464,665,665,665,Q9UKV8,AGO2,AGO2_HUMAN,"cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; micro-ribonucleoprotein complex [GO:0035068]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II core binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; transcription, DNA-templated [GO:0006351]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:23125361}. Nucleus {ECO:0000269|PubMed:23125361}. Note=Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8.",Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer),GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006351; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035068; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904,2.21767710701711E-05,1.82090127029602E-05,1.4867187775722E-05,0.00014074720325191,0.00016899824294278,0.00021774788563428,0.00016899824294278,-12.53070413251490000,0.0001574134534267,9.71243838963054E-05,5.73648822027762,0.00367216806756897,0.0472688100126171,-6.23948855620752,97208,1.32542533087794,21,0,0,1.82090127029602E-05,0.00016899824294278,9.28102175003186,3.21428364075807
420,465,666,666,666,Q96ST3,SIN3A,SIN3A_HUMAN,"kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810, ECO:0000269|PubMed:16820529}. Nucleus, nucleolus {ECO:0000269|PubMed:16820529}. Note=Recruited to the nucleolus by SAP30L.",Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),GO:0000122; GO:0000776; GO:0000976; GO:0001102; GO:0001103; GO:0001106; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006351; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0031937; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678,0.00039845626386283,0.00030076051888541,0.0002587018677887,0.0392973489732047,0.0612152107825303,0.0349596597491911,0.0392973489732047,-4.6694241992301300,0.0448381002847964,0.0227383563592438,5.71745943831692,0.00371974749036362,0.0478093671434123,-6.25504413504229,145175,1.32048700505851,19,0,0,0.00030076051888541,0.0392973489732047,130.659932090944,7.02967298480181
421,466,668,668,668,O14522,PTPRT,PTPRT_HUMAN,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0045294; GO:0045295; GO:0045296; GO:0070097,0.00059891588966614,5.06331194754731E-05,8.55811407224879E-05,0.0607479769327989,0.0318267612840374,0.0459538132273093,0.0459538132273093,-4.4436716090901500,0.0459311404314272,0.0232106135990016,5.6987718133529,0.0037672007201709,0.0482269343090599,-6.2703595604252,162134,1.31671034444294,21,0,0,8.55811407224879E-05,0.0459538132273093,536.96191519955,9.06867595638166
422,467,670,670,670,Q6ZSY5,PPP1R3F,PPR3F_HUMAN,integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycogen binding [GO:2001069]; protein phosphatase binding [GO:0019903]; regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of glycogen biosynthetic process [GO:0005979],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.,Protein phosphatase 1 regulatory subunit 3F (R3F),GO:0005979; GO:0016020; GO:0016021; GO:0019903; GO:2000465; GO:2001069,0.00023967531623851,0.00020592131311598,0.00052942098300931,0.0178808145020875,0.034407220115594,0.0281412102643227,0.0281412102643227,-5.1511718141217400,0.0264847424232134,0.0135673770823947,5.69581657595212,0.00377477172746147,0.0482269343090599,-6.27278504767643,82798,1.31671034444294,6,0,0,0.00023967531623851,0.0281412102643227,117.413886027038,6.8754592295487
423,468,671,671,671,Q9H1B7,IRF2BPL,I2BPL_HUMAN,extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),GO:0000122; GO:0005615; GO:0005634; GO:0005654; GO:0045944; GO:0046543; GO:0046872,3.5225985899605E-05,1E-07,7.04674132796062E-06,0.046008361113456,0.0354246536947256,0.0238840499295981,0.0354246536947256,-4.8191024400991500,0.0350915640035174,0.0175599062441679,5.69145405069472,0.00378598168329074,0.0482751532224918,-6.27636731790066,82659,1.31627633912128,12,1,0,7.04674132796062E-06,0.0354246536947256,5027.09721359642,12.2955098726843
424,469,672,672,672,P53999,SUB1,TCP4_HUMAN,"extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0001205]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]",SUBCELLULAR LOCATION: Nucleus.,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14),GO:0001205; GO:0003697; GO:0003713; GO:0003723; GO:0005634; GO:0005667; GO:0005730; GO:0006357; GO:0042802; GO:0060261; GO:0060395; GO:0070062,2.39284167583369E-05,0.00026708862409328,9.21207274354181E-05,0.0034152710430491,0.00186617715755481,0.00257787404759953,0.00257787404759953,-8.59960250790689000,0.00249206149330547,0.00137374333608175,5.68996191245854,0.00378982511279375,0.0482751532224918,-6.27759306396516,14395,1.31627633912128,14,0,0,9.21207274354181E-05,0.00257787404759953,27.9836484075396,4.80651216304868
425,470,673,673,673,P06241,FYN,FYN_HUMAN,"actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; T cell receptor binding [GO:0042608]; tau protein binding [GO:0048156]; type 5 metabotropic glutamate receptor binding [GO:0031802]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to glycine [GO:1905430]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]",SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. Note=Present and active in lipid rafts. Palmitoylation is crucial for proper trafficking.,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn),GO:0000165; GO:0001764; GO:0002223; GO:0002250; GO:0004713; GO:0004715; GO:0005088; GO:0005524; GO:0005634; GO:0005739; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0006468; GO:0006816; GO:0007169; GO:0007411; GO:0007417; GO:0007596; GO:0007612; GO:0007631; GO:0008360; GO:0010629; GO:0010976; GO:0014068; GO:0014069; GO:0016477; GO:0018108; GO:0019221; GO:0030154; GO:0030168; GO:0030425; GO:0030900; GO:0031234; GO:0031295; GO:0031397; GO:0031802; GO:0035556; GO:0036120; GO:0038083; GO:0038096; GO:0042110; GO:0042127; GO:0042177; GO:0042531; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0042981; GO:0043014; GO:0043123; GO:0043524; GO:0043548; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046872; GO:0046875; GO:0046934; GO:0048010; GO:0048013; GO:0048156; GO:0048813; GO:0050690; GO:0050730; GO:0050798; GO:0050852; GO:0050900; GO:0050966; GO:0051428; GO:0051897; GO:0070851; GO:0071375; GO:0071560; GO:0090314; GO:0097062; GO:0097386; GO:0097718; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1903997; GO:1904645; GO:1905232; GO:1905430; GO:1905477; GO:1905664; GO:2001056; GO:2001240,0.00562155266171465,8.80867562504496E-05,0.00017644618958321,0.0343469381398628,0.0195712469740601,0.0299635422738084,0.0299635422738084,-5.0606480012661300,0.025998547260061,0.0149613021658799,5.67358578144699,0.00383231780231763,0.0487438935926284,-6.29106175024715,60762,1.31207978294252,7,0,0,0.00017644618958321,0.0299635422738084,169.816884935778,7.40783610333011
426,472,678,678,678,Q9NYB0,TERF2IP,TE2IP_HUMAN,"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q91VL8}. Cytoplasm {ECO:0000250|UniProtKB:Q91VL8}. Chromosome {ECO:0000250|UniProtKB:Q91VL8}. Chromosome, telomere {ECO:0000250|UniProtKB:Q91VL8}. Note=Associates with chromosomes, both at telomeres and in extratelomeric sites. Also exists as a cytoplasmic form, where it associates with the IKK complex. {ECO:0000250|UniProtKB:Q91VL8}.",Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1),GO:0000228; GO:0000723; GO:0000781; GO:0000783; GO:0000784; GO:0001933; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0007004; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0031848; GO:0032204; GO:0032205; GO:0033138; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224; GO:1901985,3.99495553226072E-05,3.29248487676805E-05,3.0160023258021E-05,0.0157826257066783,0.0303403101665156,0.0282975162395896,0.0282975162395896,-5.1431807609607200,0.0247724725618117,0.012420581090022,5.64088537745025,0.00391890364384882,0.0494651824654365,-6.31804560984361,44260,1.30570038457331,15,0,0,3.29248487676805E-05,0.0282975162395896,859.45774388391,9.74728289964938
427,473,681,681,681,O15027,SEC16A,SC16A_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; protein transport [GO:0015031]; substantia nigra development [GO:0021762],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Golgi apparatus membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. Note=SAR1A activity is required to maintain SEC16A localization at discrete locations on the ER membrane perhaps by preventing its dissociation.,Protein transport protein Sec16A (SEC16 homolog A),GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0007029; GO:0015031; GO:0021762; GO:0048208,2.05403036979085E-05,1.63802091616274E-05,5.94699710505928E-06,0.0263632164102301,0.0313593473350524,0.0160163645222725,0.0263632164102301,-5.2453297945421900,0.0245653535858635,0.0122969659629199,5.63388898338992,0.0039377347610146,0.049496342957834,-6.32383441288627,233517,1.30542688777158,29,0,0,1.63802091616274E-05,0.0263632164102301,1609.45541965295,10.6523569007841